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"Well in our country," said Alice, still panting a little, "you'd generally get to 
somewhere else -  if you ran very fast for a long time, as we've been doing." 
"A slow sort of country!" said the Queen. "Now, here, you see, it takes all the 
running you can do, to keep in the same place. If you want to get somewhere 
else, you must run at least twice as fast as that!"
Through the Looking Glass and What Alice Found There
Lewis Carroll, 1871
Summary
The avermectin and milbemycin (AM) class of anthelmintics constitutes a significant 
part of the anthelmintic market and experiments on model organisms 
(Caenorhabditis elegans) suggest that they exert their nematocidal effect by 
irreversibly binding to, and opening, glutamate-gated chloride channels (GluCI). 
Prior to this study, three genes encoding four GluCI subunits, with high levels of 
identity to their C.elegans orthologues, had been identified from the parasitic 
nematode Haemonchus contortus. Only two full-length cDNAs were available, 
however, and there had been no published tests of the ability of the AM to interact 
with recombinant GluCI from parasites. The aim of this thesis was to further the 
understanding of H.contortus GluCI receptors by cloning additional subunits and 
studying their pharmacology in a mammalian expression system.
Northern blot analysis was used in this investigation to confirm that the GluCI 
subunits HG2 and HG3 are the product of an alternatively spliced gene and are 
expressed at similar levels in H.contortus eggs. RT-PCR was employed to amplify 
full-length HG2 and HG5 cDNAs from H.contortus eggs. HG5 cDNA was also 
amplified from ivermectin-resistant adult H.contortus and a comparison with wild- 
type indicated no coding differences.
Gene transfer into mammalian cells was selected as a tool to analyse the 
expression of the GluCI subunits in vitro. The production of stable cell lines 
expressing either HG3 or HG4 polypeptides was attempted. The transcription of the 
GluCI subunit RNA was apparent, but protein was not detected. Each of the four
H.contortus GluCI subunits was therefore transiently expressed in COS-7 cells. As 
predicted by functional data from the C.eiegans orthologues, the HG2 and HG4 
subunits failed to bind [3H] ivermectin. The HG3 and HG5 subunits bound [3H] 
ivermectin with high affinity; the KdS were 70 +/- 16 pM and 26 +/- 12 pM 
respectively. A variety of avermectin derivatives competed for the ivermectin-binding 
site with differing affinities, but none was as effective as ivermectin. No interaction 
was seen between GABA, glutamate, fipronil or picrotoxin and [3H] ivermectin 
binding. The affinity of [3H] ivermectin binding to H.contortus L3 larval membrane 
preparations was re-examined and found to be 70 +/- 7 pM.
The ivermectin-binding capacity of the GluCI subunits appears to be conserved 
across species, however the repertoire and relative importance of those subunits 
may vary. It is probable that the native receptor is heteromeric; this is supported by 
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1. Introduction
1.1 Phylum Nematoda
The name “Nematoda” originates from the Greek nema (thread) eidos (form) 
and the members of this phylum are one of the most successful groups of 
animals. There are over twenty thousand documented nematode species, 
the actual number is estimated to be over 40,000 (Blaxter 1998a), living in a 
diverse range of habitats including the sea, fresh-water and soil and as very 
successful parasites of plants and animals. Almost all are unsegmented, 
spindle-shaped, roundworms with bilateral symmetry, but their life-cycles 
vary enormously; ranging from very simple and direct to extremely 
complicated with the utilisation of a number of hosts (Whitfield, 1993). Most 
share a highly conserved developmental sequence, however, involving 
dioecious adults, although some are hermaphrodite, producing fertile eggs 
which hatch to L1 larvae. These then develop through three more larval 
stages before sexual maturity is reached. Between larval stages, the juvenile 
sheds its cuticle and there is an increase in body size. Under conditions of 
reduced food, an additional stage, the non-developing dauer, is formed at 
the second larval moult. The dauer larvae store food reserves and can 
survive adverse conditions for many months. When food becomes available, 
they moult to normal L4 larvae.
1.1.1 Anatomy
Nematodes share a common anatomical structure (figure 1) of two 
concentric tubes, the body wall and the gut, separated by the pseudocoelom. 
The body wall is composed of the cuticle, hypodermis and musculature. The 
multi-layer, non-cellular cuticle covers the body and is overlaid with a 
carbohydrate-rich surface coat that may be important in evasion of the host 
immune response in parasitic species. Surface invaginations of the body wall 
are also lined with cuticle (Whitfield, 1993). The somatic musculature is 
similar in structure to vertebrate striated muscle and insect flight muscle, A H 
and I bands are present and Z are absent, but the rows of filaments are
l
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Figure 1 Schematic diagram of general nematode morphology (Whitfield, 1993).
offset. The neuromuscular processes are unlike those found in other 
animals, in that they run from muscles to nerves. The body wall encloses a 
fluid-filled cavity, the pseudocoelom, and these act together as an 
hydrostatic skeleton. The musculature is composed only of longitudinal 
strands and therefore movement is achieved by a co-ordinated sinusoidal 
wave of muscular contraction operating against internal hydrostatic pressure. 
Contraction is in the dorso-ventral plane and each muscle is connected only 
to its own nerve cord, i.e. dorsal muscle synapses with dorsal nerve cord, 
allowing contraction of one muscle while the other relaxes (Chappell, 1993; 
Martin et al., 1996). Nematodes have a complete digestive system with an 
anterior mouth and an anus near the posterior tip. The buccal cavity is 
between the mouth and pharynx and is very variable between species and 
an important taxonomic tool. Pharynxes also vary considerably between 
orders and species and this can largely be correlated with feeding habits. 
The pharynx is a pumping organ that sucks food into the alimentary canal 
and forces it into the intestine. This highly muscular, cuticle-lined device is 
cylindrical with one or more enlargements (bulbs). Rapid contraction of the 
buccal muscle and anterior pharyngeal muscle causes the mouth to open 
and dilates the anterior of the pharynx, sucking in food. The high hydrostatic 
pressure in the pseudocoel closes the mouth and oesophageal lumen when 
the muscles relax. Food passes down the pharynx by waves of muscle 
contraction extending towards the posterior of the worm until the intestine is 
reached. The intestine extends from the pharynx to the rectum. It is non- 
muscular and food is pushed towards the rectum as the pharynx pumps in 
more food. When the anus opens, hydrostatic pressure causes defecation.
1.1.2 Classification
The most frequently used system of classification of nematodes is based on 
morphological traits such as structure of the pharynx or host specificity. 
Figure 2a indicates the traditional division of the phylum into two classes, 
Secernentea and Adenophorea based on the presence or absence of causal 
sense glands (Dorris et a i , 1999). However, as phasmids are often difficult 






















Figure 2a A ciadogram representing the “traditional” nematode classification. 
Species are divided into two classes, Secernentea and Adenophorea, depending on 
the presence or absence of phasmids. From Dorris et ai, 1999.
Advances in molecular techniques have allowed an alternative method of 
classification to evolve. This phylogenetic analysis questions the original 
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Figure 2b Phylogenetic classification of Nematoda. Five major clades are identified 




Adenophorea (figure 2b). Blaxter et a i (1998) discuss phylogenetic 
characterisation using small subunit rRNA and small subunit rDNA. 
Molecular phylogenic analysis allows the comparison of all taxa with a single 
defined measurement and is claimed to be a more “natural” classification 
system (Dorris et al., 1999; Blaxter et ai, 1998). Although there are a 
number of similarities shown by the two classification systems, significant 
differences are also seen. Due to constraints of culturing parasitic species, 
free-living counterparts are often used for initial characterisation. The choice 
of classification method may therefore dictate how indicative the model will 
be of the parasitic species (Nielsen, 1998). For example, when using the 
original, morphological method of classification, the free-living nematode 
Caenorhabditis elegans appeared closely related to Strongyloides sp., but 
when the phylogenetic method was used it was apparent that Panagrellus 
sp. might be a better comparative model for the order Strongyloides. 
C.elegans was most closely related to the order Strongylida. Expressed 
sequence tags (EST) projects on a number of nematode species will allow 
further investigation into the molecular evolution of nematodes.
1.1.3 Caenorhabditis elegans
The free-living soil nematode C.elegans has been used as a model system 
in research for many years. This small nematode (1.5 mm long) can easily 
be maintained in the laboratory as thousands of animals can be grown on a 
single petri dish seeded with a lawn of E.coli and incubated at 20°C (Riddle 
et a i, 1997; Hope, 1999). The life cycle is rapid, approximately 3.5 days from 
egg to adult, and 300-350 progeny are produced by a single individual. The 
presence of male and hermaphrodite worms allows both inbreeding and 
cross-fertilisation of strains, offering workers an excellent tool for genetic 
studies. The life cycle is broadly similar to all nematodes including fertile 
eggs, four larval stages and adults.
Transformation, reverse-genetic and laser ablation technologies are well 
developed and have extended the usefulness of this model. The production 
of C.elegans mutant strains has introduced functionality into our knowledge 
of this nematode and the complete sequencing and physical mapping of the
6
C.elegans genome initiated projects to generate a mutant strain for each 
gene identified (Hope, 1999). As C.elegans can be viably stored for many 
years, a bank of mutants will be readily available for all workers. Analysis of 
gene function has recently progressed due to the discovery of RNA-mediated 
interference (RNAi) (Kuwabara and Coulson, 2000). This technique involves 
the disruption of a C.elegans gene by injecting sequence-specific double­
stranded RNA into germline syncytium; soaking worms in dsRNA or feeding 
with E.coli expressing C.elegans dsRNA also results in RNAi. The injected 
animal and their offspring express the mutant phenotype, although this does 
not transfer to subsequent generations, allowing easy investigation of loss- 
of-function phenotypes and a novel tool for drug or vaccine target 
candidates.
1.1.4 Parasitic nematodes
Nematodes are serious pathogens of plants, humans and animals. Plant 
parasites cause damage to flowers, roots, stems and leaves and cause 
estimated losses of US$100 billion to agriculture worldwide (Lilley et al., 
1999). Human parasites cause a horrific number of diseases resulting in 
serious pathologies and contributing a great deal to the death toll of 
developing countries. Animal parasites are responsible for vast losses to the 
agricultural economy, through both production losses and control, and also 
infect companion animals. Zoonotic infections, whereby parasites are passed 
between vertebrate animals and man, can also result in pathology.
1.1.4.1 Animal parasites
The large intestinal roundworm Ascaris suum (15-40 cm long) is the 
causative agent of ascariasis in pigs and is closely related to the human 
nematode species Ascaris lumbricoides. The parasite has a direct life cycle 
with infection due to ingestion of fertilised eggs through contaminated food or 
drink (Whitfield, 1993; Smyth, 1994). The larvae hatch in the intestine and 
penetrate the intestinal wall before travelling to the liver, heart, lung, trachea, 
and larynx before returning to the small intestine where they develop into 
adults. The female can lay 200 to 200,000 eggs per day, which are released 
in the faeces and can survive up to 7 years. The main pathology is caused
7
by the adult worms and consists of diarrhoea, fever, malnutrition and 
intestinal obstruction. Migration of juveniles through the lung can cause 
allergic broncho-pneumonia in previously infected individuals. The large size 
and relative abundance of this parasite has allowed characterisation of its 
structure and physiology (Brownlee et a!., 2000). Much of the information 
regarding nematode neurobiology originated from Ascaris (Section 1.3).
The filarial worm Dirofilaria immitis occurs in carnivores in the chambers of 
the right side of the heart and adjacent blood vessels, including the 
pulmonary artery (Smyth, 1994). Microfilariae are carried from the heart, 
through the lungs, the left side of the heart and into the systemic circulation 
from where they are ingested by mosquitos during a blood meal. Juveniles 
moult and develop in the mosquito and infective L3-stage larvae migrate to 
the mouthparts of the host and infect their vertebrate host when the mosquito 
feeds. Juveniles spend about 80 days in the subcutaneous tissues and 
muscles before entering the heart as fourth-stage larvae. Pathogenicity is 
positively correlated with worm burden. Up to 60 worms cause circulatory 
problems and over 100 worms cause blockage of the right side of the heart 
and the pulmonary artery causing systemic degeneration. Zoonosis can 
occur if infected mosquitos feed on humans.
Members of the Family Tristrongylidae are parasites of the small intestine of 
vertebrates and a major agricultural problem. As several species have similar 
life cycles, a host can be infected with large numbers of multiple species, 
giving rise to severe pathologies and even death. In 1994, it was estimated 
that sheep roundworms cost the Australian grazing industry $222 million in 
production losses, including meat loss, wool loss and mortality (McLeod,
1995). This family includes the blood-feeding parasites of ruminants 
Haemonchus contortus and Ostertagia spp. Ostertagia are small reddish- 
brown worms found in the abomasum of ruminants in temperate climates. 
The life cycle is similar to H. contortus (section 1.1.5) but the L3 burrows into 
the gastric glands where it moults into immature adults before emerging and 
maturing to adult on the mucosal surface. A number of Tristrongylid 
nematodes exhibit “arrested development” whereby the life cycle is halted at
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one or more stages if conditions are not optimal. The developmental cycle is 
completed when optimal conditions are perceived.
1.1.5 Haemonchus contortus
H.contortus is a haematophagous tristrongylid that lives in the abomasum of 
sheep and other ruminants (Smyth, 1994) (Figure 3). Sexual dimorphism is 
seen and the white ovaries of the large female wrap around her red intestine 
(due to blood-feeding) leading to a striped appearance and the common 
name of “barbers pole worm”.
Figure 3 H.contortus attached to host abomasum. The female worm can be 
identified by her striped appearance.
This species infects sheep, goats, cattle and wild ruminants and costs the 
grazing industry millions of dollars per annum in production losses and 
treatment (McLeod, 1995). Adults live buried in the host abomasum and feed 
on blood; a single worm is thought to consume approximately 15 pi of blood 
per day. Each host may be infected with thousands of worms and medium 
infections cause anaemia and loss of condition whereas heavy infections can 
cause death. Lambs are particularly susceptible to infection, while animals 
over 6 months tend to develop an acquired immunity to H.contortus. A 
phenomenon known as “self cure” is often seen in endemic areas whereby
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sheep develop an egg producing infection, but periodically expel adult 
worms.
Female H.contortus are prolific egg producers, with estimates of moderate
infections resulting in ten million eggs released per day, and these fertile 
eggs are expelled in the host’s faeces (figure 4).
parasitic
L3 ingested by 






L3 on blades of 




Figure 4 Life cycle of the sheep parasite Haemonchus contortus
The early larval stages are microbivorous and develop in the dung, in 
favourable climatic conditions. The third larval stage retains its sheath and is 
unable to feed, but survives by slow metabolism of stored food reserves. 
This stage is positively geotrophic and climbs up grass stems from where it is 
accidentally ingested by grazing animals. Exsheathment takes place in the 
forestomachs and on reaching the abomasum, it undergoes the third and 
fourth moults and becomes sexually mature.
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Resistance to infection has been associated with an increase in serum 
antibodies, particularly IgA and IgG, and specific IgE responses to excretory- 
secretory antigens (Newton and Munn, 1999; Schallig, 2000). A type I 
immediate hypersensitivity response is suggested to play a leading role in 
worm expulsion (Schallig et al. 1997; Miller 1984; Miller, 1996) and 
eosinophils are thought to be involved in eliminating L3 in immune sheep 
(Meeusen, 1999). Young lambs are generally unresponsive to H. contortus 
challenge (Manton et al. 1962; Urquhart et al, 1966; Colditz et al, 1996) and 
this has been attributed, at least in part, to their lack of a Th2 immune 
response (Schallig et al. 1997; Gill et al. 1993), which may be due to their 
relatively low numbers of CD4+ T cells (Watson et al, 1994).
1.2 Control of parasitic nematodes
The World Health Organisation has instigated the control of many human 
parasitic nematode diseases in the last decade, through the development of 
integrated control strategies (W.H.O.,1998 , 1999, 2000). These commonly 
combine a number of control methods including education, to prevent 
transmission and infection and to alert people in endemic areas to signs of 
infection, vector targeting and drug therapy. Programs targeting the 
invertebrate host, thereby breaking the transmission cycle, have proved 
effective for many serious diseases including onchocerciasis, dracunculiasis 
and lymphatic filariasis. Drug treatment involves serial administration of one 
or more of the classes of anthelmintic (section 1.2.3). As this thesis will focus 
on the nematode parasites of ruminants, all further discussion of control 
methods will concentrate on these parasites.
1.2.1 Biological control
Increasing levels of resistance to the commercially available anthelmintics 
drugs (see section 1.2.4) has catalysed the development of additional 
control methods. Biological control methods are particularly attractive to 
organic farms as the preventative use of anthelmintics is banned (Larsen, 
1999). It is improbable, however, that biological control (B.C.) would replace
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chemotherapy as a control method; the levels of efficacy are not as high and 
not all life cycle stages are targeted. One element of the concept behind 
B.C. is that as some infective stage larvae are still viable, ruminants obtain a 
low level parasitic infection, which is enough to induce the development of 
acquired immunity but not to produce the morbidity and mortality associated 
with large worm burdens. B.C. is proposed as a component of an integrated 
control strategy, which may also involve pasture rotation, vaccines and 
dietary elements.
The most promising candidates for use in B.C. are the nematophagous 
trapping fungi (Thamsborg et al, 1999; Larsen, 1999). A number of species 
occur naturally in the dung and are able to survive the ruminant 
gastrointestinal tract (Hay et al, 1997). Duddingtonia flagrans has emerged 
as the most successful agent on numerous occasions (Thamsborg et al, 
1999, Larsen, 1999; Gronvold et al/, 1993, Githigia et al/, 1997) and can 
control larval stages in the dung thereby reducing the number of infective- 
stage larvae on the pasture. A number of studies on the effect of D.flagrans 
on tristrongyle parasites of cattle (Gronvold et al., 1993) and sheep (Githigia 
et al. 1997) show fewer larvae on pastures and lower worm burdens in 
fungal spore fed animals as compared to controls. There are still a number 
of issues to be resolved before commercial use of fungi as control agents is 
a viable option. These include the lack of suitable application system, lack of 
data from tropical and sub-tropical areas, dearth of knowledge regarding the 
long-term impact on the environment and non-target organisms and the 
acceptance by farmers of a non-chemical parasite control strategy.
1.2.2 Vaccines
A number of strategies for vaccine development have evolved during the 
past few years, particularly as DNA recombinant technology has advanced, 
however no new commercially available vaccines against nematodes have 
been developed for many years. There are presently two commercially 
available vaccines, which are based on attenuated larvae and target 
Dictyocaulus viviparous in cattle (Jarrett et al., 1958) and D.filaria in sheep 
(Sharma etal, 1988). Irradiated H.contortus larvae protect mature sheep
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from H.contortus infection but not young lambs, who are the major victims 
(Knox, 2000). Vaccines incorporating natural antigens, which are exposed to 
the host and evoke an immune response during an infection, are under 
investigation (Knox, 2000; Newton and Munn, 1999). For example, it is 
known that antibody-secreting cells are recruited to the site of a pathogenic 
infection. These can be harvested following infection and maintained in vitro 
for a few days. Secreted antibodies can be used to probe western blots of 
parasites allowing the detection and characterisation of antigens. This 
method has been used to identify protective antigens from H.contortus 
(Jacobs et al., 1999) and Teladorsagia circumcincta (Meeusen, 1996). 
Another example of a potential vaccine based on H.contortus natural 
antigens is demonstrated by Schallig et al. (1997). Adult and L4 stage larvae 
express 15 and 24 kDa excretory/secretory antigens, identified by comparing 
serum antibody responses of partly immune sheep to primary and secondary 
infection. These antigens induce a protective immune response in sheep 
and as they have been fully cloned they are being tested in recombinant 
form.
Vaccines are also being developed which are based on “novel” antigens, 
which are not exposed to the host during infection and therefore do not 
result in an immune response. Within the numerous hidden antigens 
discussed in the literature (reviewed Knox, 2000; Newton and Munn, 1999) 
there are a number of protective vaccines based on H.contortus gut 
antigens. The most promising candidate for commercial development is the 
H11 antigen, which is an integral membrane glycoprotein (Munn et al., 
1997). This is expressed only in the microvilli of parasitic stage H.contortus 
and is an effective immunogen in young lambs (Andrews et al., 1995; Munn 
et al., 1997) across all breeds tested and is competent against anthelmintic 
resistant worms (Newton and Munn, 1999). All three isoforms of H11 have 
been cloned and expressed in the baculovirus-s/9 insect cell system as full- 
length recombinant proteins and vaccine trials are ongoing for fragments of 
the extracellular domain expressed in E.coli. Homologous proteins have 
been identified in other gastrointestinal species and these have also shown 
promise as protective candidates.
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A commercially viable vaccine would need to target multiple species of 
gastrointestinal nematode, be cost-effective and be accepted into farm 
management strategies (Knox, 2000). It is unlikely that a vaccine would be 
100% efficacious, but vaccination effects persist for longer than drug 
treatment and long-term benefits may therefore be greater (Newton and 
Munn, 1999). Recent advances in recombinant DNA technology, in addition 
to increasing levels of resistance to all modern anthelmintics, have made the 
development of a successful vaccine a more likely scenario.
1.2.3 Chemical control
Chemotherapy is by far the most frequently used method of control of 
nematodes, because wide-spectrum anthelmintics with high potency are 
commercially available allowing up to 100% removal of worms. The target 
sites of all modern anthelmintics are pharmacologically distinct from the 
host, or unique to the parasite, resulting in low host toxicity. There are four 
major classes of anthelmintic drug used in the field: the benzamidazoles, the 
imidazothiazoles and tetrahydropyrimidines, piperazine and the avermectins 
and milbemycins, although piperazine is not as effective as the other classes 
and therefore does not comprise a significant part of the market. In 1996, 
parasiticides accounted for 13% and 39% of the world livestock and 
companion animal product sales respectively (Witty, 1999). The major part 
of the market was composed of the imidazothiazoles/tetrahydropyrimidines 
(US$260 million), benzimidazoles (US$365 million) and the avermectins and 
milbemycins, which commanded the greatest proportion by far at US$995 
million. The most recent introduction of a new class of drugs into the market 
was in 1981 with the development of the broad-spectrum anthelmintic 
ivermectin. The high potency, broad-spectrum of activity and low host toxicity 
of these anthelmintics has led to their dominance of the market. In 1996, the 
cost of discovering and developing a new animal drug was estimated at 
US$57 million and the time-scale from idea to launch is likely to be about 10 
years (Witty, 1999). It is therefore clear why very few pharmaceutical 
companies commit to the discovery of new classes of anthelmintic when the 
development of new analogues of an existing class is still a viable option.
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However, the widespread development of anthelmintic resistance (see 
section 1.2.4) and the toxicity of the avermectins and milbemycins to non- 
target organisms in the environment (Wall and Strong, 1990) mean that new 
classes of drug and/or alternative control strategies are urgently required.
The benzamidazoles, including thiabendazole, mebendazole, albendazole 
and fenbendazole, are broad-spectrum antheimintic agents of 
gastrointestinal parasites and are composed of a bicyclic ring system in 
which benzene has been fused to the 4- and 5- position of the heterocycle 
(figure 5) (De Silva et al., 1997).
Figure 5 The chemical structures of commonly used benzamidazoles. A 
albendazole; B fenbendazole; C:mebendazole; D thiabendazole.
The potent anthelmintic thiabendazole was introduced in 1961 and the mode 













investigated. The benzamidazoles selectively bind to nematode p-tubulin 
inhibiting its polymerisation with a-tubulin to form microtubules but without 
affecting host p-tubulin (Lacey, 1990; Lubega and Prichard, 1991a). Initial 
reports of the action of benzamidazoles indicated that nematode intestinal 
damage was observed following treatment with mebendazole (Martin et al., 
1997a; Van den Bossche et al. 1982). A loss of cytoplasmic tubules, loss of 
transport of secretory vesicles and inhibition of glucose uptake was 
associated suggesting the worms died of starvation (Beugnet et al., 1996; 
Lacey, 1990). Many of the observed structural change to the intestine are 
likely to be a direct result of the inhibition of the microtubule polymerisation. 
(Beugnet et al., 1996; Jasmer et al., 2000; Lacey, 1990), however, the 
inhibition of secretory vesicle transport in the intestine may also play a role 
in intestinal damage by initiating the release of digestive enzymes that 
damage the intestinal cells. This damage could inhibit the digestion and 
absorption of food and cause starvation. Evidence from C.elegans suggests 
that benzamidazoles also interfere with the proper formation of oocytes 
(Enos and Coles, 1990; Bernt et al., 1998). As an intact cytoskeleton is 
essential for successful meiosis this is consistent with their interaction with 
microtubules. Mitochondrial damage has also been observed (Beugnet etal.,
1996) and McCracken and Sillwell (1991) suggest an uncoupling of oxidative 
phosphorylation.
1.2.3.2 Piperazine
Piperazine is composed of a heterocyclic ring without a carboxyl group 
(figure 6), unlike GABA, and acts as a simple GABA antagonist, gating 
GABA receptors on nematode somatic muscle (Geary et al, 1992; Martin, 
1982; Martin, 1985; Martin et al., 1996). An increase in chloride conductance 
of the muscle membrane and a reduction in excitability are observed 
resulting in the relaxation of body muscle and flaccid paralysis.
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Figure 6 The chemical structure of piperazine.
Piperazine is effective against large gastrointestinal nematodes and its 
activity is potentiated by high pC02. It is suggested that C 02 may interact 
with the heterocyclic ring of piperazine and substitute for the carboxyl group 
of GABA (Geary et a/., 1992). This drug is 100 times less potent than GABA, 
with higher concentrations of piperazine required for the same channel 
opening rate in Ascaris muscle and a shorter mean duration of channel 
opening than GABA (Martin, 1985; Martin et al., 1996). Piperazine is of 
relatively little importance in nematode control, as other anthelmintics are 
more broad spectrum and more potent (Geary et al., 1992). This is illustrated 
by no mention of this drug in the major constituents of the livestock 
anthelmintic market (Witty, 1999).
1.2.3.3 Imidathiazoles and tetrahydropyrimidines
The structure of some of the imidathiazoles (levamisole) and the 
tetrahydropyrimidines (pyrantel, morantel) is shown in figure 7.
These compounds all act at the acetylcholine receptors of nematode muscle 
causing contraction and spastic paralysis at therapeutic concentrations. This 
has been demonstrated in many species including A.suum (Aubry et al., 
1970) H.contortus (Sangster et al., 1991) and C.elegans (Lewis et al., 1980). 
Application of levamisol, pyrantel or morantel to A.suum muscle cells 
resulted in depolarisation, increased spike frequency, contraction and an 
increase in input conductance of the membrane to sodium and potassium 
ions (Aubry et al., 1970; Harrow and Gration, 1985). The same effect was 





Figure 7 The chemical structures of some nicotinic anthelmintics. A levamisole; B 
morantel; C pyrantel.
Simultaneous application of acetylcholine and pyrantel indicated that both 
agonists act at the same nicotinic receptor. Patch clamp studies supported 
these findings as these anthelmintics were seen to open non-selective cation 
channels with similar properties to acetylcholine (Robertson and Martin, 
1993; Robertson et al, 1994; Dale and Martin, 1995; Evans and Martin, 
1996; reviewed Martin et al., 1998). Lewis et al. (1980, 1987a, 1987b) show 
further evidence for the action of levamisole at nicotinic acetylcholine 
receptors as C.elegans mutants lacking this receptor were not paralysed by 
levamisole and showed a decrease in binding of [3H] m-aminolevamisole. 
[3H] m-aminolevamisole binding in wild-type C.elegans was inhibited by 
acetylcholine and a range of nicotinic agonists. Three of the eleven genes 
responsible for levamisole resistance in C.elegans have been shown to
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encode subunits of the nicotinic acetylcholine receptor (Fleming et al, 1997). 
When expressed in Xenopus oocytes, these subunits encode channels 
gated by levamisole and currents are blocked by the nicotinic antagonists d- 
tubocurarine and mecamylamine. Levamisole and pyrantel have only low 
activity at vertebrate nicotinic receptors (Aubry et al., 1970) and this 
selectivity allows nematodes to be killed with low host toxicity.
1.2.3.4 Avermectins and milbemycins (AM)
The avermectins and structurally related milbemycins are extremely potent 
anthelmintics and insecticides with a broad spectrum of activity in a wide 
range of hosts. The original compounds were natural fermentation products 
isolated from a novel Streptomyces species, termed S.avermitilis to indicate 
the creation of a “wormless” environment, from a Japanese soil sample. The 
name “avermectin” was developed to denote their potent activity against 
both worms and ectoparasites (Campbell, 1981). The compounds are 
composed of a 16 membered lactone ring (figure 8) and the avermectins 
have a dissacharide substituent at C-13. Ivermectin, a semi-synthetic 
analogue produced from the natural avermectin B1, was the first of these 
compounds to be released as a commercial anthelmintic, in 1981, and still 
commands a large percentage of the market (Chabala et al., 1980; 
Campbell, 1981). The AM are used in both human and veterinary medicine 
and are active against most gastrointestinal nematodes and the larval stages 
of filarial worms. A number of the WHO control programs, including that for 
river blindness, include annual dosing with ivermectin. The lack of activity 
against adult filarial worms, although there is evidence of reduced fecundity, 
is not understood and has maintained a research effort for alternative 
chemotherapy (reviewed McKellar and Benchaoui, 1996; Campbell and 
Benz, 1984; Grant, 2000). The AM show 99% efficacy against Gl parasites 
of cattle and sheep including Haemonchus contortus (Campbell and Benz, 












Figure 8 Structure of some of the avermectins and milbemycins. A abamectin; B 
doramectin; C ivermectin; D milbemycin D.
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Numerous studies have demonstrated that the AM increase the chloride ion 
permeability of nematode muscle causing paralysis, which is recorded as 
neither flaccid nor tetonic (Martin, 1996; Martin and Pennington, 1989; Kass 
et al., 1980; Geary etal., 1992; Geary etal., 1993; Gill etal., 1995; Martin et 
al., 1996). There has been some controversy over the site of action of the 
AM. Initial reports implicated activity at GABA-gated ion channels as 
application of avermectin B1a blocked transmission between an interneuron 
and an excitatory motorneuron in the ventral nerve cord in Ascaris (Kass et 
al., 1980; Kass et al., 1984). This block could be due to a number of factors 
including attenuation of an electrical signal down the excitatory interneuron 
before the motorneuron synapse is reached or inhibition at the excitatory 
interneuron and motorneuron synapse. Either way, the avermectins were 
shown to stimulate inhibitory neurones and their effect was reversed by the 
ligand-gated chloride channel blocker picrotoxin. At this time GABAergic 
neurons had been shown to be present in nematodes and therefore research 
concentrated on the effects of the AM on GABA receptors. They were 
observed to non-competitively block GABA receptors in Ascaris muscle at 
micromolar concentrations (Holden-Dye et al., 1988; Holden-Dye and 
Walker, 1990), but had no effect on resting cells.
Martin and Pennington (1989) demonstrated essentially irreversible gating of 
GABA-independent chloride channels in A.suum muscle membrane at low 
nM concentrations of ivermectin as well as an antagonistic effect at GABA 
receptors at micromolar concentrations. The high concentrations of drug 
required to affect GABA receptors decree them unlikely candidates for the 
therapeutic mode of action of these anthelmintics. Concurrent work by 
Schaeffer and Haines (1989) identified a single high affinity ivermectin 
binding site in crude membrane preparations from C.elegans (Kd = 0.26 nM). 
The binding was a two-step mechanism with a fast reversible complex 
initially formed and following further incubation with ivermectin this converted 
to slowly reversible complex (Schaeffer and Haines, 1989; Cully and Paress, 
1991). Competition studies with several avermectin derivatives showed 
comparable results with their nematocidal activity suggesting this as a 
physiologically relevant site of action. Ivermectin binding with these
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therapeutically relevant concentrations demanded further investigation and 
injection of Xenopus oocytes with size fractionated poly [A]+ yielded 
ivermectin-sensitive irreversible chloride currents which did not respond to 
GABA (Arena et al., 1991). Glutamate was also shown to activate chloride 
currents when applied to oocytes expressing the same poly [A]+ RNA 
fractions forming a reversible complex which desensitised in the continued 
presence of glutamate (Arena et al., 1992). These currents were blocked by 
both picrotoxin and the non-selective chloride channel blocker flufenamate.
In addition to direct activation of glutamate-sensitive channels, ivermectin 
also potentiated the response to glutamate and slowed the desensitisation of 
the glutamate-sensitive current as well as showing the same pharmacology 
and current-voltage relationships as glutamate. This evidence indicated 
activation of the same chloride channel by glutamate and ivermectin and 
denoted a novel ion channel, the glutamate-gated chloride channel (GluCI) 
(section 1.3.3.2.3). The first GluCI subunit cDNAs, a  and p, were discovered 
by library screening of C.elegans size fractionated RNA (Cully et al., 1994). 
Expression of homomeric channels resulted in ivermectin- (alpha) or 
glutamate- (beta) sensitive chloride currents. Co-expression in Xenopus 
resulted in avermectin and glutamate sensitive chloride channels with similar 
properties to expressed C.elegans poly [A]+ RNA and sequence analysis 
indicated homology to mammalian glycine receptors. A strong correlation 
was observed between the activation and potentiation of glutamate sensitive 
chloride currents and the nematocidal activity of a number of AM. This was 
also seen in oocytes expressing C.elegans poly [A]+ substantiating the role 
of the GluCIs as the primary site of action of the AM (Arena et al., 1995). 
Inactivation of the C.elegans GluCIa gene did not ablate ivermectin binding 
indicating the presence of additional GluCI subunits (Vassilatis et al., 
1997b). Further GluCI genes have been identified from C.elegans (Laughton 
et al., 1997a; Horoszok et al., in press; Dent et al., 1997; Dent et al., 2000; 
Cully et al., 1996) and parasitic nematodes (Delany et al., 1998; 
Jagannathan etal., 1999; Forrester etal., 1999).
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A number of mechanisms appear to be involved in the nematocidal activity of 
the AM. Inhibition of motility and pharyngeal pumping have been reported in 
both C.elegans and parasitic nematodes, but the relative importance of the 
two sites of action remains unclear and may vary between species (Gill and 
Lacey, 1998). Pharyngeal pumping is inhibited by low concentrations (nM) of 
AM in C.elegans (Avery and Horvitz, 1990), H.contortus (Geary et al., 1993; 
Paiement et al., 1999) and A.suum (Martin, 1996; Brownlee et al., 1997) and 
this would result in starvation and destruction of the hydrostatic pressure 
required for many of the nematode body functions. Martin (1996) 
demonstrated that this inhibition is caused by irreversible activation of 
chloride channels, which are also gated by glutamate. Differences in life­
style at the different developmental stages may dictate altered effects of AM, 
but Gill et al. (1995) showed arrested development of H.contortus L1-stage 
larvae following AM treatment, which would result from starvation, and 
treatment of adults with biologically relevant (nM/pM) concentrations of AM 
(Geary et al., 1993; Paiement et al., 1999) also results in cessation of 
ingestion, as measured by [3H] inulin uptake. AM effects on motility are only 
seen at higher concentrations (high nM, pM) and paralysis is restricted to the 
mid-body region, while the head and posterior regions retain normal motility 
(Geary et al., 1993; Gill et al., 1995). The structure/activity relationships of 
different AM on motility and pharyngeal activity were comparable in both
C.elegans and H.contortus, suggesting a common site of action. Considering 
the high potency of the AM, and therefore the low concentrations which are 
required for nematode control, it appears feasible to deduce that the 
nematocidal activity of the AM is due to hyperpolarisation of pharyngeal 
muscle resulting in starvation rather than inhibition of motility.
Host drug metabolism and exposure of parasitic nematodes to AM in vivo 
may affect nematocidal activity and therefore investigation of the in vivo 
effects of the AM was required to substantiate this hypothesis (Gill and 
Lacey, 1998). Rapid expulsion of some tristrongylid gastrointestinal sheep 
nematode species following ivermectin treatment, at approximately the flow 
rate of the digesta, suggested that paralysis of somatic muscle, required to
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maintain position in the digestive tract, was the crucial mode of action of 
ivermectin, at least in these adult gastrointestinal parasites. Mild inhibition of 
motility, as caused by nM concentrations of ivermectin, would probably be 
adequate to dislodge Gl nematodes from the gut. Expulsion of one species, 
however, took longer suggesting different toxic modes of action of the AM in 
different species. Localisation of GluCI subunits in C.elegans (Laughton et 
al., 1997b; Dent et al., 1997) has shown expression of GluClp promoter and 
GluCla2 in the M4 and M5 pharyngeal muscle cells that form synapses with 
the glutamatergic inhibitory M3 motorneuron. Weaker expression of GluC!a2 
(avr-15) and the avr-14 gene products was observed in the dorsal and 
ventral nerve cords. This agrees with the observed effect of AM on free- 
living nematodes and free-living stages of parasitic nematodes.
Reduced fertility of female worms is also apparent following treatment with 
ivermectin (Le Jambre et al., 1995; Duke et al., 1991; Sasaki and Kitagawa, 
1993; Grant, 2000). The release of eggs already in utero and the production 
of new eggs are inhibited and these effects are apparent in gastrointestinal 
and filarial nematodes. The recent reporting of inhibitory glutamate activity in 
the vagina vera of Ascaris suum allows supposition that ivermectin exerts its 
effects on reproduction through activation of GluCI (Fellowes et al., 2000). 
This additional feature of the toxicity profile of AM has important implications 
as inhibition of reproduction may reduce infection levels. It is probable that 
the AM have different toxic effects on nematodes with different life-styles due 
to levels of exposure and possibly differences in the evolution of their major 
site of action, the GluCI.
The AM generally show extremely low host toxicity, but during treatment of
D.immitis in Collies high concentrations of avermectin induced a toxic effect 
(reviewed Sutherland and Campbell, 1990). Studies on the activity of 
avermectins in vertebrate brain showed activity at GABAa (Adelsberger, 
2000; Schaeffer and Haines, 1989; Sigel and Baur, 1987; Pong and Wang, 
1980) and nicotinic a7 receptors (Krause et al., 1998). The GABA and 
acetylcholine responses were potentiated by ivermectin, but the ivermectin 
binding affinity for these receptors was approximately 100 fold lower and
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showed a different mechanism than for the nematode target receptor. The 
AM do not freely cross the blood/brain barrier and studies indicate that the 
lowest drug residue levels are found in the brain (reviewed Sutherland and 
Campbell, 1990; Burkhart, 2000). These facts, coupled with the low doses 
required for efficient removal of nematodes and no evidence for GluCIs in 
vertebrates, probably account for the low host toxicity. The toxicity to Collies 
is thought to be due to a deficiency in the blood-brain barrier.
Following treatment of mammals with AM the majority of the drugs are 
excreted, largely unchanged, in the faeces (Ottesen and Campbell, 1993; 
McKellar and Benchaoui, 1996). This has resulted in concerns over 
detrimental environmental effects as the long-half life (91-217 days in winter) 
of the AM coupled with their potent insecticidal and acaricidal activity may 
cause toxicity of non-target invertebrates in the dung (Wall and Strong, 
1987). Poor degradation of faeces from slow-release bolus ivermectin- 
treated cattle, as compared to untreated controls, suggested toxic effects on 
dung-degrading insects. The method of ivermectin administration appears to 
influence subsequent environmental impact, however, as dung from cattle 
treated with ivermectin by injection or pour-on formula degraded as control 
(McKeand et al., 1988). The long-term environmental effects of the AM are 
not known.
1.2.4 Anthelmintic resistance
The widespread use of the major classes of anthelmintic has resulted in the 
evolution of resistant parasites. As yet, drug resistance has not been 
reported in human nematodes, but dosing regimes are such that treatment 
levels are far higher than is required to kill parasites and therefore resistant 
worms may be present without discovery for long periods of time. In addition, 
the mass chemotherapeutic parasite control schemes introduced by the 
WHO in the past decade will hasten the development of resistance. In 
contrast to the human situation, anthelmintic resistant nematodes have been 
reported in the majority of livestock, particularly in the tropics and subtropics 
(Waller, 1997; Chandrawathani, et al., 1999; Van Wyk et al., 1999; Waruiru,
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et al., 1998; Jackson and Coop, 2000). Resistance was first reported to the 
benzamidazoles in S. Africa in 1975 in an H.contortus strain and over 90% 
of sheep farms in S. Africa are now reported to have resistance to at least 
one type of anthelmintic (Van Wyk et al., 1997). Anthelmintic resistance is 
probably due to a pre-adaptive phenomenon, rather than to the appearance 
of a new mutation (Jackson and Coop, 2000). As such, individuals carrying 
alleles that are susceptible to the action of a drug are killed whereas those 
that possess alleles that reduce the toxic effect of a drug survive. The 
“resistance” allele is passed through generations and flourishes in the 
population and the “susceptible” allele diminishes. High genetic variability 
predisposes an organism to possess such a “resistance” allele. It is apparent 
that the tristrongylid nematodes are particularly susceptible to the 
development of resistance and reports of very high polymorphism in these 
species support this finding (Sangster, 1996). Selection of resistant alleles in 
a population has escalated at a far quicker rate than was predicted as a 
result of underdosing, use of poor quality anthelmintics and poor 
management.
The mechanism of resistance to the major classes of anthelmintic has been 
investigated at both the molecular and functional level. Benzamidazole 
resistance is fairly well understood and an alteration in the drug receptor is 
apparent (Lubega and Prichard, 1991b; Sangster et al., 1985). Further 
studies indicated altered polymorphism in resistant nematode populations 
with progressive loss of p-tubulin alleles (Lubega et al., 1994; Kwa et al., 
1993; Roos et al., 1995). Two p-tubulin isotypes are present in nematodes 
and loss of isotype 1 alleles is associated with low level resistance followed 
by elimination of isotype 2 in very highly resistant individuals. Cloning 
studies have revealed the presence of a tyrosine residue at position 200 of 
p-tubulin isotype 1 in resistant individuals, whereas susceptible individuals 
have a phenylalanine at this position (Kwa et al., 1993; Elard et al., 1996; 
Geary et al., 1999). The same mutation is seen in benzamidazole-resistant 
fungi (Fujimura et al., 1992) and mammals naturally have a tyrosine at this 
position (Lewis et al., 1985) suggesting that the parasites have learned to
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mimic their host p-tubulin thus evading the drugs’ toxic action. Kwa et al., 
(1995) demonstrated rescue of the sensitive phenotype in C.elegans by 
transforming individuals expressing the benzamidazole-resistant allele with 
the H.contortus benzamidazole-sensitive allele thereby reinforcing the 
hypothesis that benzamidazole resistance is due to a loss of susceptible p- 
tubulin alleles from the population.
Alteration of the drug receptor has also been implicated in 
imidazothiazole/tetrahydropyrimidine resistance. Binding and egg-hatch 
studies have indicated reduced sensitivity to cholinergic agonists as well as 
levamisole in both C.elegans and parasitic species (Sangster et al., 1991; 
Sangster, 1996; Lewis et al., 1987b; Moreno-Guzman et al., 1998) and, 
coupled with reduced binding affinity and an apparent increase in binding 
sites, this suggests changes in the drug receptor. Molecular studies 
implicated 11 genes in levamisole resistance in C.elegans (Fleming et al., 
1996, 1997), 3 of which encode acetylcholine receptor subunits. Comparison 
of cloned levamisole receptor subunits has yielded no mutations associated 
with levamisole resistance in T.colubriformis, H.contortus and O.circumcincta 
(Wiley et al., 1996; Hoekstra et al., 1997; Sangster and Gill, 1999). 
Electrophysiological investigation of levamisole-sensitive and -resistant 
Oesophagostomum dentatum muscle supports molecular studies as, at a 
therapeutic concentration of levamisole (30pM), there are less active 
channels in resistant than sensitive isolates (Martin and Robertson, 2000; 
Robertson et al., 1999; Martin et al., 1997b). Combined with the associated 
reduction in channel mean open time, this is proposed to result in a ten-fold 
decrease in levamisole current. The levamisole target-site shows varying 
conductances, which are suggested to be associated with altered 
combinations of subunits forming the receptor. One of these subtypes is 
missing from the levamisole-resistant isolate and this may contribute to the 
reduced levamisole efficacy.
The mechanism of AM resistance is not well understood. Resistance to this 
class developed very rapidly with ivermectin resistance being reported only 
33 months after its introduction into the market (Shoop, 1993). At the
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molecular level, a number of genes appear to have some involvement in AM 
resistance in C.elegans including amphid dysfunctional genes, GluCI 
receptor subunits and p-glycoproteins (Dent et al., 1997; Dent et al., 2000), 
but it is not known if these findings are applicable to parasitic nematodes. 
Binding studies do not implicate alteration of GluCI receptors in resistance in
H.contortus and Telodorsagia circumcincta (Rohrer et al., 1994; Hejmadi et 
al., 2000) but investigation of the functional channel would be more 
conclusive. GluCI receptor subunits have been cloned from ivermectin- 
resistant H.contortus isolates and do not appear to be involved, at least in 
terms of sequence, in the development of resistance (Delany, 1998, 
Jagannathan, 1998).
P-glycoproteins (pgp) can transport compounds from the inside to the 
outside of cells and have been shown to mediate drug resistance in humans 
(Gottesman et al., 1993; Higgins, 1995). There are 14 genes for pgp in 
C.elegans but none of the genes associated with avermectin, levamisole or 
benzamidazole resistance map to the pgp loci. However, a number of 
studies of avermectin resistance in H.contortus have demonstrated pgp 
involvement (Xu et al., 1998; Blackhall etal., 1998; Sangster and Gill., 1999; 
Molento and Prichard, 1999) and reports suggesting that ivermectin is a pgp 
substrate in mammalian cells support the hypothesis that pgps may play a 
role in avermectin resistance (Pouliot et al., 1997). These findings are not 
universal however (Kotze, 1998; Kwa et al., 1998), highlighting the need for 
more research in this area.
Functional studies of AM resistance indicate alterations at both sites of 
action (Gill et al., 1995; Gill and Lacey, 1998; Sangster, 1996; Kotze, 1998; 
Paiement et al., 1999) as inhibition of both motility and pharyngeal pumping 
require higher levels of drug in resistant isolates. It is evident that the 
resistant phenotype is dependent upon the selection procedure and 
therefore mechanisms of AM resistance may differ both between and within 
species (Gill etal., 1998; Gill and Lacey, 1998).
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1.3 Neurobiology
The rampant spread of resistance to all classes of broad-spectrum 
anthelmintics dictates an urgent requirement for the development of novel 
drugs and has highlighted our lack of knowledge of the mode of action of 
those drugs currently in use. It is known that three anthelmintic classes 
selectively act at the nematode nervous system; however much information 
regarding the exact mechanism by which they exert their effect, their 
pharmacodynamics and the molecular mechanisms involved in resistance is 
missing. Studies of basic nematode neurobiology will improve our 
understanding of the mode of action of these drugs and may also yield novel 
targets for mechanism-based screening, thereby re-igniting interest in 
anthelmintic discovery programs within pharmaceutical companies.
1.3.1 The anatomy of the nervous system
The majority of information regarding the nematode nervous system is 
derived from studies of the free-living species C.elegans and the parasite 
Ascaris. The neuroanatomy of these two species is comparable suggesting 
continuity throughout the phylum. All neurons and their synaptic connections 
have been mapped and indicate a simple system with approximately 300 
neurons, the majority of which are found in the anterior nerve ring 
surrounding the pharynx (Rand and Nonet, 1997; Thomas and Lockery, 
1999; Davis and Stretton, 1996) (figure 9). The nerve ring contains almost all 
the inter neurons and axons from most of the sensory neurons which project 
towards the anterior of the worm. Two main nerve cords extend in a posterior 
direction from the circumpharyngeal nerve ring almost to the tail in dorsal 
and ventral positions and contain inter neurons and the body muscle motor 
neurons. The ventral nerve cord contains the cell bodies of all the
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Figure 9 The Ascaris nervous system (Withers, 1992)
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motor neurons and communication to the dorsal nerve cord is via frequent 
connections by lateral commissures.
1.3.2 Neurotransmission
The simplicity of the nematode nervous system in terms of anatomy is not 
reflected in its neurochemistry. Many of the classical mammalian 
neurotransmitters are also present in nematodes including y-aminobutyric 
acid (GABA), acetylcholine, glutamate, serotonin, dopamine and octopamine 
(reviewed Brownlee et al, 2000; Bargmann, 1998). The distribution of 
nematode neurotransmitters has been investigated using direct techniques, 
such has immunohistochemistry, and by detection of synthetic enzymes and 
transporters. As with anatomical studies, the majority of information is 
derived from A.suum and C.elegans, with initial localisation and 
pharmacological observations being carried out on the former. The 
C.elegans genome project has yielded a wealth of genes with homology to 
mammalian neurotransmitters and their receptors and molecules involved in 
their synthesis, transport and reuptake (Bargmann, 1998). Functional studies 
are still in progress, but mutation analysis has already provided some 
information regarding the localisation and role of identified genes.
1.3.2.1 GABA
In 1964, GABA was shown to hyperpolarise Ascaris muscle cells (Del 
Castillo et al., 1964). This has subsequently been observed by other workers 
(Martin, 1980; Holden-Dye et al., 1988) and GABA’s role as the major 
inhibitory neurotransmitter in nematodes confirmed. The observed 
hyperpolarisation of muscle membrane is associated with relaxation of 
muscle and is a pure chloride event. Therefore, it is unsurprising that 
inhibitory motor neurons in A.suum are GABAergic (Johnson and Stretton, 
1987). In total, twenty-six GABA positive cells have been defined in both 
A.suum (Guastella et al., 1991) and C.elegans (Mclntire et al., 1993a). The 
functional roles of these neurons have been investigated by laser ablation 
and all but one are motor neurons. Molecular analysis of C.elegans has
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yielded genes for GABA expression (unc-25), GABA receptors (see section 
1.3.3.2.1) and GABA release (unc-46 and unc-47) (McIntyre et al., 1993b; 
McIntyre et al., 1997). UNC-25 and UNC-47 were localised to GABA positive 
cells. The UNC-25 protein shows 45% identity to mammalian glutamic acid 
decarboxylase, the enzyme that synthesises GABA from glutamic acid, and 
mutants in this gene have no apparent GABA. Unc-47 is thought to be 
involved in vesicular GABA transport; vertebrate homologs can package 
GABA or glycine. Mutants in GABAergic transmission, although viable, have 
several motor defects including a tendency to simultaneously contract both 
the dorsal and ventral muscles instead of the usual sinusoidal wave of 
locomotion. Although GABA’s main role is inhibitory, two excitatory motor 
neurons involved in muscle contraction during defecation also appear 
GABAergic (Reiner and Thomas, 1995).
1.3.2.2 Acetylcholine
It has been known for many years that acetylcholine is present in nematodes 
(Mellanby, 1955) and bath application causes contraction of Ascaris muscle 
strips (Baldwin and Moyle, 1949; Norton and De Beer, 1957). Supporting 
electrophysiological data shows depolarisation of muscle (Del Castillo et al., 
1963) and an increase in conductance that is mainly due to sodium ions 
(Colquhoun et al., 1991) and acetylcholine (ACh) is now accepted as the 
major excitatory neurotransmitter in this phylum. Acetylcholine esterases and 
choline acetyl transferase (ChAt) were also found in the Ascaris nervous 
system (Lee, 1962; Johnson and Stretton, 1985) and it is unsurprising that 
studies with ventral cord indicated the highest ChAt activity in the excitatory 
motor neurons. Molecular studies have identified genes for choline acetyl 
transferase (cha-1), a synaptic vesicle ACh transporter (unc-17), receptors 
(section 1.3.3.2.2) and three classes of acetylcholine esterase (ace-1X\ ace- 
21, ace-311) in C.elegans (Alfonso et al., 1993; Alfonso et al., 1994; Culotti et 
al., 1981; Johnson et al., 1981; Kolson and Russell, 1985 a, 1985b). The 
expression patterns of unc-17 and cha-1 are almost identical and are in 
agreement with results from Ascaris ventral cord, with motor neurons of the 
dorsal nerve cord, pharynx and sublateral motor neurons also showing
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expression (Rand and Nonet, 1997). Completely acetylcholine deficient 
C.elegans mutants are not viable.
1.3.2.3 Glutamic acid
The distribution of this neurotransmitter in nematodes is not as well 
characterised as GABA and acetycholine. Analysis of glutamate receptors 
(section 1.3.3.2.3) and transporters and the pharmacology of nematode 
tissues have shed some light on the function of glutamate as a 
neurotransmitter and it appears to play both an excitatory and inhibitory role. 
Injection of glutamic or kainic acid into A.suum causes paralysis indicating a 
role for these amino acids in locomotion (Davis and Stretton, 1996). Further 
analysis shows that excitatory motor neurons are depolarised following 
application of glutamate, this is a sodium ion event, and a putative glutamate 
transporter has been identified in the same neurons (Davis, 1998). Cloning 
of several potential glutamate receptor genes from C.elegans further 
establishes the excitatory role of glutamate in nematodes. Mutants of one of 
these subunits, glr-1 showing 40% identity to vertebrate AMPA receptor 
subunits, illustrate that several classes of sensory neuron use glutamate in 
this capacity (Hart et al., 1995; Maricq et al., 1995; Zheng et al., 1999). In 
Ascaris, the inhibitory role of glutamate has been demonstrated both by 
hyperpolarisation of the Dl motor neurons and by a chloride-dependent 
hyperpolarisation of the pharynx (Davis and Stretton, 1996; Martin, 1996; 
Adelsberger, 1997). This is supported by findings in C.elegans that the 
inhibitory M3 motor neuron which controls the timing of pharyngeal pumping 
is glutamatergic and the action of this neuron is mimicked when glutamate is 
applied to the pharyngeal muscle (Dent et al., 1997; Li et al., 1997). A 
number of cDNAs encoding subunits of a novel glutamate-gated chloride 




The identification of neurotransmitters in nematodes and their effects on 
membrane potentials suggested the presence of fast-acting neurotransmitter 
receptors. Three of the anthelmintic classes currently in use act at these 
receptors highlighting their importance. Their pharmacology was often 
assessed in terms of known vertebrate receptor classes and much of the 
initial characterisation was carried out in Ascaris but, once again, C.elegans 
has been an excellent resource for molecular studies and has provided a 
plethora of putative neurotransmitter receptor genes.
1.3.3.1 Vertebrate ligand-gated ion channels
In vertebrates, fast neurotransmission is mediated by a superfamily of 
receptors known as ligand-gated ion channels (LGIC), including 
acetycholine, glutamate, 5-HT, GABA and glycine receptors. The vertebrate 
nicotinic ACh receptor is the most well characterised of all LGIC due to its 
relative abundance in the electric organ of the electric eel allowing early 
studies access to workable quantities of receptor. The receptor is composed 
of a pentameric structure of subunits surrounding a central cation pore, 
which is directly gated by binding of acetylcholine (figure 10A and B) 
(Changeux, 1993; Unwin, 1995). Molecular heterogeneity has been 
demonstrated and a number of classes of subunit have been identified (apy8 
in muscle and ap in neurons) (Corringer et al., 2000). GABAa receptors are 
also heteromeric and multiple isotypes have been identified for many of the 
nACh and GABA subunit classes (MacDonald and Olsen, 1994; Stephenson, 
1995). Each subunit possesses a long, glycosylated, hydrophilic 
extracellular amino terminal region, four hydrophobic membrane-spanning 
regions (TM1-4) and a long variable intracellular loop between the third and 
fourth transmembrane regions (figure 10C). The hydrophilic region contains 
a conserved pair of cysteines that form a disulphide bridge. LGIC with this 
general structure are grouped into a subfamily, the cys-loop LGIC (cLGIC), 
which includes nACh, GABAa, glycine and 5-HT3 receptors in vertebrates 
and nACh, GABA and inhibitory glutamate receptors in invertebrates.
34
AFigure 10 Model of a cys-loop ligand-gated ion channel. A illustrates the 
pentameric structure of the functional receptor. The five subunits cluster around a 
central ion pore composed of their TM2 regions (B). C shows the composition of an 
individual subunit with its large extracellular domain and four transmembrane 
regions, denoted l-IV. = denotes the cysteine loop. P indicates potential 
phosphorylation sites (adapted from Changeux, 1993).
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The extracellular region, at least of the a-subunit, of cLGIC is thought to 
contain the neurotransmitter binding sites. Three putative binding domains 
have been identified in similar regions for each of ACh, GABA, and glycine 
in their respective receptor. (Smith and Olsen, 1995; Galzi and Changeux,
1994). Identification of neurotransmitter binding sites on non-a subunits led 
to the proposal that the neurotransmitters bind at the interface of alpha and 
non-alpha subunits in the functional receptor (Blount et al., 1990; Gu et a/., 
1991; Saedi et a/., 1991; Stephenson, 1995). The second transmembrane 
region of each subunit lines the ion channel and bestows ion charge 
selectivity upon the receptor (figure 10B) (Galzi et al., 1991). Negatively 
charged amino acid rings are present at the top and bottom of the ACh 
receptor channel (Unwin, 1993), allowing entry only to cations, whereas in 
anion-selective inhibitory channels positive or neutral residues occupy these 
positions (Barnard, 1992). This selectivity process was confirmed by the 
conversion of the a7 nACh channel to anion selectivity by the substitution of 
three amino acids in the TM2 domain with three from glycine or GABA (Galzi 
et al., 1992). An uncharged ring of leucines is observed at the centre of the 
ion channel and is thought to participate in closing the channel (Unwin, 
1993). The large intracellular loop of many subunits contains putative 
phosphorylation sites, which may regulate the function and expression of the 
receptor (Miles and Huganir, 1988; Wallace et al., 1991; Huganir and 
Grungard, 1990; Krishek et al., 1994; McDonald et al., 1998; McDonald and 
Moss, 1994; Brandon e ta i, 1999).
1.3.3.2 Nematode ligand-gated ion channels
Over a hundred genes encoding LGIC have been uncovered by the 
C.elegans genome project (Bargmann, 1998) including excitatory receptors 
for acetylcholine and glutamate and inhibitory receptors for GABAa and 
glutamate, although the encoded protein function of many of the genes is not 
yet known. Glycine and its receptor have not been identified in nematodes 
as yet, but a novel class of inhibitory ionotropic glutamate receptors 
apparently not present in vertebrates has been found. Nematode LGIC show 
similarities to their vertebrate counterparts in terms of sequence and
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proposed structure. Cloning of multiple subunits and detection of differential 
channel recordings suggests that nematode LGIC are also heteromeric and 
that neurotransmission is further complicated by the wide variety of receptor 
subunits available to these organisms. The Xenopus laevis oocyte 
expression system, whereby injected mRNA is translated in the oocyte into 
proteins that usually have similar properties to the donor tissue, has been an 
invaluable technique for physiological characterisation of subunits.
1.3.3.2.1 GABA Receptor
The observation of a fast chloride-dependent hyperpolarisation of nematode 
muscle following application of GABA indicated the presence of GABA-gated 
ion channels. Pharmacological analysis of Ascaris showed these receptors 
to be most similar, but not identical, to vertebrate GABAa receptors (Holden- 
Dye et al., 1988) although GABAa antagonists had little or no activity and the 
chloride channel blocker picrotoxin had very low potency. Molecular 
investigation of C.elegans GABA receptors produced an unusual result in 
that, in contrast to the multiple genes encoding vertebrate GABAa receptors, 
a single gene, unc-49 appears to encode all subunits for functional GABA 
receptors, at least in body wall muscle. Mutants in this gene have no muscle 
response to GABA or the GABA receptor agonist muscimol (Mclntire et al., 
1993a; Richmond and Jorgensen, 1999) and show an uncoordinated 
“shrinker” phenotype, whereby simultaneous contraction of dorsal and 
ventral muscles is observed. Further research by Bamber and colleagues 
(1999) showed that unc-49 is alternatively spliced to form three subunits with 
identical N-terminal domains but different C-terminal regions (figure 11). 
Alternative splicing also occurs in some GABAa subunits.
N- t ermi nus A B C
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Figure 11 The unc-49 gene arrangement. A single copy of the N-terminus is 
present followed by three tandem copies of the C-terminal region. The LGIC 
conserved cysteine loop and transmembrane regions are indicated. The mRNA is 
spliced such that three subunits are encoded containing common N-terminal 
domains.
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The resulting GABA receptor subunits all contain conserved residues for 
GABA binding, anion selectivity and phosphorylation. Localisation studies 
demonstrated co-expression of UNC-49B and -C mainly at neuromuscular 
junctions, with the most intense staining in the head and body wall. They 
also co-assemble in vitro in Xenopus oocytes to form a functional receptor 
with GABA-induced chloride currents, which are lower in cells co-expressing 
these subunits than in those expressing only UNC-49B. Analysis of unc-49 
mutations indicated that only UNC-49B is essential for receptor function and 
this subunit is expressed without UNC-49C in the sphincter muscle. It is 
thought that the observed decrease in chloride conductance when subunits 
are co-expressed may indicate a method for regulation of channel properties 
in vivo in certain cells or developmental stages by combining different 
subunits. UNC-49A is expressed at very low levels and its localisation and 
role in vivo is unknown.
Approximately thirty genes have been identified in C.elegans with some level 
of homology to known GABA, glutamate and glycine receptors (Bargmann, 
1998), but sequence analysis suggest that only two of these are likely to 
encode additional GABA receptor subunits (Bamber et al., 1999). These may 
form a distinct receptor sub-type in a particular neuron or muscle other than 
those required for locomotion, or they may co-localise with UNC-49 but 
require UNC-49 for GABA activation.
1.3.3.2.2 Nicotinic acetylcholine receptor
More than forty nicotinic acetylcholine receptor genes are predicted by the 
C.elegans genome project (Bargmann, 1998). Once again, the 
pharmacology of these receptors, as assessed by studies on body muscle, is 
indicative of a class of receptors that are similar to their vertebrate 
counterparts, but some differences are seen (Colquhoun et al., 1991; 
Colquhoun et al., 1993; Avery and Horvitz, 1990; Lewis et al., 1980). None of 
the vertebrate nicotinic acetylcholine receptor (nAChR) antagonists are very 
potent at the nematode receptor and the imidathiazole class of anthelmintics 
are potent agonists of the nematode, but not the vertebrate receptor.
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A number of confirmed nAChR subunits have been cloned and characterised 
from C.elegans and all show the hallmarks of the LGIC superfamily. 
Investigation of levamisole-resistant mutants led to the discovery of three 
nAChR genes, one a  and two non-a (Lewis et al., 1980; Lewis et al., 1987; 
Fleming et al., 1996). Mutations in two of these, unc-38 and unc-29, results 
in a very uncoordinated phenotype and, coupled with their localisation 
mainly to neuromuscular junctions, this suggests these subunits are part of 
the locomotory nAChR. The complete loss of levamisole sensitivity in these 
double mutants suggests that the two subunits co-exist in the same receptor 
and their co-expression in Xenopus oocytes results in the formation of a 
functional receptor that is gated by both levamisole and ACh. Homologues of 
unc-38 and/or unc-29 have been cloned from the parasitic nematodes 
T.columbriformis, O.volvulus and H.contortus (Donelson et al., 1988; 
Fleming etal., 1996; Wiley etal., 1996; Hoekstra etal., 1997).
The presence of residual locomotory function and a response to ACh in unc- 
38/unc-29 mutants implies that other subunits also exist. Further alpha 
subunits have been identified and cloned (Mongan etal., 1998) including ce- 
21 and deg-3, which show the highest sequence similarity to vertebrate a7 
subtype (Ballivet et al., 1996; Treinin and Chalfie, 1995). Expression of ce- 
21 in Xenopus oocytes results in a functional cation channel that is gated by 
both nicotine and ACh, but not levamisole. Deg-3 is expressed by a small 
subset of sensory neurons suggesting differential expression of nAChR 
subunits depending on cell type and required function. Cloned non-a 
subunits include acr-2, which is expressed in multiple motor neurons and 
mutants of which have a shrinking uncoordinated phenotype (Squire et al.,
1995), acr-3 (Baylis et al., 1997) and ce-13 (Ballivet et al., 1996) as well as 
the levamisole resistance subunits unc-29 and lev-1. Homomeric expression 
of non-a subunits does not result in a functional receptor, but co-injection 
into Xenopus oocytes with unc-38 results in levamisole-induced currents. 
Localisation of unc-38 to neurons as well as neuromuscular junctions 
suggests that this subunit may associate in vivo with subunits other than 
those implicated in levamisole sensitivity. Two AChR gene products, EAT-2,
39
a (3 subunit, and EAT-18, have been localised to the pharynx and mutant 
analysis indicates they may be involved in the control of pharyngeal pumping 
(Raizen et al., 1995; McKay, Raizen and Avery, personal communication).
1.3.3.2.3 Glutamate-gated chloride channel receptors
Investigations into the mode of action of the avermectins and milbemycins 
(AM) led to the discovery of a novel class of inhibitory ionotropic receptor, 
the glutamate-gated chloride channel (GluCI). The AM were known to have 
an inhibitory action on motorneurons and muscle and fast activation of 
chloride channels was observed, but their site of action was elusive (section 
1.2.3.4). Following the discovery of high affinity ivermectin-binding sites 
(Kd=0.2 nM) on C.elegans membrane (Schaeffer and Haines, 1989), poly [A]+ 
RNA from this species was size-fractionated on a 10-30% sucrose gradient 
and injected into Xenopus laevis oocytes for pharmacological analysis 
(Arena et al., 1991). A mRNA fragment of between 1 and 2.5 kb encoded a 
protein which responded to both ivermectin phosphate (EC50 = 90 nM) and L- 
glutamate (EC50 = 350 pM) by increasing the membrane permeability to 
chloride ions (Arena et al., 1992). Glutamate activates fast, reversible, 
desensitising chloride current whereas the ivermectin response is slower 
and essentially irreversible. The application of maximal concentrations of 
ivermectin significantly decreases responses to glutamate and low 
concentrations of ivermectin (2 nM) potentiate the glutamate response (EC50 
reduced from 350 pM to 80 pM) suggesting that the two ligands are acting at 
the same channel. A structural analogue of L-glutamate, ibotenate, also 
activates the same chloride channel and with higher potency than glutamate 
(EC50 = 87 pM), but the channel is GABA insensitive. The chloride channel 
blockers flufenamate (100 pM) and picrotoxin (500 pM) decrease the 
glutamate- or ivermectin-induced current, but no vertebrate glutamate-gated 
cation channel agonists or antagonists significantly altered the glutamate 
response.
The first GluCI subunits, GluCIa and GluClp were found by cloning cDNA 
from the mRNA fractions that elicited responses to glutamate and/or 
ivermectin (Cully et al., 1994). These subunits showed all the features of a
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typical cLGIC, but had an additional pair of cysteines in the extracellular 
domain, as do the vertebrate glycine receptor subunits. Molecular 
phylogenetic analysis indicated that these subunits share a common 
ancestral gene with the vertebrate GABAa and glycine receptors, but form a 
distinct sub-branch of the cLGIC superfamily which is orthologous to the 
glycine receptor alpha subunit (Cully et al., 1996; Vassilatis et al., 1997a). 
Both subunits form functional homomeric chloride channel receptors when 
expressed in Xenopus oocytes, although similarity to other LGIC predicts 
that the in vivo receptor is heteromeric. The a subunit is gated by ivermectin 
but not glutamate and the p subunit is gated only by glutamate, suggesting 
that different binding sites are present and giving further support to the idea 
that the functional receptor is heteromeric. The presence of a glutamate- 
binding site in the N-terminal region of the alpha subunit that is not coupled 
to channel gating suggests that all subunits may have the constituents for 
ligand binding, but that combinations of subunits are required for a functional 
channel (Etter etal., 1996).
Co-expression of GluCIa, 1.4 kb, and GluClp, 1.3 kb, resulted in a chloride 
channel gated by both glutamate and ivermectin with broadly similar 
responses to those seen with C.elegans poly [A]+ RNA. Closer inspection of 
channel properties highlighted some differences including an increase in the 
glutamate EC50 (350 pM to 1,360 pM) and a reversed order of potency for 
glutamate and ibotenate, suggesting that they do not associate in vivo and 
that further GluCI subunits are present. This was confirmed by studies on a 
C.elegans strain with an inactive GluCIa gene as these mutants were still 
ivermectin sensitive, although a decrease in the number of ivermectin 
binding sites in their membrane and a reduction in the glutamate and 
ivermectin-induced amplitude when their mRNA was expressed in Xenopus 
were noted (Vassilatis et al., 1997b). This led to the cloning of another alpha 
subunit, GluCla2 (avr-15), with 75% amino acid identity to a1 . The GluCla2 
gene is alternatively spliced producing a long form, 2.2 kb, with an extended 
N-terminal region and a shorter form, 1.7 kb, with a N-terminal region of a 
similar length to other GluCI (Dent et al., 1997). Both subunits show typical
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features of the cLGIC and have the additional cysteine pair in the N- 
terminus. The function of the longer N-terminus is not known. Homomeric 
expression led to a channel irreversibly activated by ivermectin (EC50 =107  
nM) and reversibly by glutamate (EC50 = 208 pM). Co-assembly with GluCip 
produced a receptor with similar properties to those initially seen with 
injection of C.elegans mRNA proffering this as a naturally occurring 
combination.
One of the effects of ivermectin is the inhibition of pharyngeal pumping. The 
presence of GluCla2 in the pharynx was implicated by a cessation of the fast 
inhibitory glutamatergic response to the M3 motorneuron in the pharynx of 
avr-15 mutants (Dent et a/., 1997). This was followed by its localisation, by 
GFP-fusion, to the pharyngeal muscle and this pattern of expression 
overlapped with that of GluCip, as recorded by lac-Z reporter gene 
constructs (Laughton et al., 1997b). This suggests that these subunits 
probably co-assemble in the functional receptor and that GluCla2 is an 
essential component of the pharyngeal receptor. Other subunits must also 
exist which are responsible for the organisms reduced motility in response to 
the AM.
Additional subunits cloned from C.elegans include another a-subunit glc-3 
that forms functional homomeric channels gated by both ivermectin and 
glutamate (Horoszok et al, in press) and another alternatively spliced gene, 
gbr-2 (avr-14) (Laughton et al., 1997a). The subunits encoded by gbr-2 
share N-terminal regions, but splicing just prior to the TM1 results in 
polypeptides with different transmembrane domains (figure 12). This 
suggests that the ligand-binding domains will be similar, but that the two 
isotypes will have differing channel properties. The gbr-2a cDNA is unusual 
in that it contains the transmembrane regions of the gbr-2b subunit as an 
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Figure 12 Alternative splicing of gbr-2. The encoded subunits have identical N- 
terminal domains (in yellow) but different transmembrane regions (red/green). 
Sequences for the transmembrane regions of HG3 are present within the 
untranslated region of HG2.
Sequence identity to other alpha subunits is only 45-55%, which is too low to 
assign them additional members of the alpha subtype, but neither are they 
similar to the GluCip subunit. Expression of gbr-2 has been demonstrated in 
the extrapharyngeal neurons in the ring ganglia of the head, motorneurons in 
the ventral nerve cord and mechanosensory neurons suggesting differential 
expression of GluCI subunits in nematodes.
Glutamate-gated chloride channel receptor subunits have also been 
identified in parasitic nematodes (appendix 1). In molecular terms, the 
species in which the GluCI have been studied in most detail is Haemonchus 
contortus. Three genes encoding four GluCI subunits are known in this 
species and these show a high level of sequence identity with the C.elegans 
GluCI (appendix 1). Orthologues of two C.elegans GluCI genes were 
identified in H.contortus, including a p-subunit, HG4, which shares 82% 
amino acid identity with its C.elegans counterpart, ce-glucip (Delany et al., 
1998). In contrast to ce-glucip, antibodies to HG4 localised its expression to 
motor neuron commissures in the mid-body portion of the worm and to the 
nerve cords, suggesting a role in locomotion. The expression pattern of HG4 
is identical to the non-pharyngeal regions inhibited by the AM implying that 
this subunit, probably in combination with one or more different subunits, 
may be responsible for the effects of AM on motility. This is in agreement 
with the findings of Kass et al. (1980) as the activation of GluCI on
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motorneurons may modulate their transmission of excitatory signals. 
Evidence for the involvement of GluCI, rather than GABA, receptors includes 
the picrotoxin sensitivity of these neurons, as nematode GABA receptors 
appear to be insensitive to this toxin (Holden-Dye et al., 1988). Gbr-2 
orthologues have also been cloned from both H.contortus and A.suum, but 
the pattern of alternative splicing is only conserved in H.contortus and the 
expression pattern of these subunits has yet to be investigated 
(Jagannathan et al., 1999). An additional subunit, HG5, with no clear 
C.elegans orthologue is also present in H.contortus (Delany, 1998). This 
subunit shows highest similarity to the C.elegans alpha subunits (appendix 
5).
The AM also target the nematode pharynx resulting in inhibition of 
pharyngeal pumping in H.contortus and coupled with an observed increase 
in chloride ion conductance of A.suum pharyngeal muscle following 
application of ivermectin or glutamate this implies the presence of GluCI 
receptors in the pharynx of at least these parasitic nematodes (Martin, 1996; 
Adelsberger et al., 1997). It is probable that further GluCI subunits are still to 
be identified from H.contortus.
As yet, there have been no published tests of the ability of the AM to interact 
with recombinant GluCI from parasitic nematodes. High affinity binding has 
been recorded to H.contortus whole membrane preparations and ivermectin 
is known to gate channels formed by some C.elegans GluCI subunits. 
Knowledge of the interaction of the AM with their target site would be 
interesting from both a scientific and a commercial perspective. 
Characterisation of GluCI from parasites may also shed some light on the 
development of resistance to the AM.
1.4 Aims of this research
The major goal of this research is to assess the pharmacology of the 
H.contortus GluCI receptor subunits. Although the full-length sequences of 
four H.contortus GluCI are deposited in the EMBL database, two of these 
remain to be cloned. The full-lengths of these two GluCI receptor subunits
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are to be amplified and cloned. All four GluCI subunits will be characterised 
by radioligand binding studies, following their expression in mammalian cell 
lines, to determine which, if any, form part of the ivermectin-binding site. 
Further analysis of their pharmacology will then be undertaken by competing 
against the [3H] ivermectin binding with other ligands, such as avermectin 
derivatives. The rapidly increasing spread of resistance to the four major 
classes of anthelmintic will have catastrophic consequences if it is allowed to 
continue and no alternative therapies are introduced. Alterations in the major 
target of the avermectin/milbemycin (AM) class of anthelmintics, the GluCI, 
may be involved in resistance to these drugs and comparison of receptors 
from ivermectin-sensitive and -resistant nematodes could improve 
understanding of the mechanism of AM resistance. All but one of the GluCI 
subunits have already been cloned from H.contortus field isolates that are 
resistant to ivermectin and no coding alterations that could be attributed to 
the development of resistance were identified. The remaining subunit, HG5, 
will be cloned from ivermectin-resistant H.contortus to uncover any 
sequence alterations. If differences are present, expression studies will be 
carried out and the pharmacology compared with HG5 from ivermectin- 
sensitive worms.
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2. Materials and Methods
2.1 General materials
2.1.1 Molecular biology reagents
Molecular biology grade chemicals were purchased from BDH chemicals 
(Poole, UK) Sigma Chemical Company Ltd (Poole, UK) or Fisons Scientific 
Equipment (Leicestershire, UK) Agarose was supplied by Biogene Ltd. 
(Kimbolton, UK) and ethidium bromide and diethyl pyrocarbonate (DEPC) by 
Sigma.
2.1.1.1 Enzymes
Restriction endonucleases and their buffers (10 x) were supplied by NEB 
(Hitchin, UK). T4 DNA ligase was from Gibco BRL (Renfrewshire, Scotland)
Enzyme Buffer Components
T4 DNA Ligase 50 mM Tris-CI (pH 7.5), 10 mM MgCI2, 10 
mM dithiothreitol, 1 mM ATP, 25 ng/ml BSA
BamHI Buffer 2:150 mM NaCl, 10 mM Tris-CI, 10 
mM MgCI2> 1 mM dithiothreitol (pH 7.9 @ 
25°C). Supplemented with 100 jig/ml BSA
Clal Buffer 4: 50 mM potassium acetate, 20 mM 
Tris-acetate, 10 mM magnesium acetate, 1 
mM dithiothreitol ((pH 7.9 @ 25°C). 
supplemented with 100 ng/ml BSA
EcoRI Unique Buffer: 50 mM NaCl, 100 mM Tris- 
HCI, 10 mM MgCI2, 0.025% Triton X-100 
(pH 7.5 @ 25°C)
Hindlll Buffer 2
Kpnl Buffer 1:10 mM Bis Tris Propane HCI, 10 
mM MgCI2, 1 mM dithiothreitol (pH 7 @
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25°C) supplemented with 100 pg/ml BSA
Ndel Buffer 4
Nrul Unique buffer: 100 mM KCI, 50 mM Tris-CI, 
10 mM MgCI2 (pH 7.7 @ 25°C)
Xbal Buffer 2 supplemented with 100 pg/ml BSA
Xhol Buffer 2 supplemented with 100 pg/ml BSA
2.1.2 General Buffer Compositions
Buffer Components
50 x TAE 2 M Tris Acetate, 50 mM EDTA; pH 8
10 x TBE 0.89 M Tris-CI, 0.89 M boric acid, 20 mM 
EDTA; pH 8.0
TE 10 mM Tris-CI, 1 mM EDTA; pH 7.6
PBS 140 mM NaCl, 2.7 mM KCL, 10 mM 
Na2HP04, 1.76 mM KH2PQ4; pH 7.4
2.1.3 Microbiological reagents
Media reagents were suppied by Difco laboratories (East Molesey, UK) and 
Sigma (Poole, UK) while glycerol was purchased from BDH (Poole, UK). 
Both IPTG and X-Gal were supplied by Alexis Corporation (Bingham, UK) 
and ampicillin, tetracycline and dimethylformamide were obtained from 
Sigma.
2.1.3.1 Bacterial culture media
Medium Components /L
LB broth 10 g tryptone, 5 g yeast extract, 5 g NaCl
LB agar As above with the addition of 15 g agar
SOC medium 20 g bacto-tryptone, 5 g yeast extract, 10 mM 
NaCl, 2.5 mM KCI, 10 mM MgCI2, 10 mM MgS04, 
20 mM glucose
DYT broth 16 g tryptone, 10 g yeast extract, 5 g NaCl
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2.1.3.2 Bacterial strains and plasmids
Strain/Plasmid Genotype Supplier
E.co//XL 1-Blue SupE44, hsdR17, 
recA1, endA1, gyrA46, 
thi, relA1 lac-, F 
[ProAB+, Laclq, LacZ, 
delM15, Tn10(tetR)]
Invitrogen,
pBluescript Ampr ,lacZ, 2.96 kb Stratagene
pCR®-Blunt ll-TOPO Kanr, lacZa, Zeor, ccdB 
3.6 kb
Invitrogen,
pFLAG-CMV-5c CMV, hGH, ampr, Flag, 
4.7 kb
Sigma
pcDNA3 CMV, BGH, Ampr, Neor 
5.4kb
Stratagene
2.1.4 Cell culture reagents
L929 cells and COS 7 cells were supplied by European Collection of Cell 
Cultures (ECACC) (Salisbury, UK). These were maintained in Dulbecco’s 
Modified Eagles Medium supplemented with 10% (v/v) Foetal Bovine Serum, 
2 mM L-glutamine, 100,000 units penicillin and 100mg streptomycin (all 
Sigma). Trypsin EDTA was also supplied by Sigma. FuGENE™ 6 
transfection reagent was purchased from Roche Molecular Biochemicals 
(Lewes, E.Sussex, UK) and G418 sterile-filtered solution was purchased 
from Calbiochem (Nottingham, UK).
2.1.5 Immunocytochemistry reagents
Mouse anti-flag monoclonal antibodies were supplied by Chemicon 
International (Harrow, UK). FITC-conjugated goat anti-mouse antibody was
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purchased from Jackson Scientific, PA, USA. Vectashield® antifade 
mounting media was purchased from Vector Laboratories, CA. USA.
2.1.6 Radioligand binding
Coomassie® Plus Protein Assay Reagent Kit was supplied by Pierce 
(Rockford, USA). [3H] ivermectin (specific activity 1.74TBq/mmol) custom 
synthesised by Amersham International (Bucks., UK) was a gift from Pfizer 
(Sandwich, UK). Unlabelled ivermectin (avermectin B1), HEPES, Triton X- 
100, polyethyleneimine (PEI), PMSF, leupeptin and pepstatin were from 
Sigma. UK compounds were a gift from Pfizer, (Sandwich, UK).
2.1.7 Western blotting and immunodetection
Chemicals were purchased from Sigma (Poole, UK). Electrode Paper 
Novablot filter paper, the Multiphor II Novablot electrophoretic transfer unit, 
the chemiluminescence ECL detection kit, nitrocellulose membrane and the 
rainbow molecular weight marker (10-250 kda) were from Amersham 
Pharmacia International (Aylesbury, UK). Anti-HG2 and -HG3 antibodies 
were purified from rabbits by Virginia Portillo.
2.2 Methods
2.2.1 General molecular biology methods
2.2.1.1 Agarose gel electrophoresis
Agarose gels were made by the addition of 1-1.5% (w/v) agarose to 1 x TAE 
or TBE buffer. The agarose was dissolved by heating in a microwave oven. 
Visualisation of DNA was achieved by the addition of 5 pg/ml ethidium 
bromide to this solution. Gels were poured in perspex gel rigs and allowed to 
set before running in 1 x TAE or TBE in horizontal gel apparatus. DNA 
samples were loaded with 0.25 vol. loading dye (15% (w/v) Ficoll, 0.25% 
(w/v) bromophenol blue, 0.25% (w/v) xylene cyanol) into the gel. Molecular 
weight markers were also run (100 bp, 1 kb or Pstl cut lambda DNA).
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2.2.1.2 Purification of DNA from agarose gels
The “Geneclean II®” method was used for purification (Biol01, La Jolla, 
USA). The DNA band was excised from a TBE agarose gel and weighed in a 
microcentrifuge tube. The gel slice was incubated at 55°C with 4.5 volumes 
6M Nal and 0.5 volumes “TBE modifier” until the agarose slice had 
completely dissolved (5-6min). “Glassmilk” silica matrix (5 pi) was added and 
the tube was incubated on ice for 5 min with occasional resuspension of 
resin. This was followed by a 5 second pulse in a microcentrifuge, removal of 
supernatant and resuspension of resin in 700 pi of “New Wash” 
(NaCI/Tris/EDTA in 95% (v/v) ethanol). This was centrifuged for 5 seconds 
and the wash procedure repeated twice more. DNA was then eluted by the 
addition of 5pl TE buffer followed by incubation of the tube for 3 min at 55°C. 
The suspension was centrifuged for 30 sec to make a solid pellet and the 
supernatant containing the DNA was removed.
2.2.1.3 Restriction endonuclease digestion of DNA
DNA samples of 1-5pg were digested with one or two restriction enzymes 
(10-20 units) in the reaction buffer (4 pi) recommended by the manufacturer. 
Sterile water was added to a volume of 40 pi and the reaction incubated at 
37°C for 1-4 hours.
2.2.1.4 Phenol/Choroform extraction and ethanol precipitation of DNA
Phenol (Tris-equilibrated, pH 8), chlorofom and isoamyl alcohol were added 
to restriction digested DNA in the ratio 25:24:1 in a sterile microfuge tube. 
This was shaken to form a milky suspension and spun at 12,000 x g for 1 
min. The top aqueous layer was then transferred to a clean microfuge tube 
and an equal volume of chloroform added before centrifugation at 12,000 x g 
for 1 min. The top aqueous layer was again transferred to a new tube and 
1/10 vol. sodium acetate (3 M pH 5.3) and 2 x vol. ethanol were added. This 
was left at 4°C overnight to allow precipitation of DNA. The solution was then 
spun at 12,000 x g for 1 hour at 4°C before washing the pellet in 75% (v/v) 
ethanol for 1 hour at 12,000 x g at 4°C. The DNA pellet was dried and 
resuspended in ddH20 .
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2.2.1.5 Ligation of DNA
Approximately 200 ng of linerised plasmid DNA were mixed with the 
fragment to be subcloned in a 1:1 vector:fragment molar ratio. T4 DNA 
ligase (1 unit) and 10x ligase buffer (2 pi) (250 mM Tris-CI, pH 7.5, 100 mM 
MgCI2> 100 mM DTT, 4 mM ATP, 50 pg/ml BSA) were added and the 
contents mixed. Ligations were carried out at 16°C overnight.
2.2.1.6 Preparation of E.coli competent cells
XL-1 Blue cells were made competent using calcium chloride. DYT (50 ml) 
was inoculated with 0.5 ml fresh overnight cultured XL-1 Blue cells in a 250 
ml conical flask. This was incubated at 37°C with shaking until the O.D.550 
reached 0.3. The culture was then rapidly chilled and centrifuged at 4,500 x 
g for 15 min at 4°C. Cells were resuspended in 20 ml of ice-cold 100 mM 
CaCI2. Following 20 min on ice, cells were centrifuged at 4,500 x g for 15 min 
and resuspended in 2 ml ice-cold CaCI2. The cells were transformed 
immediately.
2.2.1.7 Transformation of competent cells
Competent cells (300 pi) were mixed with 5 pi of the ligated DNA mixture in 
pre-chilled microfuge tubes and left on ice for 45 min. Cells were heat- 
shocked for 2 min at 42°C and then chilled on ice for 2 min. DYT (1ml) was 
added and the cells incubated for 1 hour at 37°C before plating onto LB agar 
containing 50 pg/ml ampicillin. After overnight incubation at 37°C individual 
colonies were transferred to 5 ml LB broth containing 50 pg/ml ampicillin. 
This was incubated overnight with at 37°C with shaking.
2.2.1.8 Small-scale preparation of plasmid DNA
The CONCERT™ Rapid Plasmid Purification System (Gibco BRI, 
Refrewenshire, UK) was used to isolate plasmid DNA from bacterial cultures.
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Solution Components
Cell suspension buffer 50 mM Tris-HCI (pH 8), 10 mM EDTA
Rnase A 20 mg/ml in water
Cell lysis solution 200 mM NaOH, 1% SDS (w/v)
Neutralization buffer contains acetate and guanidine hydrochloride
Wash buffer contains NaCl, EDTA and Tris-HCI (pH 8)
An overnight culture (3-5 ml) was centrifuged at 12,000 x g for 2 min. and all 
medium removed. The resulting pellet was resuspended in 210 pi cell 
suspension buffer (containing Rnase A) to form a homogenous solution. Cell 
lysis solution (210 pi) was added and mixed by inversion before incubation 
at room temperature for 5 min to produce a clear solution. Neutralisation 
buffer (280 pi) was added and the solution mixed by inversion before 
centrifugation of samples at 12,000 x g for 10 min. The resulting supernatant 
was placed into a spin cartridge, containing silica-based membranes where 
the plasmid DNA is selectively absorbed, which was contained in a 2 ml 
wash tube. Following removal of the flow-through the column was washed 
with 700 pi wash buffer at 12,000 x g for 1 min. DNA was eluted by the 
addition of 75 pi warm TE buffer, incubation for 1 min at room temperature 
and then final centrifugation at 12,000 x g for 2 min.
2.2.1.9 Large-scale plasmid preparations using the Qiagen Plasmid 
Maxikit (Qiagen, Surrey, UK)
Bacterial cells were cultured overnight in 100 ml LB broth. These were 
harvested by centrifugation at 6,000 x g for 15 min at 4°C.
Buffer Composition
Resuspension Buffer 50 mM Tris-HCI, pH 8.0, 10 mM 
EDTA, 100 pg/ml RNaseA
Lysis Buffer 200 mM NaOH, 1% (w/v) SDS
Neutralisation Buffer 3.0 M potassium acetate, pH 5.5
Equilibration Buffer 750 mM NaCl, 50 mM MOPS, pH 7.0,
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15% (v/v) isopropanol, 0.15% (v/v) 
Triton®X-100
Wash Buffer 1.0 M NaCl, 50 mM MOPS, pH 7.0, 
15% (v/v) isopropanol
Elution Buffer 1.25 M NaCl, 50 mM Tris-HCI, pH 
8.5,15%  (v/v) isopropanol
The pelleted cells were completely resuspended in 10 ml resuspension 
buffer and then lysed in 10 ml lysis buffer for 5 min. Chilled neutralisation 
buffer (10 ml) was added and after mixing the sample was incubated on ice 
for 20 min. The sample was mixed again and centrifuged at 20,000 x g for 30 
min at 4°C. The supernatant was re-centrifuged at 20,000 x g for 15 min at 
4°C and the resulting clear supernatant was applied to an equilibrated 
Qiagen-tip 500 and allowed to move through by gravity flow, The tip was 
washed twice with 30 ml wash buffer to remove contaminants. Elution buffer 
was applied to the tip and eluted plasmid DNA was precipitated by the 
addition of 10.5 ml room temperature isopropanol followed by centrifugation 
at 15,000 x g for 30 min at 4°C. Precipitated salts were removed from the 
resulting pellet by two 70% (v/v) ethanol washes. Plasmid DNA was 
dissolved in TE, pH 8.0.
2.2.2 Production of mRNA from Haemonchus contortus
2.2.2.1 Isolation and purification of H.contortus eggs
Worm-free lambs were experimentally infected (G .Coles, University of 
Bristol, Bristol UK) with 5000 H.contortus larvae of either the wild type 
isolate, susceptible to anthelmintics, or the South African White River 
isolate, resistant to anthelmintics (van Wyk and Mafan, 1988), The lambs 
were maintained in an indoor helminth-free environment. Faeces were 
collected overnight in polythene nappies approximately 3 weeks post­
infection. Faeces were homogenised in a blender with an equal volume of 
water to a thin paste. The mixture was washed through a 158 pm pore sized 
sieve removing the majority of the debris and allowing eggs and liquid to be
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collected in a jug. The filtrate was centrifuged at 1,500 rpm for 2 min. The 
supernatant was discarded and another 50 ml filtrate was added and spun 
down as before. This was repeated until approximately a 5 ml pellet was 
observed. The pellet was then resuspended in a saturated NaCl solution 
until a meniscus formed over the top of the tube. A large glass cover slip was 
placed over the top, ensuring no air bubbles were present and the tubes 
were spun at 1,000 rpm for 2 min. A film of eggs was then observed on the 
cover slips and this was quickly washed with distilled water into a new 
Falcon™ tube and spun at 1,500 rpm for 2 min. The supernatant was 
removed and the eggs weighed into cryotubes and frozen under liquid 
nitrogen.
2.2.2.2 Isolation of adult H.contortus
An H.contortus infected sheep was slaughtered and had its abomasum 
removed. The stomach lining was cut through and contents washed out with 
water (G.Coles, University of Bristol, Bristol, UK). It was then placed into an 
isolation apparatus (figure 13) containing DMEM and kept at 37°C using a 
heat-emitting lamp. Adult worms detached themselves from the gut lining 
and were collected live in a Falcon tube. Worms were washed in clean 
DMEM (37°C) to removed debris before transferring them to cryotubes. 
These were centrifuged at 1,500 rpm for 2 min and all liquid removed before 
freezing them in liquid nitrogen.
2.2.2.3 Isolation of total RNA from H. contortus adults and eggs
Total RNA was isolated using TRIzol® Total RNA Isolation Reagent, a 
monophasic solution of phenol and guanidine isothiocyanate (Life 
Technologies. Paisley, UK) developed from the single-step RNA isolation 
method described by Chomczynski and Sacchi (1987). Frozen tissue was 
ground to a powder under liquid nitrogen. The powder was rapidly dispersed 
in 10 ml TRIzol® Reagent per 1 g tissue and homogenised in a glass Teflon 
















Figure 13 Isolation apparatus for H.contortus adults. Designed by G.Coles, 
University of Bristol.
55
room temperature for 5 min to permit the complete dissociation of 
nucleoprotein complexes. 2 ml chloroform was added per 10 ml TRIzol® and 
the tubes vigorously shaken for 15 seconds. The samples were incubated for 
a further 3 min at room temperature before centrifugation at 12,000 x gfor 15 
min at 4°C. The upper aqueous phase, containing the RNA, was transferred 
to another Corex tube and the RNA was precipitated by the addition of 5 ml 
isopropanol per 10 ml TRIzol® used for the initial homogenisation. Samples 
were incubated at room temperature for 10 min and centrifuged at 12,000 x g 
for 10 min at 4°C. The supernatant was removed and the RNA pellet 
resuspended in 10 ml 75% (v/v) ethanol per 10 ml TRIzol® initially used. 
Samples were then centrifuged at 7,500 x g for 5 min at 4°C. The RNA pellet 
was vacuum dried for 5 min and dissolved in 0.5% (w/v) SDS by passing a 
few times through a pipette tip and incubating for 10 min at 55-60°C.
2.2.2.4 Quantitation of RNA solutions
The amount of total RNA isolated was estimated by determining the O.D.26o 
of a 1:100 dilution of the sample in DEPC-treated sterile ddH20  using a 
spectrophotometer. A 1:100 dilution of 0.5% (w/v) SDS in sterile ddH20  was 
used as a blank. The concentration was calculated using the equation:
RNA Absorbance26o x 40 x dilution factor
Standards: 1 O.D. unit for RNA corresponds to a
concentration of 40 pg/ml 
The ratio of O.D26o/O.D280 was also determined as an indication of purity.
2.2.2.5 Purification of mRNA
Poly-[A]+ RNA was isolated using Dynabeads®oligo (dT)25 magnetic beads 
(Dynal, Wirral, UK), 2.8 pm in diameter, with a 25 nucleotide long chain of 




Binding buffer 20 mM Tris-CI; pH 7.5, 1 M LiCI, 2 mM 
EDTA
Washing buffer 10 mM Tris-CI; pH 7.5, 0.15 M LiCI, 1 mM 
EDTA
Tris-HCI 10 mM Tris-CI; pH 7.5
Beads were stored in PBS containing 0.02% (w/v) NaN3. A sample (0.2 ml, 1 
mg) of bead suspension was transferred to a 1.5 ml microfuge tube and this 
was placed into a Dynal MPC®-E magnetic particle concentrator and the 
supernatant removed. The beads were washed by the addition and removal 
of 100 pi 2x binding buffer followed by resuspension in 100 pi 2x binding 
buffer. 200 pg total RNA was dissolved in 100 pi DEPC-treated water, 
heated for 2 min at 65°C to disrupt secondary structure and added to the 
washed beads. The mRNA was allowed to anneal for 5 min on a rotating 
platform at room temperature and then placed on the concentrator to allow 
removal of the supernatant. The beads were washed twice with 200 pi 
washing buffer and re-suspended in 30 pi elution buffer before heating at 
65°C for 2 min. Eluted poly [A]+ RNA was extracted immediately after 
separation from the beads and used directly for northern blot or RT-PCR.
2.2.3 Northern Blot Analysis
Solution Components
10 x MESA* 200 mM MOPS, 50 mM Sodium Acetate, 10 
mM EDTA; pH 7.0
Electrophoresis buffer* 1 x MESA
Formaldehyde gel loading 
buffer*
7.2 ml deionised formamide, 1.6 ml 10 x 
MESA, 2.6 ml deionised formaldehyde, 2.6 
ml water, 1 ml 80% glycerol, 0.01% (v/v)
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bromophenol blue
Formaldehyde Commercially available as a 37% (w/v) 
solution (12.3 M) in water
DIG Easy-hyb buffer* Commercially available hybridization buffer 
granules reconstituted in water (Roche 
Molecular Biochemicals, E. Sussex, UK))
20 x SSC* 3 M NaCl, 300 mM sodium citrate; pH 7
Mafeic acid buffer* 100 mM maleic acid, 150 mM NaCl; pH 7.5
Blocking solution* Commercially available solution diluted 
1:10 in maleic acid buffer (Roche Molecular 
Biochemicals, E. Sussex, UK)
Detection Buffer* 100 mM Tris-CI, 100 mM NaCl; pH 9.5
*RNase-free solutions were prepared in 0.1% DEPC treated water
2,2.3.1 Labelling RNA with Digoxigenin (DIG) labeled UTP mix
A 200-500 bp fragment of the gene of interest was sub-cloned into 
pBluescript SK* vector. The recombinant plasmid was linearised downstream 
of the cloned sequence by restriction digestion allowing the creation of run­
off transcripts of uniform length. This was followed by purification of the DNA 
by phenol/chloroform extraction and ethanol precipitation. The labelling 
reaction was then set up as follows: 1 pg purified DNA template, 2 pi NTP 
labeling mix (10 mM ATP, 10 mM CTP, 10 mM GTP, 6.5 mM UTP, 3.5 mM 
DIG UTP; in Tris-CI, pH 7.5), 2 pi 10 x transcription buffer (400 mM Tris-CI, 
pH 8; 60 mM MgCI2, 100 mM dithioerythritol, 20 mM spermidine, 100 mM 
NaCl), 0.5 pi RNase inhibitor (20 units/pl), DEPC-treated (Roche Molecular 
Biochemicals, E. Sussex, UK). Following mixing and brief centrifugation, this 
reaction was allowed to proceed at 37°C for 2 hr before the addition of 2 pi 
RNase free, DNase I (10 units/pl) for a further 15 min at 37°C. 200 mM 
EDTA, pH8 (2pl) was added to terminate the reaction.
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2,2.3,1.1 Estimation of yield of DIG-labelled RNA
The yield of DIG-labelled RNA was estimated by comparison against 
labelled control RNA in a spot test. Labelled control RNA (5 pi) was mixed 
with 20 pi DEPC-treated water (final concentration 20 ng/pl). This was then 




Stepwise dilution Final concentration
20 ng/pl 1:20 1 ng/pl
1 ng/pl 1:10 100 pg/pl
100 pg/pl 1:10 10 pg/pl
10 pg/pl 1:10 1 pg/pl
1 pg/pl 1:10 0.1 pg/pl
0.1 pg/pl 1:10 0.01 pg/pl
The experimental probe was diluted in the same way. Each control dilution 
(1 pi) was then spotted on a piece of dry positively charged nylon membrane 
(Roche Boehringer Mannheim). The experimental RNA dilutions were 
spotted on a second row and the nucleic acids were fixed to the membrane 
by UV cross-linking for 5 min. The membrane was briefly washed in washing 
buffer (maleic acid buffer with 0.3% (v/v) Tween®20) before incubation in 
blocking buffer for 30 min. Anti-DIG antibody was diluted 1:10,000 in 
blocking buffer and the membrane was incubated for 30 min in the diluted 
antibody solution at room temperature. The membrane was washed twice, 15 
min per wash, in washing buffer at room temperature before equilibration of 
membrane in detection buffer for 2 min. A 1:100 dilution of CSPD® (25 mM 
Disodium 3-(4-methoxyspiro {1,2-dioxetane-3,2’-(5’-
chloro)tricyclo[3.3.1.13,7]decan}-4-yl) phenyl phosphate) in detection buffer 
was carried out before applying 0.5 ml of this chemiluminescent substrate 
dropwise to the membrane between two sheets of acetate. The acetate was 
sealed at all sides using a heat sealer and the filter was incubated at 37°C
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for 15 min to shorten exposure time. The membrane was then exposed to X- 
ray film for 2 hours.
2.2.3.2 Denaturing formaldehyde gel electrophoresis
Agarose (1 g) was added to 124 ml DEPC treated water in a conical flask 
and heated in a microwave to melt the agarose. 10 x MESA (15 ml) and 11 
ml 37% (w/v) formaldehyde were added and following swirling to mix the gel 
was poured immediately in a perspex gel rig, and left to set. All apparatus 
was pre-treated with 1% (v/v) hydrogen peroxide to denature RNAses. The 
gel rig was placed in a horizontal electrophoresis tank and 1 x MESA was 
added until the gel was submerged. Samples were prepared by mixing poly 
[Af, or total, RNA with 10-20 pi freshly prepared formaldehyde gel loading 
buffer and the DIG-labelled RNA molecular weight marker was prepared by 
the addition of 16 pi loading buffer to 4 pi marker. All samples were 
incubated at 65°C for 15 min and then chilled on ice. Samples were loaded 
onto the gel and the gel was run at 80V for 4 hours. The cast and gel were 
then transferred to a tupperware box and washed with 20 x SSC to remove 
formaldehyde.
2.2.3.3 Northern transfer
The RNA was blotted from the gel onto Boehringer positively charged nylon 
membrane by capillary transfer overnight at room temperature. RNA was 
then UV cross-linked to the membrane for 5 min.
2.2.3.4 Hybridisation and detection of Northern blot
Following removal of the marker lane, the blot was placed in a hybridisation 
bottle and incubated with 20 ml prehybridisation solution (DIG Easy Hyb, 
Roche Boehringer Mannheim) at 68°C for 1 hour. The DIG-labelled probe 
was meanwhile heat-denatured in a boiling water bath for 10 min and diluted 
in 5 ml prehybridisation solution to a concentration of 100 ng/ml 
(hybridisation buffer). Prehybridisation buffer was discarded and the blot was 
incubated with hybridisation buffer at 68°C overnight. Following hybridisation 
the blot was washed twice, 15 min per wash, in 2 x wash solution (2 x SSC,
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containing 0.1% (w/v) SDS) at room temperature followed by 2 washes in 0.5 
x wash solution (0.5 x SSC, containing 0.1% (w/v) SDS at 68°C. All further 
steps were carried out at room temperature unless stated. The marker lane 
was included in all further steps. The membrane was then equilibrated in 
washing buffer for 1 min (maleic acid buffer containing 0.3% (v/v) 
Tween®20). This was discarded and the membrane was blocked by gentle 
agitation in blocking solution for 1 hour. Anti-Digoxigenin antibody was 
meanwhile diluted 1:10 000 in blocking solution and the blot was then 
incubated in this solution, with gentle agitation for 30 min. The antibody 
solution was discarded and the membrane gently washed twice in washing 
buffer. The membrane was then equilibrated in detection buffer for 2 min. 
meanwhile CSPD® was diluted 1:100 in detection buffer. The membrane was 
placed between 2 sheets of acetate and 0.5 ml chemiluminescent substrate 
was scattered dropwise on the surface. The top sheet was then lowered and 
wiped with a damp tissue to remove air bubbles and the bag was sealed and 
incubated at room temperature for 5 min. To decrease time taken for the 
chemiluminescent substrate to reach equilibrium, the membrane was 
incubated at 37°C for 15 min before exposure to X-ray film overnight. Films 
were developed using a X-Ograph Compact X2 processor.
2.2.4 Amplification of cDNA
2.2.4.1 Oligonucleotide production
As full-length sequences of all genes investigated were available, gene 
specific primers were designed with the following common parameters: 1) 
The length of the primer was a minimum of 18 nucleotides. Each additional 
nucleotide made the primer four times more specific. 2) The terminal 
nucleotide in the primer had a G or C residue. 3) Primer pairs, particularly at 
3’ ends, were not complementary to each other to avoid primer-dimers. 4) 
Primers were best designed with -50%  GC content. Primer pairs were 
designed such that their GC content and Tm (melting temperature, defined 
as the dissociation of the primer/template duplex) were similar. 5)
The Tm was calculated using the equation (Lowe et al., 1990)
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Tm = 81.5+16.6(log10(Na+)) + 41(G+C)-675
A+G+C+T
where Na+ is assumed to be 0.1 M.
Oligonucleotides were custom synthesised by Life Technologies, Paisley, 
UK. They were supplied lyophilised and were reconstituted in sterile ddH20  
on receipt to give a stock concentration of 20 pM.
2.2.4.2 Reverse transcription-polymerase chain reaction (RT-PCR)
The Titan™ RT-PCR system (Roche Molecular Biochemicals) or Access RT- 
PCR (Promega, Madison, USA) were used to amplify cDNAs of interest. The 
Titan™ system uses the AMV reverse transcriptase for first strand synthesis 
and the Expand™High Fidelity enzyme blend, which consists of Taq DNA 
polymerase and Pwo DNA polymerase, for the PCR. The combination of 
thermostable Taq DNA polymerase and Pwo DNA polymerase allows 3 -5 ’ 
proofreading to occur increasing the fidelity of the reaction. The Access 
System uses AMV reverse transcriptase for first strand synthesis and Tfl 
DNA polymerase for the PCR. Tfl DNA polymerase does not have 3’ 
exonuclease activity. Poly [A]+ RNA from wild-type H.contortus eggs was 
used for all full-length amplifications of subunits. Poly [A]+ RNA from 
ivermectin resistant H.contortus adults was used for full length amplifications 
of subunits Total RNA was used for amplification from cell lines. All reactions 
were carried out on a PTC-150 hot-bonnet minicycler (GRI, Braintree, UK).
2.2.4.2.1 Titan™ RT-PCR system
A typical Titan™ reaction contained 4 pi dNTP mix (10 mM each 
triphosphate), 2.5 pi DTT (100 mM), 1 pi Rnase inhibitor (5 units/pl), 0.4 pM 
of both sense and anti-sense primers, 100 ng Poly [A]+ RNA, 10 pi 5 x RT- 
PCR buffer, 1 pi RT-PCR enzyme mix (1 unit/pl) and nuclease-free water to 
give a final volume of 50 pi. Thermocycling conditions included an initial 
reverse transcription of 30 min at 55°C followed by denaturation of cDNA for 
2 min at 94°C. This was followed by 30 sec at 94°C, primers were made to 
hybridise to the template at previously calculated annealing temperature for
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30sec-1min and then strands were elongated at 72°C for 2 min and this was 
repeated for 40 cycles. Finally a 7 min step at 72°C was included to ensure 
the PCR fragments were fully elongated. The exact parameters of the 
temperature cycling, however, were determined by the primers used. 
Following thermocycling 20 pi of the reaction was run on an agarose 
electrophoretic gel for analysis. If cloning of the gene was required, a TAE 
gel was used and the DNA was purified from the gel using the Geneclean II® 
method.
2.2.4.2.2 Access RT-PCR system
A typical Access RT-PCR system reaction contained 10 pi AMV/777 reaction 
buffer (5 x), 1 pi dNTP mix (10mM), 2.5 pi of both sense and anti-sense 
primers (20 pM), 2 pi MgS04 (25 mM), 1 pi AMV reverse transcriptase (5 
u/pl), 1 pi Tfl DNA polymerase (5 u/pl), 100ng poly [A]+ RNA or 1 pg total 
RNA and nuclease-free water to give a final volume of 50pl. Thermocycling 
conditions were as the Titan™ RT-PCR system except for the initial reverse 
transcription which was carried out at 48°C for 45 min.
2.2.4.3 Blunt-ending PCR products
As Tfl DNA Polymerase does not have proofreading activity, it was 
necessary to remove any non-template dependent nucleotides that may 
have been added to the 3’ end of the PCR product to allow cloning into the 
pCR®-Blunt ll-TOPO vector. T4 DNA Polymerase has 3’ exonuclease activity 
and will therefore convert a 3’-protruding end to a blunt end. Gel-purified 
DNA was resuspended in T4 DNA polymerase buffer (33 mM Tris-acetate, 
pH 7.9, 66 mM potassium acetate, 10 mM magnesium acetate, 0.5 mM DTT) 
containing 100 pM of each dNTP and 0.1 mg/ml BSA. Five units of T4 DNA 
Polymerase were added per microgram of DNA in a final volume of 20 pi. 
The reaction was incubated at 37°C for 5 min., before termination by heating 
at 75°C for 10 min.
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2.2.5 Cloning of PCR products
PCR products were cloned into the vector pCR®-Blunt ll-TOPO using the 
Zero Blunt™ TOPO™ PCR cloning kit (Invitrogen, Holland). The vector was 
supplied linearised and has vaccinia virus topoisomerase 1 covalently bound 
to the 3’ end allowing spontaneous ligation of the vector with a blunt-ended 
PCR product. Approximately 50 ng purified PCR product and 1 pi pCR®- 
Blunt II TOPO vector were added to sterile water, in a final volume of 5pl. 
The reaction was mixed gently and incubated for 5 min at room temperature. 
Following the incubation, 1 pi 6 x TOPO™ Cloning Stop Solution was added 
and the reaction was mixed and placed on ice. A vial of TOP10™ One 
Shot™ cells was thawed on ice and 20 pi of the ligation mix was added to 
the cells. This was gently mixed and incubated on ice for 30 min. Cells were 
then heat shocked for 30 sec in a 42°C water bath followed by immediate 
transfer to ice for 2 min. Room temperature SOC medium (250 pi) was 
added to the cells before horizontal shaking of tubes for 1 hour at 37°C to 
induce expression of antibiotic resistance genes. The transformed cells (50- 
100pl) were spread on pre-warmed LB agar plates containing 50 pg/ml 
kanamycin and these were incubated at 37°C overnight. Colonies were 
picked and grown for 12-16 hours in LB medium containing 50 pg/ml 
kanamycin and plasmid DNA was purified from the bacteria using the 
CONCERT™ Rapid Plasmid Purification System (Life Technologies, Paisley, 
UK). The DNA was analysed initially by restriction digest and then 
sequenced using the M13 forward and reverse primers.
2.2.5.1 Sequencing of clones
Approximately 1 pg of CONCERT™ DNA preparation was sent to DNAShef, 
Edinburgh, UK for sequencing. Sequence analysis was carried out on the 
GCG (Genetic Computer group, Wisconsin, USA) suite of programs, 
accessible via the gnome workstation, for analysis and comparison with 
existing sequences in the database.
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2.2.6 Cell culture methods
2.2.6.1 Maintenance of L929 mouse fibroblast cells and COS 7 primate 
kidney fibroblast cells
Cells were grown in 75 cm2 vented flasks containing 12 ml supplemented 
DMEM medium. These were incubated at 37°C with 5% C 0 2. At 80-85% 
confluence cells were washed with pre-warmed PBS before harvesting with 2 
ml trypsin/EDTA. Cells were split 1:8 for 85% confluence after 3-4 days.
2.2.6.1.1 Preparation of cells for storage in liquid nitrogen
Approximately 80% confluent cells were harvested into 10 ml media and 
centrifuged in sterile Sterilin 20 ml tubes at 1,500 rpm for 5 min. The 
resulting pellet was resuspended in 1 ml FBS containing 10% (v/v) DMSO 
(dimethylsulphoxide). The cell solution was then transferred to cryotubes 
and cooled slowly for 24 hours in liquid nitrogen fumes before transfer to 
liquid nitrogen.
2.2.6.1.2 Re-establishment of frozen cells
Frozen aliquots of cells were rapidly thawed in a 37°C water bath. They were 
then added to 10 ml fresh medium before centrifugation at 1,500 rpm for 5 
min. The resulting cell pellet was resuspended in 15 ml fresh medium, 
transferred to a 75 cm2 vented flask and incubated as before.
2.2.6.2 Establishment of stable cell lines
2.2.6.2.1 Optimisation of G418 selection
Cells were seeded in 6 well plates for 70-80% confluence the following day. 
After 24 hours incubation, cells were treated with 300, 350, 400, 450, 500 or 
700 pg/ml G418 and incubated for a further 24 hours. Cells were observed 
for a further 48 hours and percentage confluence recorded.
2.2.6.2.2 Transfection of L929 mouse fibroblast cells
Cells were seeded overnight at 5x103 in 4.5 mm cell culture dishes to reach 
50-60% confluence the following day. FuGENE™ 6 transfection reagent (6
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pi) was added directly to 94 pi serum-free medium and incubated at room 
temperature for 5 min. This mixture was then added dropwise to 3 pg DNA, 
mixed and incubated at room temperature for 15 min. This was then added 
dropwise to the cells, whilst swirling the flask for even distribution. The cells 
were incubated for 48 hours before resistance selection to the antibiotic 
G418 was begun by the addition of 450 pg/ml G418. This concentration of 
G418 will kill cells unless they contain the G418 (neomycin) resistance gene, 
which is present in the pcDNA3 genome. During the initial selection 
procedure, minimal essential medium (MEM) replaced DMEM to allow slower 
growth of cells. Colonies were apparent after 7 days and picked after 12 
days for individual growth. Trypsin/EDTA/PBS (15 pi) was added directly to 
an individual colony and the colony was sucked into a pipette tip. Each 
colony was transferred to a well in a 24 well plate and selection pressure 
was maintained by the presence of 400pg/ml G418 in the medium. Cells 
were transferred to 6 well plates a week after initial transfer to 24 well plates. 
Four days later each colony was split into two and grown to 80% confluence. 
One set of the clones was then frozen and the other set had their RNA 
extracted.
2.2.6.2.3 Isolation of total RNA from cultured cells
TriPure® RNA isolation reagent (Roche Molecular Biochemicals, E.Sussex, 
UK) was used to extract total RNA from L929 cells. TriPure® Isolation 
Reagent (0.5 ml) was added directly to each well of a 6 well plate containing 
monolayers of transfected and untransfected (control) L929 cells. The cell 
lysate was passed through the pipette tip several times and transferred to
1.5 ml microfuge tubes. Each sample was incubated at room temperature for 
5 min to ensure the complete dissociation of nucleoprotein complexes. 0.1 
ml chloroform was then added and each tube shaken vigorously for 15 sec 
before incubation at room temperature for 15 min. Separation of phases was 
achieved by centrifugation of the samples at 12,000 x g for 15 min at 4°C. 
The RNA containing upper layer was transferred to a new microfuge tube 
and 0.25 ml isopropanol added to each sample Following mixing the 
samples were incubated at room temperature for 10 min to allow the RNA
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precipitate to form. The samples were again centrifuged at 12,000 x g for at 
4°C for 10 min. The resulting RNA pellet was then washed in 1 ml 75% 
ethanol by vortexing and centrifugation at 7 500 x g for 5 min at 4°C. The 
pellet was dried and the samples resuspended in 100 pi DEPC-treated 
water.
2.2.6.2.4 Transcription of cRNA
RNA from each gene to be investigated was required as a positive control 
during RT-PCR analysis of transfected cells. cDNA was available in a 
plasmid for each subunit to be investigated and therefore cRNA could be 
transcribed. The plasmid was linearised at the 5’ end of the H.contortus 
cDNA of interest by restriction digestion and the resulting DNA purified by 
phenol/chloroform extraction. cRNA was transcribed using T7 RNA 
polymerase, as the plasmid contained the T7 promoter just downstream of 
the GluCI subunit sequences. A typical transcription reaction was composed 
of 10 pg linearised DNA, 10 pi 10 x transcription buffer, 10 pi DTT(100 mM), 
4 pi RNAguard (38 units/pl), 5 pi rNTPs (5 mM), 2 pi T7 RNA polymerase (20 
units/pl) and sterile, RNase-free water to 100 pi. This was incubated at 37°c 
for 1 hour before the addition of 5pl RNase-free DNase 1 (10 units/pl) for an 
additional 15 min at 37°C to remove residual DNA. A phenol (water- 
saturated)/chloroform extraction was then carried out and the purified DNA 
was resuspended in 25 pi Rnase-free water.
2.2.6.3 Transient expression in COS 7 cells
2.2.6.3.1 Transfection of COS 7 cells
Cells were seeded overnight in 75 cm2 tissue culture flasks to reach 
approximately 40% confluence the following day. For transfection of cells, 15 
pi FuGENE™ 6 transfection reagent was added directly to 85 pi serum-free 
media and incubated at room temperature for 5 min. This mixture was then 
added dropwise to 10 pg DNA, mixed and incubated at room temperature for 
15 min. This was then added dropwise to the cells, whilst swirling the flask
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for even distribution. The cells were incubated for 48 hours before 
harvesting.
2.2.7 Immunofluorescence
COS 7 cells were seeded overnight on glass cover slips, contained in 6 well 
plates, to give a confluence of approximately 40% the following day. Cells 
were added only to the cover slips and incubated for 1 hr to allow attachment 
before flooding the plate with 2 ml medium. The cells were transfected as 
previously described, using a ratio of 3 pi FuGENE™ 6:1 pg DNA and 
incubated for 48 hours. The medium was removed and the cover slips 
washed 3 times (5 min each) with PBS before fixing cells with 4% (w/v) 
paraformaldehyde in PBS at room temperature for 20 min. Cells were 
washed with PBS ( 3 x 5  min) and permeabilised with 0.1% (v/v) Triton X-100 
in PBS for 5 min to allow antibody to bind within the cells. Following washing 
with PBS (5 min) cells were blocked with 0.2% (w/v) BSA in PBS for 30 min 
at room temperature. Cover slips were inverted onto 70 pi primary antibody 
diluted in 0.2% (w/v) BSA in PBS and incubated for an hour at room 
temperature. Cover slips were returned to their well and washed 2 x 5  min in 
0.2% (w/v) BSA and 2 x 5  min washes in PBS to remove any unbound 
primary antibody. Coverslips were inverted onto 70 pi mouse anti-flag 
antibody diluted in 0.2% (w/v) BSA in PBS and incubated for an hour at room 
temperature. Cover slips were returned to their well and washed 2 x 5  min in 
0.2% (w/v) BSA and 2 x 5  min washes in PBS to remove any unbound 
primary antibody. Cover slips were inverted onto 70 pi goat anti-mouse 
(FITC-conjugated) secondary antibody diluted in 0.2% (w/v) BSA for 20 min 
in the dark, to prevent bleaching of fluorescence. They were returned to their 
well and washed as after primary antibody to prevent background 
fluorescence. Cover slips were mounted onto a drop of Vectashield® 
mounting media on a microscope slide and left overnight in the dark. Cells 
were viewed on a Zeiss LSM 510 inverted Axiovert 100M confocal 
microscope using a fluorescein filter set.
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2.2.8 Membrane preparation
2.2.8.1 Preparation of membranes from cultured cells
Transiently transfected COS 7 cells were harvested 48 hours post­
transfection by which time they were approximately 85% confluent. Control 
cells and stably transfected L929 cells were harvested at approximately 85% 
confluence. Medium was removed from the flask by aspiration and the cells 
were washed three times with ice-cold 50 mM HEPES (pH 7.4) containing 
0.01% (w/v) sodium azide. The cells were harvested using a cell scraper and 
resuspended in 10 ml 50 mM HEPES (pH 7.4), 0.01% (w/v) sodium azide. 
Cells were disrupted further by sonication (3 x 15 sec pulses). They were 
then transferred to 10 ml ultracentrifuge tubes and centrifuged at 28,000 rpm 
for 30 min at 4°C. The resulting pellet was resuspended in 1 ml ice-cold 50 
mM HEPES (pH 7.4) containing 0.01% (w/v) sodium azide and 0.2 mM 
PMSF. The protein was quantified using the Coomassie® plus Protein Assay 
Reagent Kit (Pierce, Rockford, USA).
2.2.8.2 Membrane preparations from H.contortus L3-stage larvae
L3-stage larvae were supplied by Gerald Coles (University of Bristol, Bristol, 
UK). Approximately 1-4g larvae were used per preparation. These were 
suspended in 7ml membrane buffer (50 mM HEPES (pH 7.4), 0.2 mM PMSF, 
leupeptin (0.5 pg/ml), pepstatin (0.7 pg/ml)) and the nematode cuticle was 
disrupted by the addition of 15-20 crushed glass cover slips followed by 
approximately 5 cycles of 1 min vortexing and 2 min cooling on ice. This 
procedure was continued until all worms appeared broken upon microscopic 
inspection. The volume of homogenate was adjusted to 40 ml with 50 mM 
HEPES (pH 7.4) and this was centrifuged at 1,000 x g for 10 min. The pellet 
was discarded and the supernatant centrifuged at 28,000 x g for 30 min at 
4°C. Membranes were resuspended in 50 mM HEPES buffer (pH 7.4) to a 
final concentration of 1 mg/ml (quantified by Coomassie® plus Protein Assay 
Reagent Kit) and stored at -20°C.
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2.2.8.3 Quantitation of protein in membrane preparations
The protein content of each membrane preparation was analysed by 
comparison with a series of standard bovine serum albumin (BSA) solutions 
in 50 mM HEPES (pH 7.4) ranging from 0.1 to 1 mg/ml using the 
Coomassie® protein assay kit. This is a variation on the Bradford, 
Coomassie®, colorimetric method (Bradford, 1976) whereby the binding of 
Coomassie® Brilliant Blue G-250 to protein causes a shift in the maximum 
absorbance of the dye from 465 to 595 nm under acidic conditions. The 
assay can be monitored by the simultaneous colour change of the reagent 
from green/brown to blue. The assay was carried out in a 96 well plate using 
only 10 pi of each sample with 300 pi of Coomassie® Protein Assay Reagent 
(contains Coomassie® G-250, methanol, phosphoric acid and solubilizing 
agents in water). Standards were measured in quadruplicate and cell 
samples were diluted 1/10 before analysis. All samples were measured 
against a blank of 10 pi buffer with 300 pi protein reagent. The optical 
density was measured at 595 nm.
2.2.9 Radioligand binding
2.2.9.1 Binding of [3H] ivermectin to membrane preparations
[3H] ivermectin binding experiments were carried out in 5 ml polypropylene 
test tubes. Membranes were incubated with [3H] ivermectin in 50 mM HEPES 
(pH 7.4) with 5-40 pg protein. Non-specific binding was determined by 
binding in the presence of 10 pM unlabelled ivermectin. Final assay volumes 
were 1ml and reactions were incubated at room temperature for 2 hours. The 
binding reaction was terminated by dilution with 3 ml cold wash buffer (50 
mM HEPES (pH 7.4) containing 0.25% (v/v) Triton X-100) followed by 
filtration through type A/B glass fibre filters (Whatman, Kent, UK)) which 
were pre-soaked in 0.15% (v/v) Polyethyleneimine (PEI) in wash buffer. 
Filters were washed twice more with 3 ml wash buffer (Hejmadi et al., 2000, 
Rohrer et al., 1994, Smith et al., 2000). Bound radioactivity was determined 
by liquid scintillant spectrometry in mini-vials containing 5 ml Optiphase Safe 
(Wallac, Bucks., UK). For the competition studies, membranes were
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incubated with 140 pM (HG3) or 150 pM (HG5) [3H]ivermectin at room 
temperature for 2  hours with various concentrations of competing ligands. 
Non-specific binding was determined in the presence of 10pM unlabelled 
ivermectin. All reactions were carried out in duplicate and experiments were 
repeated between 3 and 6  times.
2.2.9.2 Radioligand binding data analysis
Non-linear regression analysis (Sigma plot v 4.0, Jandel Scientific) was used 
to determine the dissociation constant for the equilibrium binding of the 
radiolabel (Kd) fitted to a single-site binding model. Data were fitted to the 
equation
y = (Bm axtfHJIigandD/Kd + [[3H]ligand].
The parameters, IC50 (the concentration of competing drug that inhibits 50% 
of the specific binding) and Kj (the affinity of the inhibitor for the receptor) 
were determined from competition assays. Data were fitted to the Hill 
equation to determine IC50 values for each competitor.
B = 100%/1 +([ligand]/ICso)nH 
(where B = % bound radiolabel, [ligand] = concentration of displacing ligand 
and nH = Hill number)
These were converted to K, using the equation
Kj = IC50/1 + ([radioligand]/!^).
2.2.10 Protein analysis
2.2.10.1 SDS-Polyacrylamide gel electrophoresis
Reagents Component
Protogel® solution (National 
diagnostics, Hull, UK)
30% (w/v) acrylamide, 0.8% (w/v) bis 
acrylamide
Resolving gel buffer (4x) 1.5 M Tris-CI, 0.4% (w/v) SDS (pH 
8 .8 )*
Stacking gel buffer (4x) 0.5 M Tris-CI, 0.4% (w/v) SDS (pH 
6 .8 )*
APS 1 0 % (w/v) ammonium persulphate in
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ddH20 ‘
6x SDS loading buffer 0.35 M Tris-CI, pH 6.8, 10.28% (w/v) 
SDS, 36% (v/v) glycerol, 5% (v/v) p- 
mercaptoethanol, 0.012% (w/v) 
bromophenol blue#
5x running buffer 3 g Tris-base, 14.4 g glycine, 0.5 g 
SDS in 100 ml ddH20
‘Adjusted to pH 8.8 with 1 N HCI, filtered through a 0.45pm filter and stored 
at 4°C. ‘ Stored at 4°C for 5 days only. #Stored at -20°C.
To prepare two 12% (v/v) separating gels, 6 ml Protogel® solution was mixed 
with 3.75 ml 4 x resolving gel buffer and 5.25 ml ddH20 . The mixture was de­
gassed under vacuum for 10 min and 100 pi APS and 10 pi TEMED were 
added immediately before pouring into Atto™ mini-gel rigs. The gel was 
overlaid with isopropanol and allowed to polymerise. Once set, the 
isopropanol was removed from the gel and the gel interface washed with 
ddH20 . A 4% (v/v) stacking gel (0.65 ml Protogel® solution, 1.25 ml stacking 
buffer, 3.05 ml ddH20 , 25 pi APS, 5 pi TEMED) was pipetted over the 
separating gel and a comb inserted. Once set, gels were placed into an 
electrophoretic chamber and 1 x running buffer was added. Combs were 
removed and wells rinsed with ddH20 . Membrane preparations were 
prepared for loading (10-20 pg) by the addition of 6 x SDS loading buffer 
and denaturation by incubation in a boiling water bath for 5 min. A rainbow 
molecular weight marker (10-250 kda) (Amersham Life Sciences, Bucks., 
UK) was also run. Samples were spun down at 12,000 rpm for 1 min 
immediately prior to loading. Gels were run at 100 V until the bromophenol 
blue tracking dye had just run off the bottom.
2.2.10.1.1 Western Blotting and Immunodetection
2.2.10.1.1.1 Electrophoretic transfer to nitrocellulose
Gels were placed in a tray containing SDS transfer buffer. A sheet of 
nitrocellulose blotting membrane and 18 sheets of filter paper were cut to the 
size of the gel and pre-wet in SDS transfer buffer. Nine sheets of pre-wet
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filter paper were placed on the anode of the Multiphor II Novablot 
electrophoretic transfer unit and air bubbles removed by rolling with a 5 ml 
pipette tip. The nitrocellulose was placed on the filter paper, followed by a 
gel and the other nine sheets of pre-wet filter paper. The cathode surface of 
the transfer unit was wet before placing on top of the anode. The transfer 
was run at 0.8 mA/cm2 of gel for 1 hr 50 min.
2.2.10.1.1.2 Immunoprobing and detection
Buffer Components
Transfer buffer 25 mM Tris-CI, pH 8.3, 150 mM 
glycine, 0.037% (w/v) SDS, 20% (v/v) 
ethanol*
TBST 10 mM Tris-CI pH 8, 150 mM NaCI, 
0.1% (v/v) Tween 20
Blocking solution 5% (w/v) Marvel™ non-fat milk 
powder in TBST
* ethanol was added immediately before use
A nitrocellulose membrane containing transferred protein was washed briefly 
in washing buffer before incubating overnight at 4°C in blocking solution. 
The blot was rinsed in washing buffer to remove any unbound milk proteins 
before incubation with primary antibody diluted in blocking solution for 1 
hour at room temperature. The membrane was rinsed in washing buffer for 5 
min, 10 min and 15 min on a rotating platform to remove unbound primary 
antibody before incubating with secondary antibody (horseradish 
peroxidase-conjugated), diluted in blocking buffer, for 1.5 hrs. The blot was 
washed as after primary antibody incubation. The chemiluminescence ECL 
detection kit was used to detect immunoreactivity in the blot. An equal 
volume of detection solution 1 and detection solution 2 were mixed and 
incubated on the membrane for 1 min at room temperature. Excess fluid was 
removed and the blot placed between acetate before exposing to X-ray film 
(Roche Molecular Biochemicals, E. Sussex, UK) for 2-5 min. Films were 
developed using a X-Ograph Compact X2 processor.
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3. Molecular analysis of Haemonchus contortus Glutamate- 
gated Chloride Channels
Previous workers in the laboratory identified five partial cDNAs from 
H.contortus by Reverse Transcription-Polymerase Chain Reaction (RT-PCR), 
using degenerate oligonucleotides primers corresponding to conserved 
regions of ligand-gated chloride channels (Laughton, 1993). Four of the 
cDNAs showed characteristic features of the cys-loop ligand-gated ion 
channels and had highest sequence identity to the C.elegans glutamate- 
gated chloride channel subunits. A full-length C.elegans (3-subunit 
homologue, HG4 (Hc-gluclp), which shared 82% amino acid identity with its 
C.elegans counterpart (Cully et al., 1994), was cloned from H.contortus eggs 
(Delany et al., 1998). Jagannathan (1998) demonstrated by Rapid 
Amplification of cDNA ends (RACE) PCR that the gbr-2 (avr-14) gene was 
present in H.contortus eggs and that the pattern of alternative splicing which 
had been observed in C.elegans (Laughton et al., 1997) appeared to be 
conserved. Two subunits, with identical N-terminal regions but different C- 
terminal domains, are thereby produced from a single gene. Although one of 
these subunits, HG3 (gbr-2b), had been amplified and cloned, problems were 
encountered detecting sufficient quantities of HG2 (gbr-2a) mRNA to allow 
cloning. Semi-quantitative PCR analysis suggested that very low levels of the 
HG2 variant were present in H.contortus eggs and it was assumed that there 
was insufficient mRNA for successful cloning.
An additional subunit, HG5, with no clear C.elegans homologue was also 
amplified, but although sufficient partial cDNAs were amplified and cloned to 
publish the full sequence of this subunit, attempts to amplify the entire 
subunit were ineffective (Delany, 1998). Forrester et al., (1999) suggest that 
this gene may also be alternatively spliced resulting in two products, one of 
which is truncated at the 5’ end. They also indicated, by semi-quantitative 
PCR, that expression of HG5 varies through the H.contortus life cycle and is 
maximal in adults. HG5 shows high sequence identity to C.elegans GluCla2 
(60%) and gbr-2a (62%).
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As discussed (section 1.2.4), anthelmintic resistance is a major problem in 
the livestock industry. The mechanism of nematode resistance to the 
avermectins and milbemycins (AM) is not known, but in benzamidazole and 
imidathiazole resistance an altered site of action is involved. It is possible that 
altered GluCI subunits may contribute to the observed AM resistance. No 
consistent coding changes were observed in HG2, HG3 or HG4 cDNA from 
ivermectin-resistant field-isolated H.contortus (Delany, 1998, Jagannathan, 
1998), but allelic changes in the remaining subunit, HG5, have been 
discovered in laboratory isolates (Blackhall etal.t 1998).
Full-length clones of all four H.contortus GluCI subunits were required for 
expression studies (chapters 4 and 5). Alternative methods to assess the 
quantity of HG2 mRNA and to amplify and clone this subunit and HG5 are 
discussed in this chapter. Knowledge of the full-length sequence of these two 
cDNAs allowed gene-specific oligonucleotides to be produced and used in 
the sensitive technique of RT-PCR to amplify the complete HG2 and HG5 
cDNAs from H.contortus eggs. Amplification of the full-length HG5 subunit 
cDNA was also attempted from ivermectin-resistant H.contortus for sequence 
comparison with HG5 from ivermectin-sensitive H.contortus.
3.1 Results
3.1.1 Expression of HG2 and HG3 mRNA in H.contortus eggs
Semi-quantitative PCR is not always a reliable method of quantifying the 
expression levels of DNA as there are so many variables in a PCR reaction, 
nor can it always be used as conclusive proof of alternative splicing of a gene 
transcript. Northern hybridisation, however, is carried out on RNA and does 
not have the huge number of variables that are found in semi-quantitative 
PCR. The relative abundance of HG2 and HG3 in H.contortus mRNA was 
investigated by northern blot analysis using a cRNA probe and the 
Digoxygenin method. The Digoxigenin (DIG) method of hybridisation is non­
isotopic, but instead allows detection of RNA by binding of an anti-DIG 
antibody-alkaline phosphatase conjugate to a DIG-labelled probe hybridised 
to the RNA of interest. The signal is then detected using chemiluminescent 
alkaline phosphatase substrates (DIG System User Guide, Boehringer 
Mannheim). H.contortus eggs, rather than adults or larvae, were used to
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maintain continuity with previous work. Eggs are easy to obtain and purify in 
large quantities and yield high quality mRNA without necessitating the 
sacrifice of the infected animal.
3.1.1.1 Northern Blot probe design and production
A probe was designed to incorporate the HG3 intracellular loop region, as 
this is also present in the untranslated region of HG2 and the probe would 
consequently detect both mRNAs (figure 14). The intracellular loop is the 
most variable part of the GluCI subunits and the probe would therefore not 
detect subunits other than HG2 and HG3 in the mRNA.
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Figure 14 gbr-2 probe design. The 180bp northern blot probe was designed to the 
HG3 intracellular loop.
I I Extracellular domain □  □  Transmembrane domains
O  Probe —  Untranslated region
RNA probes are recommended for use with northern blots as an RNA:RNA 
bond is stronger than RNA:DNA. cDNA encoding the intracellular loop of 
HG3 was amplified by PCR and cloned into the vector pCRBIunt (appendix 2) 
by Virginia Portillo. The HG3 cDNA was digested from its original vector 
(figure 15) and subcloned into the multiple cloning site of pBluescript II 
(appendix 3) to allow the T7 promoter to be used for RNA transcription. The 
approximately 180 bp DNA band was cut from the gel and purified before 
ligation with EcoRI/BamHI digested pBluescript II DNA. Competent XL-1 Blue 
bacterial cells were transformed with the ligated DNA (5 pi). The resulting 
recombinant plasmid was linearised with Xbal (10 units)(2 hours at 37°C) and 
1 pg was used as a template for RNA transcription. RNA was Digoxigenin-
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11-UTP (DIG) labelled during transcription, with one DIG molecule 
incorporated every 20-25 nucleotides. The DIG protocol predicted 2-10 pg of 




Figure 15 Restriction endonuclease digestion of HG3 intracellular loop from 
pCRBIunt. The restriction enzymes EcoRI and BamHI (10 units each) (in buffer 2) 
were used to cut 10 pg DNA for three hours at 37°C. The DNA was 
electrophoresed through a 1.5% (w/v) agarose gel in TAE buffer. Lanes 1 and 2: 
digested recombinant plasmid. Lane 3: 100 bp molecular weight marker.
A more accurate assessment of the quantity of RNA present after the 
transcription reaction was required to ensure the correct amount of RNA was 
used as a probe. The yield of DIG-labelled RNA was estimated by 
comparison against a DIG-labelled control (figure 16).
A B c D
Control
HG3
Figure 16 Spot test to estimate the concentration of the HG3 RNA probe. Control 
DIG-labelled RNA of known concentration was serially diluted and compared against 
the HG3 RNA probe by spotting on positively charged nylon membrane and 
detection using chemiluminescence. A = 1 ng/pl, B = 100 pg/pl, C = 10 pg/pl, D = 1 
pg/pi
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The HG3 RNA probe was labelled at a slightly lower concentration than 
control and 6.825 pg labelled RNA was estimated to be present in the final 
20 pi volume.
Total RNA was extracted from 1.9 g H.contortus eggs and final resuspension 
was in 500 pi 0.5% SDS. The purity and quantity of the RNA was assessed 
initiaiiy by agarose gel electrophoresis (figure 17) followed by 
spectrophotometric analysis (O.D.260), which estimated a final concentration 
of 5.5 pg/pl and a purity ratio (O.D. 260/O.D.280) of 1.8. In general, a reduction 
in non-specific hybridisation can be obtained by using mRNA, rather than 
total RNA, in a northern hybridisation. This additional step also concentrates 
the target message and therefore, poly [A]+ RNA was extracted from 1 mg
H.contortus total RNA using magnetic beads coated with Oligo(dT)25 
(Dynabeads®, Dynal). The poly A residues at the 3’ end of the mRNA base 
pair with the oligo dT residues on the beads, whereas RNA species lacking a 
poly A tail do not and can be washed off. The expected mRNA yield was 
approximately 10 pg, which was resuspended in 50 pi Rnase-free water.
Figure 17 H.contortus egg RNA. 5pl total RNA (5.5 pg/pl) was electrophoresed 
through a 1% (w/v) agarose gel in TBE buffer. The 18S and 28S bands are 
indicated.
Following denaturation, the mRNA was electrophoresed through a 0.7% (w/v) 
agarose denaturing formaldehyde (2.2 M) gel alongside a DIG-labelled RNA 
marker for 4 hours at 80V. A total RNA (100pg) sample was also included as
3.1.1.2 H.contortus Northern Blot
28S
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a control. This lane was removed and stained with ethidium bromide (figure 
18).
M  28S
< -----  18S
Figure 18 Ethidium bromide stained total RNA following denaturing 0.7% (w/v) 
agarose formaldehyde gel electrophoresis. The gel lane containing the total RNA 
(100^g) was removed and stained for 5 minutes with ethidium bromide (5 ng/ml) in 
the dark. Excess ethidium bromide was removed by washing for 2 hours in RNase- 
free water.
The probe detected two mRNAs, which correspond to the predicted size of 
HG2 (2 kb) and HG3 (1.3 kb) (figure 19) and confirmed that the gbr-2  gene is 
alternatively spliced. It is evident that the two spliced variants are equally 
prevalent in the mRNA as the detected bands were of similar intensity.
2.8 ►
1.6 —
Figure 19 Northern blot analysis of H.contortus gbr-2 mRNAs. 10 i^g poly [A]+ RNA 
from H.contortus eggs was electrophoresed through a 0.7% (w/v) agarose 
formaldehyde denaturing gel and hybridised to a DIG-labelled RNA probe (100 
ng/ml) representing the intracellular loop of the H.contortus HG3 sequence. Arrows 
on the right hand side of the figure indicate the two bands identified by the probe. 
The position of DIG labelled RNA markers (in kb) are indicated by arrowheads on 
the left-hand side of the figure.
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3.1.2 Amplification and cloning of HG2 cDNA
3.1.2.1 HG2 cDNA amplification
The similar levels of expression of the gbr-2 spliced variants, HG2 and HG3, 
suggested that the problems experienced in amplifying full-length HG2 were 
not due to a lower mRNA concentration than HG3. Amplification of HG2 was 
attempted using sequence-specific primers and the sensitive detection 
technique reverse-transcription PCR (RT-PCR) technique. The full length 
HG2 sequence was available and gene-specific primers were designed to the 
regions just preceding the start codon and just succeeding the stop codon 
(figure 20). The untranslated region of HG2, which contains the sequence for 
the HG3 C-terminal domain, was not required for subsequent work and 
primers were not designed to include this region in transcription and 
amplification.
5> —► M 3>
Figure 20 Schematic of primer design strategy for amplification of full length HG2 
cDNA. Primers were designed to the available sequence on the EMBL database. M 
corresponds to the start codon, represents the stop codon. —► corresponds to 
5HG2full. —► represents 3HG2full. Primer sequences are shown in appendix 4.
The Titan™ RT-PCR system was used for amplification of HG2 cDNA. Initial 
attempts to amplify HG2 cDNA from total RNA were unsuccessful, resulting 
in non-specific or no product. Poly [A]+ RNA was used as template for 
subsequent reactions, both to ensure contaminating genomic DNA was not 
present and to enrich the targeted message.
A RT-PCR reaction including the sequence specific oligonucleotides 
3HG2full and 5HG2full successfully amplified a PCR product of 




Figure 21 Amplification of full length HG2 cDNA from H.contortus eggs’ mRNA. The 
gene-specific oligonucleotides 5HG2full and 3HG2full were used. RT-PCR 
conditions were as follows: 30 min incubation at 55°C, 2 min at 94°C and then 40 
cycles of 94°C for 30 sec, 55°C for 1 min, 52°C for 1 min and 72°C for 2 min 
followed by 72°C for 7 min. Amplification products were identified by electrophoresis 
through a 1% (w/v) agarose gel and staining with ethidium bromide. Lane 1; RT- 
PCR amplification products. Lane 2; 100 bp molecular weight markers.—► indicates 
the PCR product of approximately 1.4 kb.
3.1.2.2 Cloning and sequence analysis of HG2 cDNA
The approximately 1.4 kb PCR amplification product (figure 20) was cut from 
the gel and cloned into the bacterial expression vector pCRBIunt. Before 
seqencing, clones were digested to ensure the correct size of insert was 
present (figure 22).
Restriction endonuclease digestion of recombinant pCRBIunt indicated that 
cloning of the PCR product had been successful and two clones were 
sequenced. The pCRBIunt vector sequence includes the M13 forward and 
reverse priming sites and sequencing of the full-length cDNA was achieved 
using the M13 primers and the primer HG2seq (appendix 4). Sequence 
analysis confirmed that the clones were HG2 cDNA. Figure 23 illustrates the 
amino acid sequence for the two clones. As shown, HG2 cDNA was 
successfully amplified from the initial methionine to the stop codon. The 
cDNA contains 1360 nucleotides.
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Figure 22 Restriction endonuclease digestion of recombinant pCRBIunt. DNA (5 i^g) 
was cut with Nde I and Xba I (10 units each) (in buffer 2) for 2 hours at 37°C. The 
digests were run on a 1.3% (w/v) agarose gel in TAE buffer. Successful HG2 cloning 
resulted in digestion products of approximately 670 bp and 4.22 kb in all clones. 
Lanes 1-6: digested recombinant pCRBIunt. Lane 7: 1 kb molecular weight marker.
HG2cll MRNSVPLATR IGPMLALICT VSTIMSAVEA KRKLKEQEII QRILNNYDWR
HG2cl2 MRNSVPLATR IGPMLALICT VSTIMSAVEA KRKLKEQEII QRILNNYDWR
100
HG2cll VRPRGLNASW PDTGGPVLVT VNIYLRSISK IDDVNMEYSA QFTFREEWVD
HG2cl2 VRPRGLNAS* PDTGGPVLVT VNIYLRSISK IDDVNMEYSA QFTFREEWVD
HG2cll ARLAYGRFED ESTEVPPFW LATSENADQS QQIWMPDTFF QNEKQARRHL
HG2cl2 ARLAYGRFED ESTEVPPFW LATSENADQS QQIWMPDTFF QNEKQARRHL
200
HG2cll IDKPNVLIRI HKDGSILYSV RLSLVLSCPM SLEFYPLDRQ NCLIDLASYG
HG2cl2 IDKPNVLIRI HKDGSILYSV RLSLVLSCPM SLEFYPLDRQ NCLIDLASYG
HG2cll YTTQDIKYEW KEQNPVQQKD GLRQSLPSFE LQDWTKYCT SKTNTGEYSC
HG2cl2 YTTQDIKYEW KEQNPVQQKD GLRQSLPSFE LQDWTKYCT SKTNTGEYSC
300
HG2cll LRTQMVLRRE FSYYLLQLYI PSFMLVIVSW VSFWLDKDSV PARVTLGVTT
HG2cl2 LRTQMVLRRE FSYYLLQLYI PSFMLVIVSW VSFWLDKDSV PARVTLGVTT
HG2cll LLTMTTQSSG INANVPPVSY TKAIDVWIGV CLAFIFGALL EFALVNYAAR
HG2cl2 LLTMTTQSSG INANVPPVSY TKAIGVWIGV CLAFIFGALL EFALVNYAAR
400
HG2cll KDMSCGQRMM KQLPQDGYRP LAGSQPRTSF CCRIFVRRYK ERSKRIDWS
HG2cl2 KDMSCGQRIM KQLPQDGYRP LAGSQPRTSF CCRIFVRRYK ERSKRIDWS
422
HG2cll RLVFPIGYAC FNVLYWAVYL M*
HG2cl2 RLVFPIGYAC FNVLYWAVYL M*
Figure 23 Alignment of RT-PCR amplified HG2 clones. Blue indicates 
transmembrane regions. Conserved cysteine pairs are shown in green. Amino acids
shown in red indicate differences between clones. Stop codons are represented by
*
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Three amino acid differences were found between the clones including the 
conversion of a tryptophan to a stop codon in clone 2. Subsequent 
experiments were carried out with clone 1.
Y14233 MRNSVPLATR IGPMLALICT VSTIMSAVEA KRKLKEQEII QRILNNYDWR
HG2cll MRNSVPLATR IGPMLALICT VSTIMSAVEA KRKLKEQEII QRILNNYDWR
51 100
Y14233 VRPRGLNASW PDTGGPVLVT VNIYLRSISK IDDVNMEYSA QFTFREEWVD
HG2cll VRPRGLNASW PDTGGPVLVT VNIYLRSISK IDDVNMEYSA QFTFREEWVD
101 150
Y14233 ARLAYGRFED ESTEVPPFW LATSENADQS QQIWMPDTFF QNEKEARRHL
HG2cl1 ARLAYGRFED ESTEVPPFW LATSENADQS QQIWMPDTFF QNEKEARRHL
151 200
Y14233 IDKPNVLIRI HKDGSILYSV RLSLVLSCPM SLEFYPLDRQ NCLIDLASYG
HG2cll IDKPNVLIRI HKDGSILYSV RLSLVLSCPM SLEFYPLDRQ NCLIDLASYG
201 250
Y14233 YTTQDIKYEW KEQNPVQQKD GLRQSLPSFE LQDWTKY T SKTNTGEYSC
HG2cll YTTQDIKYEW KEQNPVQQKD GLRQSLPSFE LQDWTKYCT SKTNTGEYSC
251 300
Y14233 LRTQMVLRRE FSYYLLQLYI PSFMLVIVSW VSFWLDKDSV PARVTLGVTT
HG2cll LRTQMVLRRE FSYYLLQLYI PSFMLVIVSW VSFWLDKDSV PARVTLGVTT
301 350
Y14233 LLTMTTQSSG INANVPPVSY TKAIDVWIGV CLAFIFGALL EFAWVNYAAR
HG2cll LLTMTTQSSG INANVPPVSY TKAIDVWIGV CLAFIFGALL EFALVNYAAR
351 400
Y14233 KDMSCGQRMM KQLPQDGYRP LAGSQPRTSF CCRIFVRRYK ERSKRIDWS
HG2cll KDMSCGQRMM KQLPQDGYRP LAGSQPRTSF CCRIFVRRYK ERSKRIDWS
401 422
Y14233 RLVFPIGYAC FNVLYWAVYL M*
HG2cll RLVFPIGYAC FNVLYWAVYL M*
Figure 24 Alignment of the HG2 amino acid sequence available on the EMBL 
database (accession number Y14233) and RT-PCR amplified HG2. 
Transmembrane regions are shown in blue. Conserved cysteine residues are shown 
in green. Differences between the sequences are highlighted in red. * represents the 
stop codon.
Comparison of clone 1 with the HG2 sequence available on the EMBL 
database (accession number Y14233) identified one amino change at the 3’ 
end of the TM3 region (position 344 shown in red) (figure 24). A trypotophan
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residue has been replaced by a leucine. The C.elegans homologue CE- 
GBR2A has a leucine in this position (Laughton et al., 1997).
3.1.3 Amplification and cloning of HG5 cDNA
3.1.3.1 HG5 cDNA amplification
Previous workers had cloned HG5 as two partial cDNAs, but experienced 
difficulties in amplifying the entire sequence as a single clone (Delany, 1998). 
The partial HG5 cDNAs had been amplified from eggs and so RT-PCR was 
attempted using poly [A]+ RNA from this life-cycle stage. Subunit-specific 
oligonucleotides were designed to the regions just prior to the start codon 
(5HG5full) and after the stop codon (3HG5full) (see appendix 4).
1 2 3
< ------- 1.5 kb
A  1 kb
Figure 25 Amplification of HG5 full length cDNA from H.contortus eggs’ mRNA. The 
gene-specific oligonucleotides 5HG5full and 3HG5full were used for amplification. 
RT-PCR conditions were as follows: 30 min at 55°C, 2 min at 94°C and then 40 
cycles of 94°C for 45 sec, 54°C for 1 min, 50°C for 1 min, 72°C for 2 min followed by 
72°C for 7 min. Amplification products were identified by electrophoresis through a 
1% agarose gel and staining with ethidium bromide. Lane 1; amplification products. 
Lane 2; control amplification. Lane 3; DNA molecular weight marker, 
indicates the PCR product of approximately the expected molecular weight of HG5.
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RT-PCR amplification of HG5 cDNA using the Titan™ RT-PCR system 
appeared successful as a band of approximately 1.4 kb was detected 
following gel electrophoresis as predicted (figure 25).
3.1.3.2 Cloning and sequence analysis of HG5 cDNA
The approximately 1.4 kb band was cut from the gel and cloned into the 
bacterial expression vector pCRBIunt. Purified recombinant plasmid DNA 
was digested with enzymes with unique restriction sites to ensure HG5 
cloning had been successful before sequencing was undertaken (figure 26).
1 2  3 4
1 kb -----► M----
Figure 26 Analysis of recombinant pCRBIunt by restriction endonuclease digestion. 
DNA (3jag) was cut with Nde I and Pst I (10 units each) (in buffer 4) for 2 hours at 
37°C. The digests were run on a 1% (w/v) agarose gel in TAE buffer. Successful 
cloning of HG5 was evident as digestion resulted in DNA bands of approximately 
990 bp and 3.96 kb. Lane 1: 100 bp molecular weight marker. Lanes 2-4: digested 
recombinant pCRBIunt.
Restriction endonuclease digestion of recombinant pCRBIunt (figure 26) 
implied that cloning had been successful so two clones were sequenced. The 
M13 forward and reverse primers were used in conjunction with the primers 
5hg5seq and 3hg5seq (appendix 4) to sequence the amplified cDNA. 
Sequence analysis confirmed that the clones were HG5 cDNA. As shown, 
this subunit had been successfully amplified from the initial methiothine to the 
stop codon (figure 27). A quite high degree of nucleotide variation was found 
between the clones but few coding differences were seen.
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HG5cll MFALILPFLL HFTRSEGFGY EKLLDEQKII KHLLESPYSD YDWRVRPRGR
HG5cl2 MFALILPFLL HFTRSEGFGY EKLLDEQKIT KHLLESPYSD YDWRVRPRGR
100
HG5cll LGPADDDDYD SEPVFITVNM YLRSISKVDD VNMEYSLHFT FREEWIDERL
HG5cl2 LGPADDDDYD SEPVFITVNM YLRSISKVDD VNMEYSLHFT FREEWIDERL
HG5cll YFNSPTLKHI VLSPGQRIWV PDTFFQNEKD GKKHDIDTPN ILIRIHNGTG
HG5cl2 YFNSPTLKHI VLSPGQRIWV PDTFFQNEKD GKKHDIDTPN ILIRIHNGTG
200
HG5cll KILYSCRLTL TLS PMRLAD YPLDVQTCW DFASYAYTTK DIEYGWKEEK
HG5cl2 KILYSCRLTL TLS PMRLAD CPLDVQTGW DFASYAYTTK DIEYGWKEEK
HG5cll PIQIKDGLRQ SLPSFLLSNV KTGN TSVTN TGAYS LRTI IELKREFSYY
HG5cl2 PIQIKDGLRQ SLPSFLLSNV KTGN TSVTN TGAYS LRTI IELKREFSYY
300
HG5cll LLQLYIPSFM LVAVSWVSFW LDKDSVPARV TLGVTTLLTM TTQASGVNAN
HG5cl2 LLQLYIPSFM LVAVSWVSFW LDKDSVPARV TLGVTTLLTM TTQASGVNAN
HG5cll LPPVSYTKAI DIWIGVCLAF IFGALLEFAL VNWAARQDLV AHSRARYRQS
HG5cl2 LPPVSYTKAI DIWIGVCLAF IFGALLEFAL VNWAARQDLV AHSRARYRQS
400
HG5cll PLFFRNPDSR QENSHHFYAP IQQEVTLEDL PFSWWDKIWK IRYKERSRRI
HG5cl2 PLFFRNPDSR QENSHHFYAP IQQEVTLEDL PFSWWDKIWK
436
IRYRERSRRI
HG5cll DLISRVMFPL CFIIFNIMYW WRYLIPYMAV QAQLE*
HG5cl2 DLISRVMFPL CFIIFNIMYW WRYLIPYMAV QAQLE*
Figure 27 Alignment of HG5 cDNA amplified by RT-PCR. Blue indicates 
transmembrane regions. Conserved cysteine pairs are shown in green. Amino acids
shown in red indicate differences between clones. Stop codons are represented by
*
There are two almost identical sequences deposited in the EMBL database 
corresponding to HG5. In addition to that identified by our laboratory 
(accession number AJ131347) a sequence deposited by Forrester et al., 
(1999) (accession number AF076682) shows only two amino acid differences 
to HG5, but is identified as an alpha subunit. All available full-length HG5 
sequences were compared to find a consensus (figure 28). Very few coding 
differences are seen between FIG5 sequences. The RT-PCR amplified clone 
2 has three nucleic acid mutations resulting in variations in the encoded 
amino acid (positions 30,171, 394). The mutation at position 171 results in an 
additional cysteine within the first cysteine loop. The RT-PCR amplified clone 
1 is identical to the consensus sequence.
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HG5cll MFALILPFLL HFTRSEGFGY 
HG5cl2 MFALILPFLL HFTRSEGFGY 
AF07 6682 MFALILPFLL HFTRSEGFGY 
NSDcll MFALILPFLL HFTRSEGFGY 
NSDC12 MFALILPFLL HFTRSEGFGY 
AJ131347 MFALILPFLL HFTRSEGFGY 
Consensus MFALILPFLL HFTRSEGFGY
HG5cll LGPADDDDYD SEPVFITVNM 
HG5cl2 LGPADDDDYD SEPVFITVNM 
AF07 6682 LGPADDDDYD SEPVFITVNM 
NSDcll LGPADDDDYD SEPVFITVNM 
NDScl2 LGPADDDDYD SEPVFITVNM 
AJ131347 LGPADDDDYD SEPVFITVNM 
Consensus LGPADDDDYD SEPVFITVNM
HG5cll YFNSPTLKHI VLSPGQRIWV 
HG5cl2 YFNSPTLKHI VLSPGQRIWV 
AF07 6682 YFNSPTLKHI VLSPGQRIWV 
NSDcll YFNSPTLKHI VLSPGQRIWV 
NSDcl2 YFNSPTLKHI VLSPGQRIWV 
AJ131347 YFNSPTLKHI VLSPGQRIWV 
Consensus YFNSPTLKHI VLSPGQRIWV
HG5cll KILYSCRLTL TLS PMRLAD 
HG5cl2 KILYSCRLTL TLS PMRLAD 
AF076682 KILYSCRLTL TLS PMRLAD 
NSDcll KILYSCRLTL TLS PMRLAD 
NSDcl2 KILYSCRLTL TLS PMRLAD 
AJ131347 KILYSCRLTL TLS PMRLAD 
Consensus KILYSCRLTL TLS PMRLAD
HG5cll PIQIKDGLRQ SLPSFLLSNV 
HG5cl2 PIQIKDGLRQ SLPSFLLSNV 
AF076682 PIQIKDGLRQ SLPSFLLSNV 
NSDcll PIQIKDGLRQ SLPSFLLSNV 
NSDcl2 PIQIKDGLRQ SLPSFLLSNV 
AJ131347 PIQIKDGLRQ SLPSFLLSNV 
Consensus PIQIKDGLRQ SLPSFLLSNV
HG5cll LLQLYIPSFM LVAVSWVSFW 
HG5cl2 LLQLYIPSFM LVAVSWVSFW 
AF076682 LLQLYIPSFM LVAVSWVSFW 
NSDcll LLQLYIPSFM LVAVSWVSFW 
NSDcl2 LLQLYIPSFM LVAVSWVSFW 
AJ131347 LLQLYIPSFM LVAVSWVSFW 
Consensus LLQLYIPSFM LVAVSWVSFW
HG5cll LPPVSYTKAI DIWIGVCLAF 
HG5cl2 LPPVSYTKAI DIWIGVCLAF 
AF076682 LPPVSYTKAI DIWIGVCLAF 
NSDcll LPPVSYTKAI DIWIGVCLAF 
NSDcl2 LPPVSYTKAI DIWIGVCLAF 
AJ131347 LPPVSYTKAI DIWIGVCLAF 
Consensus LPPVSYTKAI DIWIGVCLAF
EKLLDEQKII KHLLESPYSD YDWRVRPRGR 
EKLLDEQKIT KHLLESPYSD YDWRVRPRGR 
EKLLDEQKII KHLLESPYSD YDWRVRPRGR 
EKLLDEQKII KHLLESPYSD YDWRVRPRGR 
EKLLDEQKII KHLLESPYSD YDWRVRPRGR 
EKLLDEQKII KHLLESPYSD YDWRVRPRGR 
EKLLDEQKII KHLLESPYSD YDWRVRPRGR
100
YLRSISKVDD VNMEYSLHFT FREEWIDERL 
YLRSISKVDD VNMEYSLHFT FREEWIDERL 
YLRSISKVDD VNMEYSLHFT FREEWIDERL 
YLRSISKVDD VNMEYSLHFT FREEWIDERL 
YLRSISKVDD VNMEYSLHFT FREEWIDERL 
YLRSISKVDD VNMEYSLHFT FREEWIDERL 
YLRSISKVDD VNMEYSLHFT FREEWIDERL
PDTFFQNEKD GKKHDIDTPN ILIRIHNGTG 
PDTFFQNEKD GKKHDIDTPN ILIRIHNGTG 
PDTFFQNEKD GKKHDIDTPN ILIRIHNGTG 
PDTFFQNEKD GKKHDIDTPN ILIRIHNGTG 
PDTFFQNEKD GKKHDIDTPN ILIRIHNGTG 
PDTFFQNEKD GKKHDIDTPN ILIRIHNGTG 
PDTFFQNEKD GKKHDIDTPN ILIRIHNGTG
200
YPLDVQTCW DFASYAYTTK DIEYGWKEEK 
CPLDVQTCW DFASYAYTTK DIEYGWKEEK 
YPLDVQTCW DFASYAYTTK DIEYGWKEEK 
YPLDVQTCW DFASYAYTTK DIEYGWKEEK 
YPLDVQTCW DFASYAYTTK DIEYGWKEEK 
YPLDVQTCW DFASYAYTTK DIEYGWKEEK 
YPLDVQT W  DFASYAYTTK DIEYGWKEEK
KTGN TSVTN TGAYSCLRTI IELKREFSYY 
KTGNCTSVTN TGAYS LRTI IELKREFSYY 
KTSN TSVTN TGAYS LRTI IELKREFSYY 
KTGN TSVTN TGAYS LRTI IELKREFSYY 
KTGN TSVTN TGAYS LRTI IELKREFSYY 
KTGN TSVTN TGAYSCLRTI IELKREFSYY 
KTGN TSVTN TGAYS LRTI IELKREFSYY
300
LDKDSVPARV TLGVTTLLTM TTQASGVNAN 
LDKDSVPARV TLGVTTLLTM TTQASGVNAN 
LDKDSVPARV TLGVTTLLTM TTQASGVNAN 
LDKDSVPARV TLGVTTLLTM TTQASGVNAN 
LDKDSVPARV TLGVTTLLTM TTQASGVNAN 
LDKDSVPARV TLGVTTLLTM TTQASGVNAN 
LDKDSVPARV TLGVTTLLTM TTQASGVNAN
IFGALLEFAL VNWAARQDLV AHSRARYRQS 
IFGALLEFAL VNWAARQDLV AHSRARYRQS 
IFGALLEFAL VNWAARQDLV AHSRARYRQS 
IFGALLEFAL VNWAARQDLV AHSRARYRQS 
IFGALLEFAL VNWAARQDLV AHSRARYRQS 




HG5cll PLFFRNPDSR QENSHHFYAP IQQEVTLEDL PFSWWDKIWK IRYKERSRRI
HG5cl2 PLFFRNPDSR QENSHHFYAP IQQEVTLEDL PFSWWDKIWK IRYRERSRRI
AF07 6682 PLFFRNPDSR QENSHHFYAP IQQEVTLEDL PFSWWDKIWK IRYKERSRRI
NSDcll PLFFRNPDSR QENSHHFYAP IQQEVTLEDL PFSWWDKIWK IRYKERSRRI
NSDcl2 PLFFRNPDSR QENSHHFYAP IQQEVTLEDL PFSWWDKIWK IRYKERSRRI
AJ131347 PLFFRNPDSR QGNSHHFYAP IQQEVTLEDL PFSWWDKIWK IRYKERSRRI
Consensus PLFFRNPDSR QENSHHFYAP IQQEVTLEDL PFSWWDKIWK IRYKERSRRI
436
HG5cll DLISRVMFPL CFIIFNIMYW WRYLIPYMAV QAQLE*
HG5cl2 DLISRVMFPL CFIIFNIMYW WRYLIPYMAV QAQLE*
AF076682 DLISRVMFPL CFIIFNIMYW WRYLIPYMAV QAQLE*
NSDcll DLISRVMFPL CFIIFNIMYW WRYLIPYMAV QAQLE*
NSDcl2 DLISRVMFPL CFIIFNIMYW WRYLIPYMAV QAQLE*
AJ131347 DLISRVMFPL CFIIFNIMYW WRYLIPYMAV QAQLE*
Consensus DLISRVMFPL CFIIFNIMYW WRYLIPYMAV QAQLE*
Figure 28 Alignment of available HG5 (Hcglucla) amino acid sequences. Blue 
indicates transmembrane regions. Conserved cysteine pairs are shown in green. 
Amino acids shown in red indicate differences between clones. Stop codons are 
represented by *. AF076682 and AJ131347 are deposited in the EMBL database. 
NSDcll and NSDcl2 were available from previous workers in the laboratory (Delany, 
1998).
3.1.4 Amplification and cloning of HG5 cDNA from ivermectin resistant 
H.contortus.
3.1.4.1 Amplification of HG5 cDNA from ivermectin-resistant 
H.contortus
Initially attempts to amplify HG5 cDNA from the ivermectin-resistant (IVR) 
South African White River II H.contortus isolate (Van Wyk and Malan, 1988) 
incorporated poly [A]+ RNA isolated from eggs and the same sequence 
specific oligonucleotides (5HG5full and 3HG5full) and reaction condition that 
had previously proved successful in amplifying HG5 from ivermectin-sensitive
H.contortus (IVS) (30 min at 55°C, 2 min at 94°C and then 40 cycles of 95°C 





Figure 29 Total RNA extracted from IVR H.contortus eggs (720 mg). RNA (5 pi at 
[1.6 pg/pl]) was electrophoresed through a 1% agarose gei in TBE buffer. 
Ribosomal RNA bands are indicated.
No product was amplified under these conditions. Analysis of total RNA did 
not implicate degradation as the cause of this problem (figure 29). Differential 
expression of HG5 has been observed through the life cycle of H.contortus, 
with the maximum level in the adult stage (Forrester et al., 1999). Poly [A]+ 






Figure 30 Amplification of HG5 from IVR H.contortus adults. The gene-specific 
oligonucleotides 5HG5full and 3HG5full were used with the Titan™ RT-PCR system 
for amplification. RT-PCR conditions were as follows: 30 min at 55°C, 2 min at 94°C 
and then 40 cycles of 94°C for 45 sec, 54°C for 1 min, 50°C for 1 min, 72°C for 2 
min followed by 72°C for 7 min. Amplification products were identified by 
electrophoresis through a 1% agarose gel and staining with ethidium bromide. Lane 
1; 1 kb molecular weight marker. Lane 2; PCR amplification product. A very faint 
band could be seen at approximately 1.35 kb.
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Attempts to amplify HG5 cDNA from IVR adults maintaining IVS HG5 
reaction conditions resulted in a very low yield of a product of approximately 
the correct molecular weight for HG5 (figure 30). The quantity of cDNA was 
too low to allow cloning.
The Titan™ RT-PCR system employs AMV reverse transcriptase and Tag 
and Pwo DNA polymerases for RNA detection. Many other DNA polymerase 
enzymes are available with differing levels of fidelity. The Access RT-PCR kit 
includes AMV for first strand synthesis, but Tfl DNA polymerase for cDNA 
amplification. HG5 amplification from IVR H.contortus adults was undertaken 
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Figure 31 Amplification of HG5 from IVR H.contortus adults. The gene-specific 
oligonucleotides 5HG5full and 3HG5full were used with the Access RT-PCR kit for 
amplification. Reaction conditions were as follows: 45 min at 48°C, 2 min at 94°C 
and then 40 cycles of 94°C for 45 sec, 54°C for 1 min, 50°C for 1 min, 72°C for 2 
min followed by 72°C for 7 min. Amplification products were identified by 
electrophoresis through a 1% agarose gel in TAE buffer and staining with ethidium 
bromide. Lane 1: 1 kb molecular weight marker. Lane 2: RT-PCR amplification 
products. cDNA of approximately 1.35 kb was detected.
A RT-PCR reaction including the enzymes AMV reverse transcriptase and Tfl 
DNA polymerase appeared to amplify HG5 from IVR adults as cDNA of
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approximately 1.35 kb was evident following gel electrophoresis of PCR 
products (figure 31). HG5 cDNA from IVS eggs contains 1331 bp.
3.1.4.2 Cloning and sequence analysis of HG5 from ivermectin- 
resistant H.contortus adults
The PCR product of approximately 1.35 kb was removed from the gel and 
blunt-ended before cloning into the bacterial expression vector pCRBIunt. 
Recombinant plasmid DNA was digested to ensure that HG5 cDNA was 
present (figure 32).
1 2 3 4 5
500 bp -----► A--------
Figure 32 Restriction endonuclease digestion of recombinant pCRBIunt. The 
enzymes Ndel and Pstl (10 units each) (in buffer 4) were used to analyse purified 
plasmid DNA (5 pg) for the presence of HG5. Digested DNA was electrophoresed 
through a 1.3% agarose gel in TBE buffer. Successful cloning is apparent, with 
cDNA of approximately 450 bp and 4.5 kb detected. Lane 1: 100 bp DNA molecular 
weight marker. Lanes 2-5: Digested recombinant pCRBIunt.
Digestion of recombinant pCRBIunt suggested that IVR HG5 cloning was 
successful and three clones were sequenced. Sequencing of the amplified 
cDNA was achieved with the oligonucleotides ivrseq and revivr (appendix 4) 
and the M13 forward and reverse primers. Sequence analysis confirmed that 
the clones were HG5 cDNA. The three clones were compared to obtain a 
consensus (figure 33). Although a fairly high level of nucleotide variation was 
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Figure 33 Alignment of HG5 clones amplified from IVR adult H.contortus. Blue 
indicates transmembrane regions. Conserved cysteine pairs are shown in green. 
Amino acids shown in red indicate differences between clones. Stop codons are 
represented by *.
HG5 consensus sequences from IVR and IVS H.contortus were compared to 
detect changes associated with the development of resistance. No coding 
differences were found in the sequences from ivermectin-resistant and - 
sensitive isolates (figure 34).
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ivscon MFALILPFLL HFTRSEGFGY EKLLDEQKII KHLLESPYSD YDWRVRPRGR
ivrcon MFALILPFLL HFTRSEGFGY EKLLDEQKII KHLLESPYSD YDWRVRPRGR
100
ivscon LGPADDDDYD SEPVFITVNM YLRSISKVDD VNMEYSLHFT FREEWIDERL
ivrcon LGPADDDDYD SEPVFITVNM YLRSISKVDD VNMEYSLHFT FREEWIDERL
ivscon YFNSPTLKHI VLSPGQRIWV PDTFFQNEKD GKKHDIDTPN ILIRIHNGTG
ivrcon YFNSPTLKHI VLSPGQRIWV PDTFFQNEKD GKKHDIDTPN ILIRIHNGTG
200
ivscon KILYSCRLTL TLS PMRLAD YPLDVQT W DFASYAYTTK DIEYGWKEEK
ivrcon KILYSCRLTL TLS PMRLAD YPLDVQT W DFASYAYTTK DIEYGWKEEK
ivscon PIQIKDGLRQ SLPSFLLSNV KTGN TSVTN TGAYS LRTI IELKREFSYY
ivrcon PIQIKDGLRQ SLPSFLLSNV KTGN TSVTN TGAYS LRTI IELKREFSYY
300
ivscon LLQLYIPSFM LVAVSWVSFW LDKDSVPARV TLGVTTLLTM TTQASGVNAN
ivrcon LLQLYIPSFM LVAVSWVSFW LDKDSVPARV TLGVTTLLTM TTQASGVNAN
ivscon LPPVSYTKAI DIWIGVCLAF IFGALLEFAL VNWAARQDLV AHSRARYRQS
ivrcon LPPVSYTKAI DIWIGVCLAF IFGALLEFAL VNWAARQDLV AHSRARYRQS 
♦ 400
ivscon PLFFRNPDSR QENSHHFYAP IQQEVTLEDL PFSWWDKIWK IRYKERSRRI
ivrcon PLFFRNPDSR QENSHHFYAP IQQEVTLEDL PFSWWDKIWK
436
IRYKERSRRI
ivscon DLISRVMFPL CFIIFNIMYW WRYLIPYMAV QAQLE*
ivrcon DLISRVMFPL CFIIFNIMYW WRYLIPYMAV QAQLE*
Figure 34 Alignment of consensus HG5 sequences from IVS and IVR H.contortus. 
Blue indicates transmembrane regions. Conserved cysteine pairs are shown in 
m. Stop codons are represented by *. The conserved protein kinase C 
phosphorylation recognition sequence is shown (♦).
3.2 Discussion
Northern blot analysis of H.contortus mRNA confirmed that the pattern of 
alternative splicing of gbr-2 observed in C.elegans is conserved. Expression 
of this gene and its products in a variety of nematodes suggests they play an 
important role in the nervous system, the partial GluCI subunit cDNA 
identified from Onchocerca volvulus shows 80% similarity to the gbr-2 
products (appendix 1). Alternative splicing of gbr-2 has only been confirmed 
in C.elegans and H.contortus; only one gbr-2 product was detected in Ascaris 
suum (Jagannathan et al., 1999) by RACE-PCR. It is possible that the partial 
gene duplication resulting in the two mRNAs occurred quite late in the 
evolution of nematodes as molecular phylogeny predicts H.contortus and
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C.elegans to be closely related, whereas Ascaris spp. are found in a different 
clade (Blaxter, 1998). However, Northern blot analysis of A.suum may reveal 
conservation of gene duplication.
Attempts to compare the expression levels of the putative GluCI subunits 
HG2 and HG3 by semi-quantitative PCR indicated that HG2 was expressed 
at very low levels. HG2 and HG3 mRNAs were detected at very similar levels 
by Northern hybridisation, demonstrating that semi-quantitative PCR was not 
a reliable method of mRNA quantitation. Northern blot analysis was a more 
reliable method of detection, in this instance, as the two mRNAs could be 
directly compared in the same sample. The problems encountered by 
previous workers in the laboratory in amplifying HG2 were not due to very 
low mRNA levels
Full-length HG2 cDNA was amplified from H.contortus eggs and two clones 
were sequenced. Although a quite high level of nucleotide variation was 
apparent there were only three amino acid differences between the clones. 
One of these resulted in a coding change from a tryptophan to a termination 
signal (position 60) implying a PCR induced change. The sequence of the 
other HG2 clone was almost identical to that deposited in the EMBL 
database (accession number Y14233). One amino acid difference was found 
between the two sequences (position 344); a tryptophan residue was 
replaced with a leucine residue. Comparison with the C.elegans homologue 
CE-GBR2A revealed a leucine in this position suggesting that this alteration 
would not be detrimental to the expression of this subunit (Laughton et a/.,
1997). It is possible that the amino acid residue at this position in the 
sequence deposited in the EMBL database is not representative of HG2 in 
the population.
Full-length cDNA of the putative GluCI subunit HG5 was amplified from 
H.contortus eggs and two clones were sequenced. A relatively high degree of 
non-coding nucleotide sequence variation has been observed between 
individual clones for all H.contortus receptor subunits reported as yet and this 
trend was continued in HG5. Three amino acid coding differences were seen 
between clones (positions 30, 171, 394), and the clones were compared with 
all available HG5 sequences. These include two sequences deposited in the 
EMBL database and sequences resulting from the amplification of partial
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HG5 cDNAs in our laboratory. Very few coding differences were present 
between clones, even though one of the cDNAs had been amplified from 
adult H.contortus (AF076682) and the others originated from eggs. 
Comparison of all sequences produced a consensus and this was identical to 
RT-PCR amplified clone 1. Forrester et al., (1999) indicated alternative 
splicing of the HG5 transcript by semi-quantitative PCR. This resulted in two 
cDNAs, one of which lacks 81 nucleotides at the 5’ end (Forrester et al., 
1999). This phenomenon was not seen in any HG5 amplification in our 
laboratory.
A neighbour-joining tree was constructed to compare the C.elegans and 
H.contortus GluCI sequences, using the HG2 and HG5 sequences presented 
here (appendix 6). As shown previously, HG2 has a direct orthologue in 
C.elegans, gbr-2a, whereas, although HG5 is closely related to the gbr-2 
gene products of both species, no clear C.elegans orthologue is identified for 
HG5. Orthologues of C.elegans GluClal and GluCla2 have not been 
identified in H.contortus. The upregulation of expression of HG5 in adult 
H.contortus as compared to larvae and eggs (Forrester et al., 1999) coupled 
with the apparent lack of orthologues of this gene in the free-living species 
C.elegans, allows supposition that this gene may be the product of a novel 
gene that diverged as part of the adaptation to a parasitic life-style. Dent et 
al., (2000) recently suggested that the C.elegans gbr-2 gene products are 
additional members of the alpha class of GluCI receptors (glucla3). Inclusion 
of their H.contortus counterparts, HG2 and HG3, within this class appears 
plausible and the high level of identity of HG5 to the gbr-2 products and 
GluCla2 suggests that this subunit is also a member of this class.
Resistance to the avermectin/milbemycin (AM) class of anthelmintics in 
livestock nematode populations is a serious problem worldwide. Although a 
great deal of research on this resistance has been undertaken the 
mechanism remains elusive. Resistance to the other classes of anthelmintic 
is apparently achieved by alteration of the drug target (section 1.2.4) and this 
is also a possibility in AM resistance. No coding differences were identified 
between the putative H.contortus GluCI subunits HG2, HG3 and HG4 from 
ivermectin-sensitive and ivermectin-resistant field isolates but population
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genetic studies have identified alleles of the HG5 gene that may be selected 
during the evolution of ivermectin and moxidectin resistance (Blackhall et al.,
1998). HG5 cDNA sequences from ivermectin-sensitive and -resistant 
H.contortus strains were compared to determine if this subunit was involved 
in the development of drug resistance.
Amplification of HG5 cDNA from ivermectin-resistant H.contortus (IVR) eggs 
was unsuccessful when conditions that had achieved detection of this subunit 
from ivermectin-sensitive H.contortus (IVS) eggs were maintained. 
Downregulation of HG5 expression in H.contortus eggs as compared to 
adults has been reported (Forrester et al., 1999). If resistance to ivermectin is 
achieved, at least in part, by reduced expression of HG5 it is possible that the 
mRNA message in eggs is reduced below detectable levels. Amplification 
was therefore attempted from adult worms and a very faint cDNA band of 
approximately the expected molecular weight for HG5 was observed. 
Alternative DNA polymerase enzymes were included in the RT-PCR reaction 
and the full-length cDNA was amplified and sequenced.
A quite high degree of nucleotide sequence variation was found between 
individual HG5 clones (<5%). As with subunits amplified from IVS isolates, 
few coding differences were seen implying that nucleotide variation is due to 
polymorphic parasite populations rather than PCR-induced error. 
Comparison of HG5 consensus sequences from IVR and IVS isolates 
revealed no coding alterations. This suggests that if selection at the HG5 
gene occurs during the development of ivermectin resistance, as predicted 
by Blackhall and co- workers (1998), it results in altered expression of this 
subunit rather than modification of the amino acid sequence. The problems 
encountered in amplifying HG5 cDNA from IVR isolates substantiate this 
hypothesis. Northern blot or quantitative PCR analysis of HG5 expression in 
IVR and IVS H.contortus could be used to reveal altered regulation of HG5 
message.
The results shown here cannot be directly compared with those of Blackhall 
and co-workers as different ivermectin-resistant isolates were used in the two 
studies. The White River II field isolate (Van Wyk et al., 1988) was used in 
this study, whereas those used in the work of Blackhall et al. were laboratory 
isolates in which ivermectin resistance was induced by repeated exposure of
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worms to increasing levels of drug. Gill et al. (1998; Gill and Lacey, 1998) 
present evidence that different selection protocols induce different resistant 
phenotypes in tristrongylids. The gradual selection of resistant H.contortus 
isolates using slowly increasing doses of ivermectin results in individuals that 
show no reduction in their sensitivity to the AM in terms of larval motility or 
development (e.g. IVC and TcR-1). In contrast, single-step selection of 
resistant individuals with ivermectin concentrations 10-fold higher than the 
L . D . 9 5  produced a phenotype that involved reduced inhibition of both larval 
motility and development by the AM in vitro. This second scenario is thought 
to be most similar to the situation in the field and the White River II isolate 
was included in this type. The isotypes discussed by Blackhall et al. (1998) 
were selected under similar conditions to the TcR-1 and IVC isolates and are 
expected to have a different resistance phenotype to White River II. The 
differences in phenotype may well be reflected in the genotypes of isolates 
selected by different methods. Resistance in the Chiswick avermectin 
resistant H.contortus isolate (CAVR), which has a similar resistance 
phenotype to White River II isolates, is attributed to a single dominant trait 
(Le Jambre et al., 2000), whereas in a laboratory-selected T.columbriformis 
resistant isolate, resistance appears a partially dominant trait and is not due 
to a single gene (Gill and Lacey, 1998). Resistance due to a single gene 
would rapidly spread through a population, as has been the case with the 
AM. The results of Gill and Lacey (1998) predict differences in resistance 
mechanisms both within and between species and further genetic studies on 
multiple resistant isolates are required to ascertain the usefulness of non-field 
strains as models.
Mutation studies in C.elegans have implicated a number of genes in high- 
level ivermectin resistance (Dent et al., 2000). These include three GluCI 
genes, avr-14. avr-15 and glc-1, and a complicated parallel genetic pathway 
that is defined by these GluCI genes, but that also involves genes encoding 
innexins and amphid sensory neurons is suggested. Mutations in individual 
genes do not confer resistance. There is no evidence that these resistant 
mutants are analogous to the genotypes of ivermectin-resistant parasitic 
nematodes. Although AM resistance has been attributed to a single gene in 
the CAVR isolate, it is possible that multiple genes may be involved in AM
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resistance, both in this and other isolates, but that they either have a 
modifying effect on and/or are linked to the major resistance gene. The 
observed variability in the nucleotide sequence of HG5 cDNA seen in this 
study confirms the observation by Blackhall et al (1998) that multiple HG5 
alleles are present in the population. Further genetic and expression studies 
may implicate HG5, and other GluCI from parasitic nematodes, in the 
development of resistance.
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4. Stable expression of inhibitory glutamate receptor 
subunits in a mammalian cell line
The successful cloning of four glutamate-gated chloride channel (GluCI) 
subunits from H.contortus paves the route for in vitro analysis of their function 
and for the development of an assay system to evaluate the efficacy of novel 
anthelmintics. Though there have been some studies on the pharmacology 
and physiology of the C.elegans GluCI subunits (Cully et al., 1994; Laughton 
et al., 1997; Dent et al., 1997; Vassilatis et al., 1997; Dent et al., 2000; 
Horoszok et al., in press) little is known about the function of these subunits 
in parasitic nematodes. The high sequence identity of the GluCIs (appendix 
1) and similar mode of action of the avermectins on C.elegans and
H.contortus (Avery and Horvitz, 1990; Geary et al., 1993; Paiement et al., 
1999; Gill et al., 1995) predicts similar pharmacology for the GluCI subunits in 
these species, although adaptation to a parasitic life-style may have resulted 
in some modifications.
At present, the activity of novel avermectin analogues is primarily determined 
using whole organism fly and nematode assays. This is a time-consuming 
and inefficient process and the development of an assay system that could 
be easily maintained and used in high throughput screens is an attractive 
prospect. The industrial CASE sponsors of this PhD also viewed this as an 
important aspect of this project.
Gene transfer into mammalian cells is a powerful means of studying gene 
expression and allowing analysis of protein function (Spector et al., 1998; 
Fernendez and Hoeffler, 1999). Relatively large amounts of target protein 
can be produced; reducing the time spent purifying protein and also removing 
the need for animal experimentation. Following the transfection of host cells a 
small percentage incorporate the foreign DNA into their genome and 
selection pressure can be applied to isolate these cells. If successful, this 
results in discrete colonies that can be isolated, expanded and analysed. 
These clonal cell lines are continually expressing the target gene, thereby 
producing a constant supply of the protein of interest.
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A recipient cell line that grows in monolayers with a rapid doubling time 
increases the probability of successful gene transfer (Spector et al., 1998). 
Mouse fibroblast L929 cells fit these criteria and were chosen for the 
production of cell lines stably expressing individual GluCI subunits. These 
cells do not naturally express ligand-gated ion channels thus reducing the 
likelihood of non-specific interactions and previous workers in our laboratory 
had used L929 cells for transient expression studies. Identification of cells 
with foreign DNA integrated into their genome requires the transfer of a 
selectable marker. A mammalian expression vector, pcDNA3, which contains 
a gene conferring drug resistance on transfected cells, was chosen as a 
vehicle for GluCI cDNA (appendix 6). The bacterial antibiotic neomycin 
affects the function of prokaryotic ribosomes and its analogue G418 blocks 
protein synthesis in mammalian cells by interfering with ribosomal function. 
The neomycin resistance gene (neor), included in the pcDNA3 genome, 
encodes a bacterial phosphotransferase that detoxifies G418. Eukaryotic 
cells expressing neor can survive in medium containing otherwise toxic 
concentrations of G418.
This chapter discusses the transfection of mammalian cells with recombinant 
plasmids containing GluCI cDNA and attempts to analyse the resulting cell 
lines using RT-PCR and radioligand binding. Two GluCI subunits, HG3 and 
HG4, were chosen for initial construction of cell lines as their C.elegans 
counterparts, ce-gbr2b and -gluclp respectively, have physiological 
responses to ivermectin and/or glutamate when expressed in Xenopus 
oocytes (Cully etal., 1994, Dent etai ,  2000).
4.1 Results
4.1.1 Attempted construction of an HG3 cell line
4.1.1.1 Sub-cloning HG3 for expression in mammalian cells
Jagannathan (1998) had previously cloned HG3 into the vector pBluescript II 
(appendix 3). A vector containing eukaryotic elements to control initiation of 
transcription and processing of DNA transcripts was required for expression 
of the subunit in mammalian cells. The HG3 cDNA was excised from
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pBluescript II (figure 35) and sub-cloned into the mammalian expression 
vector pcDNA3 (appendix 6). Purified DNA from the resulting colonies was 
assessed for the presence of HG3 by restriction endonuclease digestion 
(figure 36).
1 2
Figure 35 Restriction endonuclease digestion of recombinant pBluescript II. The 
enzymes Xba I and Hind III (20 units each) in buffer 2 were used to digest DNA (5 
pg) for an hour at 37°C. The reaction was analysed by 1% (w/v) agarose gel 
electrophoresis in TAE buffer. Lane 1: X pst I molecular weight marker. Lane 2: 
digested recombinant plasmid
A band of approximately the correct size for HG3 (1.3 kb) was cut from the 
gel and purified before ligation with Xba I/Hind III digested pcDNA3 DNA. 
Competent XL-1 Blue bacterial cells were transformed with the ligated DNA
(5 pi).
1 2 3 4  5 6
Figure 36 Analysis of recombinant pcDNA3 by restriction digestion. Plasmid DNAs 
(5 pg) were cut with Xba I and Hind III (20 units each) in buffer 2 for 2 hours at 37°C. 
The digested DNA was run on a 1% (w/v) agarose gel in TBE buffer and stained 
with ethidium bromide. Successful sub-cloning of HG3 was evident as digestion 
resulted in DNA bands of approximately 1.3 kb and 5.4 kb. Lanes 1-5: digested 
recombinant pcDNA3. Lane 6: X pst I molecular weight marker.
1.2 kb ---- ►
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HG3 cDNA was present in all recombinant plasmids analysed. The Qiagen 
Plasmid Maxikit was used to produce ultrapure recombinant DNA, as purity is 
a major determinant in the success of transfection. The resulting DNA was 
analysed by spectrophotometry (O.D.260), which indicated a concentration of
1.1 pg/pl and a purity ratio of 1.8 (O.D. 26o/O.D.28o)-
4 1.1.2 Sensitivity of L929 mouse fibroblast cells to the antibiotic G418
Selection of cells expressing foreign DNA on the basis of their antibiotic 
resistance requires toxicity of the antibiotic to untransfected cells. Cells 
exhibit varying sensitivities to G418 and therefore L929 cells were assayed to 
identify the minimum G418 lethal dose. Cells were incubated with a range of 
G418 concentrations and effects on viability were recorded (figure 37). All 
concentrations reduced cell confluence after 48 hours, but 450 pg/ml was the 
lowest concentration to entirely prevent cell division after 72 hours, although 
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Figure 37 Sensitivity of L929 cells to the antibiotic G418. Cells were seeded at a 
concentration of 1 x 104 in 6 well plates containing minimal essential medium (3 ml) 
supplemented with 200-700 jig/ml G418. Cell viability was observed at 24 hour 
intervals for 72 hours and recorded as percentage confluence.
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Cell viability was reduced more slowly by 400 pg/ml G418 but only 5% were 
still dividing 72 hours after treatment; confluence was reduced to 40% in this 
sample group. A concentration of 450 pg/ml was used for selection of cells 
expressing the neor gene and this was reduced to 400 pg/ml for maintenance 
of selection.
4.1.1.3 Transfection and selection of L929 cells
Transfected cells were selected approximately 48 hours post-transfection by 
the addition of 450 pg/ml G418 antibiotic to the growth media. Control 
(untransfected) cells were also treated with antibiotic and were all dead 7 
days post-treatment. Clones were grown individually, as the plasmid may be 
inserted into the genome in a different position in each clone, thereby 
determining the level of protein expression of the transfected gene.
4.1.2 Analysis of HG3 transformed L929 cells
4.1.2.1 RT-PCR amplification of partial HG3 cDNA
Total RNA was extracted from each of 24 G418 resistant L929 colonies and 
run on an Rnase-free agarose gel to ensure degradation had not occurred 
(figure 38).
1 2 3 4 5
Figure 38 Total RNA from transformed L929 clones. RNA (3 i^g) was run on a 1% 
(w/v) agarose TBE gel and stained with ethidium bromide to verify that extraction 
had been successful. RNA was observed in all 24 clones, but concentrations varied. 
Five representative clones are shown.
The low yield of RNA in some clones suggested that RT-PCR amplification 
would be the most efficient method for initial assessment of HG3 expression.
103
A positive control sample was produced for use in the RT-PCR amplification. 
Recombinant pcDNA3 expressing HG3 cDNA (10 pg) was linearised 
upstream of the HG3 sequence with the restriction enzyme Nru I and the T7 
promoter was utilised to transcribe cRNA.
Primers were designed to internal regions of HG3 (5HG3part and 3HG3part. 
Appendix 4), as short lengths of cDNA should amplify more easily than full- 
length sequence. The access RT-PCR kit was used in conjunction with these 
primers to attempt detection of HG3 mRNA in the L929 clones (figure 39).
— 500 bp
Figure 39 RT-PCR amplification of partial HG3 cDNA from transfected L929 cells. 
Sequence specific oligonucleotides 5HG3part and 3HG3part were used with the 
Access RT-PCR kit to amplify part of the HG3 subunit cDNA (approx. 550 bp) from 
total RNA. Positive and negative controls were included in the form of 200 ng HG3 
cRNA and 1 pg total RNA from L929 cells transfected with pcDNA3 respectively. 
RT-PCR conditions were as follows: 45 min at 48°C, 2 min at 94°C and then 40 
cycles of 95°C for 30 sec., 62°C for 30 sec., 72°C for 30 sec., followed by 72°C for 5 
min. Amplification products were identified by electrophoresis through a 1.3% (w/v) 
agarose gel in TBE buffer and staining with ethidium bromide. Lanes 1-5: 
amplification products from transformed L929 cells. Lane 6: Negative control 
amplification. Lane 7: Positive control amplification. Lane 8: 100 bp molecular weight 
marker. cDNA of approximately the expected molecular weight was amplified from 
20 clones. Five representative amplifications are shown.
RT-PCR amplification of partial HG3 RNA indicated that twenty L929 clones 
were expressing mRNA for this subunit.
4.1.2.2 Investigation of HG3 protein expression in transformed L929 cells
As HG3 mRNA was present in a number of the L929 clones, protein 
expression was looked for. Membranes were prepared from transformed
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L929 cells of approximately 80% confluence and resuspended in 50 mM 
HEPES buffer at a concentration of 1 mg/ml.
4.1.2.2.1 Radioligand binding
Initial assessment of protein expression was attempted by measuring [3H] 
ivermectin binding to membrane preparations. The C.elegans HG3 
homologue forms channels that are gated by both ivermectin and glutamate, 
when expressed in Xenopus oocytes (Dent et al., 2000), and the high 
sequence identity between the two subunits predicts similar pharmacology 
for HG3. Binding was determined by incubating varying concentrations of 
membranes (5-40 pg) with 0.5 nM [3H] ivermectin for two hours at room 
temperature. No specific binding was observed to membrane preparations 
from any clone. Cells were grown at a reduced temperature (30°C), as this 
has previously been shown to up-regulate expression of recombinant LGIC 
subunits in mammalian cells (Cooper et al., 1999). [3H] ivermectin binding 
experiments were executed as at 37°C and no specific binding was observed 
to membranes from any clone.
4.1.2.2.2 Western blotting
The lack of specific binding to transformed L929 membranes demanded 
further investigation and Western analysis of expressed protein was 
attempted (figure 40). No candidate HG3 protein band (predicted to be 
approximately 48 kDa) could be detected in any of the clones.
105




Figure 40 Western blot analysis of transformed L929 cell membranes. Membranes 
(20 fig) extracted from each transfected L929 clone were subjected to SDS- 
polyacrylamide gel electrophoresis and probing with an HG3 antibody (1/50 dilution) 
to the intracellular loop (designed and purified from rabbits by Virginia Portillo) 
before chemiluminescent detection. A positive control sample was included in the 
form of a recombinant plasmid with an inducible promoter (pGEX-GSTHG3) (32 
kDa). No differences were observed between protein from untransfected and 
transfected cells. Lanes 1-5: transformed L929 cells. Lane 6: negative control. Lane 
7: positive control.
4.1.3 Attempted construction of an HG4 cell line
Delany (1998) had previously cloned HG4 into the mammalian expression 
vector pcDNA3 and ultrapure DNA was extracted from XL-1 Blue cells 
expressing this recombinant plasmid. The DNA was analysed by 
spectrophotometry (O.D.26o) and a concentration of 0.5 pg/pl and purity ratio 
of 1.7 were specified. Transfection and selection of colonies with the 
recombinant plasmid DNA incorporated into their genome proceeded as 
described for HG3.
4.1.4 Analysis of HG4 transformed L929 cells
4.1.4.1 RT-PCR amplification of partial HG4 cDNA
Total RNA was extracted from each of 36 L929 colonies selected for the 
presence of recombinant pcDNA3. Sequence-specific oligonucleotides 
(5HG4part and 3HG4part) (appendix 4) were designed to internal regions of 
HG4 and RT-PCR amplification was used for initial detection of clones 
expressing this subunit (figure 41). A positive control sample was produced 
for use in the RT-PCR amplification. Recombinant pcDNA3 expressing HG4
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cDNA (10 jig) was linearised upstream of the HG4 sequence with the 
restriction enzyme Nru I and the T7 promoter was utilised to transcribe 
cRNA.
RT-PCR amplification of partial HG4 cDNA indicated that all 36 L929 clones 
were expressing HG4 message.
1 2 3 4 5
1 kb
Figure 41 RT-PCR amplification of partial HG4 cDNA from transformed L929 cells. 
Sequence specific oligonucleotides 5HG4part and 3HG4part were used with the 
Access RT-PCR kit to amplify part of the HG4 subunit (approx. 900 bp) from total 
RNA. Positive and negative controls were included in the form of 200 ng HG4 cRNA 
and 1 fig total RNA from L929 cells transfected with pcDNA3 respectively. RT-PCR 
conditions were as follows: 45 min at 48°C, 2 min at 94°C and then 40 cycles of 
94°C for 30 sec., 55°C for 30 sec., 72°C for 2 min, followed by 72°C for 5 min. 
Amplification products were identified by electrophoresis through a 1.2% (w/v) 
agarose gel in TBE buffer and staining with ethidium bromide. Lanes 1-2: 
amplification products from transformed L929 cells. Lane 3: Negative control 
amplification. Lane 4: Positive control amplification. Lane 5: molecular weight 
marker. cDNA of approximately the expected molecular weight was amplified from 
all clones. Two representative amplifications are shown.
4.1.4.2 Investigation of HG4 protein expression in transformed L929 cells
Membranes were prepared from all transformed L929 clones and binding of 
[3H] ivermectin to the protein was measured as described for HG3. No 
specific ivermectin binding was seen to any clone. Attempts at Western blot 
analysis of expressed protein were obstructed by non-specific binding of the 
available HG4 antibody (Delany etal., 1998) to untransfected L929 cells.
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4.2 Discussion
Mammalian cell lines stably expressing HG3 and HG4 mRNA were 
successfully created. These clonal cell lines did not produce detectable 
protein encoded by the GluCI subunit gene. This suggests that the 
incorporation of recombinant plasmid DNA into the host cell genome was 
successful, but that incorrect processing occurred within the synthetic 
pathway.
It is probable that the lack of [3H] ivermectin binding to HG3 transfected L929 
clones was due to the non-existence of the HG3 protein. This is supported by 
the absence of this protein following Western blot analysis of transformed 
cells; the detection of the HG3 positive control sample suggested no 
problems with the experimental conditions. The C.elegans HG3 homologue, 
ce-gbr2b, has been shown to form homomeric channels that are gated by 
both ivermectin and glutamate when expressed in Xenopus laevis oocytes 
(Dent et al., 2000). The high sequence identity of this subunit between 
H.contortus and C.elegans (87%) predicts a similar pharmacology.
The absence of specific [3H] ivermectin binding to the HG4 transfected L929 
cells was not altogether surprising as homomeric expression of the 
C.elegans homologue, GluClp, in Xenopus oocytes results in channels that 
are gated by glutamate but not ivermectin. A high level of sequence 
conservation is seen between these subunits (80%) and a comparable 
pharmacology is again probable. Binding experiments using radiolabelled 
glutamate were attempted, but the low affinity of this ligand for the GluCI 
receptor (Hejmadi et al., 2000) coupled with the ubiquity of this amino acid 
and its binding sites in cells resulted in unmanageable levels of non-specific 
binding.
The reasons behind the observed lack of GluCI protein translation require 
further investigation beyond the scope of this project. Other workers have 
also attempted permanent expression of C.elegans (D. Cully, personal 
communication) and H.contortus (R. Prichard, personal communication) 
GluCI subunits in different mammalian cell lines and have obtained the same 
results. This suggests that the lack of protein expression is not due to the use 
of L929 cells. It is possible that permanent expression of the GluCI subunits
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may be toxic to the mammalian cells. The transfer of GluCI genes to an 
insect cell line, or the development of a nematode cell line, may be more 
successful. It is probable that the functional GluCI receptor follows the pattern 
of expression observed in all LGIC in that a heteromeric pentamer of 
subunits is formed. The translation and processing of GluCI polypeptides 
may require signals from multiple subunits for completion, as is evident in 
mammalian GABAa receptors (Gorrie etal., 1997, Taylor eta l., 2000). 
Assessment of the ivermectin-binding properties of the H.contortus GluCI 
receptor subunits was therefore attempted using a transient gene expression 
system. Large quantities of foreign DNA can be expressed in such a system 
and, although the commercial application of this research may be reduced, 
this should determine which, if any, of the GluCI subunits form part of the 
ivermectin-binding site.
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5. Pharmacology of glutamate-gated chloride channels
The avermectins bind to membrane preparations from parasitic nematodes 
with high affinity (Rohrer et al., 1995; Hejmadi et al., 2000), but their 
interaction with parasite recombinant GluCI is not known. Most C.elegans 
GluCIa subunits form chloride channels gated by ivermectin (EC50 = 108-140 
nM) (Cully et al., 1994; Vassilatis et al., 1997; Dent et al., 2000; Horoszok et 
al., in press).
The commercially available avermectins vary widely in their in vivo efficacy 
and their spectrum of activity. Studies in C.elegans comparing the activity of 
several avermectins and milbemycins have found strong correlation between 
the activation of glutamate-sensitive chloride currents, membrane binding 
and nematocidal activity (Arena et al., 1995). The structure-activity 
relationships of the avermectins and their two modes of action, motility and 
development, have been investigated in parasitic nematodes (Gill and Lacey, 
1998), but no data are available regarding their receptor-binding properties. 
The absence of GluCI polypeptides in the HG3 and HG4 stable cell lines 
reduces the commercial potential of this study, but transient expression of the 
H.contortus GluCI subunits in a mammalian cell line should determine at 
least some of the components of the ivermectin-binding site. Following 
transfection of a mammalian cell line, approximately 5-50% of the cells will 
take up and express the foreign DNA (Spector et al., 1998). A small 
percentage of these cells incorporate this DNA into their genome and if not 
selected, cells expressing the transfected protein will slowly be removed from 
the population. The plasmid DNA is transcribed within hours of transfection 
and cells can be assayed for gene products 24-72 hours post-transfection. 
Transient expression experiments preclude the effects of integration sites on 
expression and the possibility of harvesting cells that harbour mutations in 
the transfected DNA.
Cells vary in their transfection capacity, both in terms of DNA uptake and 
expression, and the most frequently used cell lines for transient expression 
are COS cells (Fernandez and Hoeffler, 1999). These are derived from 
African green monkey kidney cells by transformation with an origin defective 
simian virus 40 (SV40). High levels of the SV40 large tumour (T) antigen are
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expressed by COS cells and this initiates viral DNA replication at the SV40 
origin. Plasmids containing the SV40 origin of replication are thereby 
expressed at very high levels and copy numbers can be amplified to over 
100,000. These cells cannot be used for stable expression of plasmids as a 
very high copy number is eventually lethal.
This chapter discusses the transient expression of each of the four cloned 
H.contortus GluCI subunits in the COS 7 cell line. Their potential role in the 
ivermectin-binding site was assessed and [3H] ivermectin binding was 
characterised by saturation and competition studies. The structure-activity 
relationship of several avermectins and the recombinant GluCI subunits was 
analysed by competition against [3H] ivermectin.
5.1 Results
5.1.1 Transient expression and analysis of HG2 in COS 7 cells
5.1.1.1 Subcloning HG2 cDNA for expression in mammalian cells
HG2 cDNA was previously cloned into the PCR cloning vector pCRBIunt 
(section 3.1.2.2), but expression in mammalian cells required the presence of 
the subunit in a mammalian expression vector. The vector pcDNA3 contains 
the SV40 origin of replication for high-level expression in COS cells. The 
HG2 cDNA was digested from pCRBIunt for subcloning into pcDNA3 (figure 
42). The HG2 band (approximately 1.45 kb) was cut from the gel and purified 
before ligation with Xba I and Kpn I digested pcDNA3. Competent XL-1 Blue 
cells were transformed with the ligated DNA. Purified DNA from the resulting 
colonies was assessed for the presence of HG2 cDNA by restriction 
endonuclease digestion (figure 43).
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Figure 42 Restriction endonuclease digestion of recombinant pCRBIunt. DNA (5 fig) 
was cut with Xba I and Kpn I (10 units each) (in buffer 2) for 2 hours at 37°C. 
Samples were analysed by electrophoresis through a 1% (w/v) agarose gel in TAE 
buffer and staining with ethidium bromide. Lane 1: digested pcDNA3. Lane 2: 
digested recombinant pcrBlunt. Lane 3: 1 kb molecular weight marker.
1 2 3
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Figure 43 Restriction endonuclease digestion of recombinant pcDNA3. DNA (5 pg) 
was digested with Hind III and Apa I (10 units each) (in buffer 4) for 2 hours at 37°C. 
Digested DNA was run on a 1% (w/v) agarose gel in TBE buffer and stained with 
ethidium bromide. Successful subcloning of HG2 was evident as digestion resulted 
in DNA bands of approximately 1. 45 kb and 5.4 kb. Lane 1: 1 kb molecular weight 
marker. Lanes 2-3: digested recombinant pcDNA3.
HG2 cDNA was present in both pcDNA3 clones. Ultrapure DNA was 
extracted from one of these clones and its purity and concentration assessed 
by spectrophotometry. The DNA was at a concentration of 1.1 pg/jul (O.D.260) 
and had a purity ratio of 1.8 (O.D.26o/O.D.28o)-
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5.1.1.2 Transfection and harvesting of COS 7 cells
Cells were harvested approximately 48 hours post-transfection at which time 
they were approximately 85% confluent. Membranes were extracted and 
resuspended at a concentration of 1 mg/ml in ice-cold 50mM HEPES, pH 7.4.
5.1.1.3 Analysis of expressed protein
5.1.1.3.1 Radioligand binding
The role played by the HG2 polypeptide in the H.contortus ivermectin binding 
site was assessed by [3H] ivermectin binding experiments. Binding conditions 
were a combination of those described previously for H.contortus and 
Drosophila membranes (Hejmadi et al., 2000; Smith et a/., 2000). Binding 
was determined by incubating varying concentrations of transfected COS 7 
cell membranes (5-40 pg) with 0.5 nM [3H] ivermectin for two hours at room 
temperature. No specific binding was apparent (n = 3).
5.1.1.3.2 Western Blotting
The technique of immunoblotting can be used to determine the presence and 
quantity of an antigen. Western blotting of transfected COS 7 cell 
membranes was attempted to reveal if transfection had been successful, 
resulting in HG2 protein expression in the host cells (figure 44). Protein of 
approximately the predicted molecular weight of HG2 (predicted to be ~ 46 
kDa) was detected in the HG2 transfected cells suggesting that HG2 protein 






Figure 44 Western blot analysis of HG2 transfected COS 7 cell membranes. Protein 
(20 jig) was electrophoresed through an SDS polyacrylamide gel and probed with 
an HG2 antibody (1/50 dilution)(designed to the HG2 intracellular loop and purified 
from rabbits by Virginia Portillo) before chemiluminescent detection. Membranes 
were also analysed from pcDNA3 transfected COS 7 cells. Lane 1: negative control 
protein. Lane 2: HG2 transfected COS 7 cells.
5.1.2Transient expression and analysis of HG3 in COS 7 cells
HG3 had previously been subcloned into the mammalian expression vector 
pcDNA3 (section 4.1.1.1) and this recombinant plasmid was used to transfect 
COS 7 cells. Cells were transfected and harvested as described for HG2.
5.1.2.1 Radioligand binding
Radiolabelled ivermectin was used to determine if HG3 forms part of the 
ivermectin-binding site. The C.elegans orthologue, gbr-2b, is included in the 
“alpha” subunit class of GluCI due to its relatively high level of homology to 
the other known alpha subunits (approx. 60%) (appendix 1) and its ability to 
form chloride channels that are gated by ivermectin (Dent et al., 2000). 
Binding was determined by incubating varying concentrations of transfected 
COS 7 cell membranes (5-40 jig) with 0.5 nM [3H] ivermectin for two hours at 
room temperature. Specific binding was easily measured to membrane 
preparations from COS 7 cells transfected with HG3 cDNA (figure 45). [3H] 
ivermectin did not specifically bind to COS 7 cells transfected with pcDNA3. 
Binding was approximately linear over the range of protein used. No ligand 
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Figure 45 [3H] ivermectin binding to membrane preparations from COS 7 cells 
transiently expressing HG3. Protein was incubated with 0.5 nM [3H] ivermectin in a 
final assay volume of 1 ml for two hours at room temperature. Non-specific binding 
was determined by incubation in the presence of 10 jaM unlabelled ivermectin. A 
shows total binding to membranes with g  = non-specific binding and g = specific 
binding. B shows specific binding, n = 3.
5.1.2.1.1 Saturation and competition analysis of [3H] ivermectin binding 
Ivermectin binds with high affinity to membranes from H.contortus L3-stage 
larvae (reported Kd < 1 nM) (Rohrer et al.,1994; Hejmadi et al., 2000) and
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saturation studies were attempted to ascertain if recombinant HG3 showed 
similar binding properties.
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Figure 46 Saturation of membranes from COS 7 cells transiently expressing HG3 
with [3H] ivermectin. Protein (10 fig) was incubated with various concentrations of 
[3H] ivermectin (1 pM -  1 nM) for 2 hours at room temperature. Non-specific binding 
was determined in the presence of 10 jiM unlabelled ivermectin. Inset is the 
Scatchard plot. Replica experiments were carried out on membranes from the same 
transfection, n = 4.
Specific high-affinity [3H] ivermectin binding was observed to membranes 
from HG3 transfected COS 7 cells (figure 46). This binding was saturable 
with a K<j of 70 +/- 16 pM and a Bmax of 1.6 +/- 0.1 pmol/mg. Variation in Bmax 
values between transfections was not significant.
Competition assays were also carried out, using various concentrations of 
unlabelled ivermectin to compete with [3H] ivermectin for the binding site 
(figure 47). This is an additional means of confirming the estimated Kd value. 
High-affinity specific binding was measured and fitted to a one-site model 
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Figure 47 Competition between [3H] ivermectin and unlabelled ivermectin for their 
binding sites on membranes from COS 7 cells transiently expressing HG3. Protein 
(10 pg) was incubated with 70 pM [3H] ivermectin and various concentrations of 
unlabelled ivermectin (100 fM -  100 nM) for 2 hours at room temperature, n = 3.
5.1.2.1.2 Pharmacology of [3H] ivermectin binding
There are no reported inhibitors of ivermectin binding in the literature except 
for other macrocyclic lactones and nodulisporic acid, a fungal product that 
binds with high affinity to insect, but not nematode, GluCI (Smith et al. 2000). 
Wide variation is seen between the macrocyclic lactones’ spectra of activity 
and this is conserved in their ability to bind to membrane preparations from 
C.elegans (Arena et al., 1995). The ability of a number of avermectin 
derivatives to compete for the ivermectin-binding site on COS 7 cell 
membranes expressing HG3 polypeptides was examined (figure 48). 
Structures are not shown due to intellectual property constraints.
All of the macrocylic lactones studied were able to compete for the 
ivermectin-binding site. Differences were observed in their binding affinities 
and none of them was as effective as ivermectin itself in this assay. Table 1 
shows Kj values for the avermectins. The rank order of affinity was ivermectin 
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Figure 48 Competition for [3H] ivermectin binding by different avermectins. P2 
membranes (10 pg) from COS 7 cells expressing HG3 were incubated with 140 pM 
[3H] ivermectin and various concentrations of each avermectin (100 fM -  1 |iM) for 2 
hours at room temperature. Competition with ivermectin (•), avm A (•), avm B (•), 
avm C (•), avm D ( ) and avm E (•) was studied, n = 3 for each ligand.
Cold ligand Ki Hill Number
Ivermectin 50 +/- 5 pM 0.7
Avm A 182 +/- 30 pM 1.2
Avm B 334 +/- 60 pM 0.7
Avm C 233 +/- 18 pM 0.9
Avm D 233 +/- 64 pM 0.5





Table 1 Affinity of various avermectins for the ivermectin-binding site of recombinant 
HG3 as measured by competition with [3H] ivermectin.
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The ivermectin-binding site was analysed with further competition assays 
(Table 1). Most of the ligands used had been shown to have some activity at 
C.elegans GluCI and/or interact with ivermectin. The amino acids glutamate 
and GABA (10 mM), picrotoxin (100 pM), a potent antagonist of vertebrate 
GABAa receptors and some GluCI receptors, and fipronil (100 pM), a
3
phenylpyrazole insecticide, did not compete with [ H] ivermectin binding (70 
pM) under these conditions.
5.1.3 Transient expression and analysis of HG4 in COS 7 cells
Delany (1998) had subcloned HG4 into the mammalian expression vector 
pcDNA3 and this recombinant plasmid was used to transfect COS 7 cells.
5.1.3.1 Analysis of expressed protein
5.1.3.1.1 Radioligand binding
The HG4 C.elegans orthologue, GluCip, forms channels that are gated by 
glutamate but not ivermectin (Cully et al., 1994). Radiolabelled ivermectin 
studies were undertaken on membranes prepared from COS 7 cells 
transfected with HG4 cDNA to determine if this pattern was conserved. 
Binding was determined by incubating varying concentrations of transfected 
COS 7 cell membranes (5-40 pg) with 0.5 nM [3H] ivermectin for two hours at 
room temperature. No specific binding could be detected (n = 3).
5.1.3.1.2 Immunofluorescence microscopy
Antibodies raised to a protein of interest can be used at the light microscopic 
level to detect and localise antigens within cells. Primary antibodies raised to 
HG4 (Delany, 1998) showed high non-specific binding to COS 7 cells, but an 
epitope-tagged form of HG4 cDNA (HG4pFLAG-CMVrM-5c) was available 
(produced by Virginia Portillo) and could be used with commercial antibodies 
for detection. COS 7 cells were transfected with the tagged recombinant HG4 
cDNA and expression was assessed by confocal microscopy (figure 49). 
Fluorescence was observed in HG4-flag transfected cells, but not in 
untransfected cells. A punctuate pattern of expression was observed in the 
cytoplasm. HG4 was not expressed at the plasma membrane.
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Figure 49 Expression of epitope-tagged HG4 in COS 7 cells. Forty eight hours after 
transfection, COS 7 cells were incubated with primary antibody (mouse anti-flag, 
1/300 dilution) and secondary antibody (FITC-conjugated anti mouse, 1/200 dilution) 
before viewing on a confocal microscope. Negative control samples were included in 
the form of untransfected COS 7 cells. Antigen was detected in HG4-flag transfected 
cells but not untransfected cells. A: untransfected cells. B: HG4-flag transfected 
cells.
5.1.4 Transient expression and analysis of HG5 in COS 7 cells
5.1.4.1 Subcloning HG5 cDNA for expression in mammalian cells
The GluCI subunit HG5 was originally cloned into the bacterial expression 
vector pCRBIunt (section 3.1.3.2), but expression in COS 7 cells required 
transfer into a mammalian expression vector. HG5 cDNA was removed from 
pCRBIunt and subcloned into the plasmid pcDNA3 (figure 50). The resulting 
colonies were checked for the presence of HG5 by restriction endonuclease 
digestion (figure 51). The observed band of approximately the size of HG5 
(1.45 kb) was purified and ligated with Kpn l/Xho I digested pcDNA3. 
Competent XL-1 blue cells were transformed with the ligated DNA (5 pi).
1 2 3
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Figure 50 Removal of HG5 cDNA from the plasmid pCRBIunt. The restriction 
enzymes Kpn I and Xho I (10 units each) in buffer 2 were used to cut the 
recombinant plasmid (5 jig) for 2 hours at 37°C. The digested DNA was 
electrophoresed through a 1% (w/v) agarose gel in TAE buffer before staining with 
ethidium bromide. Lane 1: 1 kb molecular weight marker. Lane 2: digested 
recombinant pCRBIunt. Lane 3: digested pcDNA3.
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Figure 51 Restriction endonuclease digestion of recombinant pcDNA3. Plasmid 
DNA (5 pg) was cut with the enzymes Xba I and Hind III (10 units each) in buffer 2 
for 2 hours at 37°C to verify successful subcloning of HG5 cDNA. Digested samples 
were run on a 1% (w/v) agarose gel in TBE buffer before staining with ethidium 
bromide. The presence of HG5 cDNA in the recombinant plasmid was confirmed as 
DNA bands of approximately 1.5 kb and 5.4 kb were apparent on the gel. Lane 1: 1 
kb molecular weight marker. Lane 2-3: digested recombinant pcDNA3.
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5.1.4.2 Radioligand binding
HG5 shows the highest identity to GluCla2 and the gbr-2 subunits 
(appendices 1 and 2). However, it does not appear to be orthologous with 
any of the C.elegans alpha subunits, as it is less similar to them than the Hc- 
gluclp (HG4) or Hc-gbr2 (HG2 and HG3) genes are to their orthologues. The 
alpha class of GluCI subunits form part of the C.elegans ivermectin binding 
site and it seemed interesting to investigate whether this novel gene played a 
role in the interaction with ivermectin in a parasitic nematode. Binding was 
determined by incubating varying concentrations of transfected COS 7 cell 
membranes (5-40 jag) with 0.5 nM [3H] ivermectin for two hours at room 
temperature. Specific binding to recombinant HG5 protein was measured and 
was approximately linear over the range of protein concentrations tested 
(figure 52). No ligand depletion was apparent and a concentration of 20 pg 
was used in all further experiments.
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Figure 52 [3H] ivermectin binding to membrane preparations from COS 7 cells 
transiently expressing HG5. Protein was incubated with 0.5 nM [3H] ivermectin in a 
final assay volume of 1 ml for two hours at room temperature. Non-specific binding 
was determined by incubation in the presence of 10 pM unlabelled ivermectin. A 
shows total binding to membranes with ^  = non-specific binding and y  = specific 
binding. B shows specific binding, n = 3.
5.1.4.2.1 Saturation and competition analysis of [3H] ivermectin binding
The observed binding to recombinant HG5 was characterised further, both 
for comparison with ivermectin binding to HG3 and to H.contortus 
membranes (figure 53). Specific high-affinity binding was measured to HG5 
transfected COS 7 cell membranes. This binding was saturable with a Kd of 
26 +/- 12 pM and a Bmax of 0.08 +/- 0.01 fmol/mg. Competition of unlabelled 
ivermectin for the ivermectin-binding site was determined as confimation of 
the calculated Kd (figure 54). High-affinity specific binding was observed and 
fitted to a one-site model with a Hill number of 0.98. The Kj was calculated as 
9 +/- 0.7 pM.
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Figure 53 Saturation of membranes from COS 7 cells transiently expressing HG5 
with [3H] ivermectin. Protein (15 pg) was incubated with various concentrations of 
[3H] ivermectin (1 pM -  1 nM) for 2 hours at room temperature. Non-specific binding 
was determined in the presence of 10 unlabelled ivermectin. Inset is the 
Scatchard plot, n = 3.
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Figure 54 Competition between [3H] ivermectin and unlabelled ivermectin for their 
binding sites on membranes from COS 7 cells transiently expressing HG5. Protein 
(15 jig) was incubated with 100 pM [3H] ivermectin and various concentrations of 
unlabelled ivermectin (100 fM -  100 nM) for 2 hours at room temperature, n = 3.
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5.1.4.2.2 Pharmacology of the recombinant HG5 ivermectin-binding site
The ability of a number of avermectin derivatives to compete for the 
ivermectin-binding site on COS 7 cell membranes transiently expressing HG5 
was examined (figure 55). This allowed further characterisation of the 
ivermectin-binding site and direct comparison with binding to HG3.
All avermectins studied competed with [3H] ivermectin binding, but with 
varying affinities. Ivermectin had the highest affinity for its binding site and 
the rank order was ivermectin > avm A = avm B > avm E > avm D > avm C. 
Kj values for competition studies with the avermectins on recombinant HG3 
and HG5 are shown in table 2. Differences are seen between the two 
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Figure 55 Competition for [3H]ivermectin binding by different avermectins. P2 
membranes (15 jig) from COS 7 cells expressing HG5 were incubated with 150 pM 
[3H] ivermectin and various concentrations of each avermectin (100 fM -  1 ^M) for 2 
hours at room temperature. Competition with ivermectin (•), avm A (•), avm B ( ), 
avm C (•), avm D (•) and avm E (•) was studied, n = 3 for each ligand.
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Cold ligand Ki HG5 Hill Number
Ivermectin 9 +/- 0.7 pM 1
Avm A 37 +/- 3 pM 1
Avm B 37 +/- 7 pM 1
Avm C 110+/-9  pM 0.58
Avm D 64 +/- 6 pM 0.64





Table 2 Affinity of various avermectins for the ivermectin-binding site of recombinant 
HG5 as measured by competition with [3H] ivermectin.
Ivermectin binding to recombinant HG5 was further characterised using 
ligands that had previously been described to have some interaction with 
ivermectin and/or the C.elegans GluCI. Glutamate, GABA (10 mM each), 
picrotoxin and fipronil (100 pM each) did not compete with [3H] ivermectin 
binding (150 pM) under these conditions (table 2).
5.1.5 Ivermectin binding to H.contortus membranes
The affinity of [3H] ivermectin binding to the recombinant H.contortus GluCI 
subunits was slightly higher than was reported in the literature for H.contortus 
L3 membrane preparations (0.16-0.6 nM) (Rohrer et a/., 1994; Hejmadi et al., 
2000). Research on larval membranes had been carried out under different 
experimental conditions. We examined the binding of ivermectin to P2 
membrane preparations from H.contortus L3 larvae under similar conditions 
to those used for experiments with the recombinant subunits (figure 56). 
Under these conditions, [3H] ivermectin bound to larval membranes with a Kd 
of 70 +/- 7 pM. Additional binding sites may be present that were not 
detected in these experiments. A comparison of [3H] ivermectin binding to 
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Figure 56 Saturation curve of [3H] ivermectin binding to P2 membranes from 
H.contortus L3 stage larvae. Protein (15 fig) was incubated with various 
concentrations of [3H] ivermectin (1 pM -  1 nM) for 2 hours at room temperature. 
Non-specific binding was determined by the presence of 10 pM unlabelled 
ivermectin. Inset is the Scatchard plot, n = 3.
Substrate Kd Ki
H.contortus L3 70 +/- 7 pM N.D.
HG2 No binding
HG3 70 +/- 16 pM 50 +/- 5 pM
HG4 No binding
HG5 26 +/- 12 pM 9 +/- 0.7 pM
Table 3 [3H] ivermectin binding to recombinant GluCI subunits and H.contortus L3 
larvae. N.D. not determined.
The highest affinity [3H]ivermectin binding was to recombinant HG5. 
Ivermectin had very similar affinity for L3 membranes and recombinant HG3.
5.2 Discussion
The four known glutamate-gated chloride channel subunits from H.contortus 
have been successfully expressed in a mammalian cell line. The subunits
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show differences in their pharmacology with respect to their interaction with 
ivermectin. No [3H] ivermectin binding was observed to cells transfected with 
HG2 or HG4, but western hybridisation and epitope-tagged confocal imaging 
respectively demonstrated that the subunit polypeptides were present. The 
lack of [3H] ivermectin binding to HG4 is not unexpected as its orthologue in 
C.elegans, GluCip, forms channels gated by L-glutamate but not ivermectin 
(Cully et al., 1994). The high sequence identity between these subunits is 
reflected in their pharmacology, at least in terms of ivermectin (appendix 1) 
(table 4). The C.elegans orthologues of HG3 and HG4 form channels gated 
by glutamate (Cully et al., 1994; Dent et al., 2000). Attempts to investigate 
the binding capacity of radiolabelled glutamate to HG3 and HG4 polypeptides 
were hampered by the low affinity of this ligand for the GluCI receptor 
(Hejmadi et al., 2000) and the ubiquity of glutamate and its binding sites 
within the host cell. This resulted in very high levels of non-specific binding. 
The alternatively spliced gene, gbr-2, appears to encode two subunits with 
different pharmacology. The HG2 polypeptide was expressed in transfected 
COS 7 cell membranes, but did not specifically bind [3H] ivermectin. In 
contrast, specific [3H] ivermectin binding was easily measured to the HG3 
variant. The H.contortus subunits HG2 and HG3 have clear orthologues in 
C.elegans, GBR-2A and GBR-2B, based on a very high level of sequence 
identity and conservation of alternative splicing (Laughton et al., 1997; 
Jagannathan et al., 1999). Gating of GBR-2B channels but not GBR-2A 
channels with ivermectin has recently been reported (Dent et al., 2000) 
suggesting that the interaction of these subunits with ivermectin is also 
conserved between species. The observed difference in ivermectin binding 
between the gbr-2 encoded polypeptides from both H.contortus and 
C.elegans is somewhat surprising as the N-terminal regions of the spliced 
variants, which are thought to contain most of the ligand binding sites, are 
identical. It is apparent that sequences in the C-terminal half of the GluCI 
receptor are important in the formation of the ivermectin-binding site 
The subunits HG3 and HG5 specifically bind [3H] ivermectin with very high 
affinity. Binding to both recombinant subunits was saturable and KdS were 
calculated as 70 +/- 16pM for HG3 and 26 +/-12 pM for HG5. These figures
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were supported by competition assays with unlabelled ivermectin as 
measured K j  values were very similar at 50 +/- 5 pM for HG3 and 9 +/- 0.7 
pM for HG5. Although ivermectin showed higher affinity for recombinant HG5 
than HG3, the quantity of bound radioligand (fmol/mg) was much lower to 
HG5 suggesting a reduced number of binding sites. Co-workers in the 
laboratory have identified HG5 expression both intracellularly and at the 
plasma membrane of transfected mammalian cells (Virginia Portillo, personal 
communication) and co-expression studies may result in enhanced transport 
of HG5 to the plasma membrane. It is possible that HG3 is able to form a 
functional receptor without the need for additional subunits. 
Electrophysiological investigations of C.elegans GluCI have intimated that 
only GluCI a-subunits form channels that are gated by ivermectin. Table 4 
illustrates the pharmacology of the known GluCI subunits from H.contortus 
and C.elegans. Channels formed by the C.elegans p-subunit are gated by L- 
glutamate and require co-expression with an a-subunit for ivermectin 
activation (Cully et al., 1994). Horoszok et al. (in press) report the formation 
of an ivermectin- and glutamate-sensitive channel on expression of the GluCI 
subunit GLC-3 in Xenopus laevis oocytes. This subunit shows highest 
identity to GluCla2 (66%), which also forms channels gated by both 
ivermectin and glutamate (Vassilatis et al., 1997). The C.elegans gbr-2 (avr- 
14) encoded subunits are also suggested to be a-subunits due to the gating 
of GBR-2B channels by ivermectin and the high identity of both variants to 
the other alpha subunits (appendix 1). GBR-2A is apparently the only 
C.elegans a-subunit that does not possess an ivermectin binding site. HG5 
does not have a clear orthologue in C.elegans (appendices 1 and 5), 
although it has high sequence identity to glucla2 and is most similar to the 
gbr-2 genes of both C.elegans and H.contortus. If this is coupled with its 
ivermectin-binding capacity, the inclusion of HG5 in the a class of GluCI 
subunits, as suggested by Forrester et al. (1999), is not unreasonable. The 
ability to interact with ivermectin is therefore proposed as a distinguishing 
feature of GluCI a-subunits from both free-living and parasitic nematodes. 
Analysis of the ivermectin-binding site of H.contortus L3 larvae was repeated 
under the conditions used for ivermectin binding to the recombinant subunits
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for direct comparison. The affinity of [3H] ivermectin binding to L3 membranes 
(70 +/- 7 pM) was higher under these conditions than had originally been 
reported (0.16-0.6 nM) (Rohrer et al., 1994; Hejmadi et al., 2000) and was 
very similar to that measured for recombinant HG3 (table 2). Reports that 
HG5 is predominantly expressed in adult H.contortus (Forrester et al., 1999); 
and the apparent lack of further a-subunits in this species, allow supposition 
that HG3 represents the major ivermectin-binding site in the free-living larval 
stages and that this is reflected in the similar affinity of ivermectin for larval 
membranes. Recently it was reported that the K<j of [35S] sulphonamide- 
ivermectin binding to C.elegans membranes could be modelled at 3 pM, but 
that the GBR-2 (AVR-14) subunits contributed a relatively small proportion of 
the total binding (Dent et al., 2000). It is clear that the drug binds with very 
high affinity to the native nematode receptor, but it is possible that the 
importance of the individual subunits to the overall binding may differ 
between species and/or at different stages of the life cycle. It would be 
interesting to assess the ivermectin-binding site of the other stages of the 
H.contortus life cycle to determine any changes in affinity which may 
represent the dominance of alternative subunits, but it is not as simple to 
isolate the large quantities of membrane required for these experiments from 
adults or eggs; isolation of adult H.contortus would require the sacrifice of a 
number of hosts.
The interaction of the amino acids L-glutamate and GABA with the 
ivermectin-binding site was investigated. Ivermectin has low affinity for 
nematode (Holden-Dye et al., 1988; Holden-Dye and Walker, 1990) and 
mammalian (GABAa) GABA receptors (Pong and Wang, 1980; Sigel and 
Baur, 1987; Adelsberger et al., 2000) but GABA does not activate GluCI 
(Dent et al., 1997; Cully et al., 1996; Horoszok, et al., in press).L-glutamate 
gates native and some recombinant nematode GluCI channels and 
ivermectin potentiates the glutamate response (Arena et al., 1992; Martin, 
1995; Cully etal., 1994; Dent etal., 1997; Vassilatis et al., 1997; Dent et al., 
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Does not bind 
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C27H5.5 Does not form 
functional channels 
(Cully etal., 1996)
Table 4 Pharmacology of C.elegans and H.contortus GluCI subunits
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ivermectin-binding site under these conditions at concentrations up to 10 
mM.
The plant-derived convulsant, picrotoxin, blocks most C.elegans recombinant 
GluCI subunits (Arena et al., 1991; Arena et al., 1992; Cully etal., 1994) and 
its binding site has been localised by point mutation to the second 
transmembrane region (Etter et al., 1999). The position of the ivermectin- 
binding site is not known, but HG2/HG3 binding data indicates that it may be 
in the C-terminal half of the receptor. Interactions between these two ligands 
were assessed. Picrotoxin did not block channels formed by the C.elegans 
GluCI subunit GLC-3, but fipronil, an insecticide which blocks GABA-gated 
chloride channels (Bloomquist, 1996) showed dose-dependent inhibition of 
the response to L-glutamate. A point mutation in the TM2 of the Drosophila 
GABA receptor subunit, RDL, has been shown to reduce fipronil potency 
(Hosie et al., 1995). Neither of these ligands competed with [3H] ivermectin 
for its binding site on recombinant HG3 and HG5. It is evident from these 
results that these four ligands either do not interact with these GluCI 
subunits, or that they have a different binding site to ivermectin. 
Electrophysiological studies would help to resolve this matter.
The success of the avermectin and milbemycin class of anthelmintics is 
shown by their financial dominance of the market (Witty, 1999). The vast cost 
of discovering new anthelmintics coupled with the triumph of the avermectins 
currently in use has made the development of avermectin analogues the 
most lucrative commercial prospect. The interaction of a number of 
avermectins with their biologically relevant site of action has been studied in 
C.elegans and binding, electrophysiology and nematocidal activity correlate 
well (Arena et al., 1995). The capability of five structural analogues of 
ivermectin to compete for the ivermectin-binding site of recombinant 
H.contortus GluCI subunits was analysed. All compounds tested competed 
with [3H]ivermectin for its binding site. Varying levels of affinity were 
measured and none was as effective as ivermectin on either recombinant 
HG3 or HG5. All of the avermectins showed higher affinity for COS 7 cell 
membranes expressing the HG5 polypeptide and differences in the rank 
order of affinity were observed between the two subunits. This suggests that 
there are differences in the composition of the ivermectin-binding site
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between subunits. Differences in Hill coefficients were also observed 
between avermectins. This suggests that allosteric modulation, whereby 
binding of a molecule alters the conformation of a receptor and its binding 
sites and therefore the binding parameters of a second molecule, of 
receptors by these compounds may be present. As discussed, [3H]ivermectin 
shows very similar affinity for H.contortus L3 membranes and recombinant 
HG3 implying that this subunit may be a major constituent of the binding site 
in this stage of the life cycle. It would be interesting to compare the ability of 
these avermectin derivatives to compete for the native ivermectin-binding site 
with the results shown for HG3 and HG5.
The efficacy and spectra of activity of the avermectins shows wide variation 
and it is probable that metabolism of the drugs by the nematode impacts on 
their efficacy in vivo. In C.elegans, metabolism of the avermectins does not 
seem to destroy the correlation between their biological activity and their 
action at the recombinant GluCI subunits (Arena et al., 1995), but this may 
not be the case with all nematodes. An additional element is introduced when 
the interaction of anthelmintics with parasitic nematodes is considered. Host 
metabolism of the avermectins has been studied and it is apparent that the 
majority of the drug is excreted, largely unchanged, in the bile or faeces 
(Steel, 1993; McKellar and Benchaoui, 1996). The formulation, route of 
administration and bioavailability of avermectins will also have an impact on 
anthelmintic activity in the host.
Studies to ascertain the in vitro nematocidal activity of these compounds on 
H.contortus could be undertaken and compared with their effects on the 
recombinant GluCI subunits to discover if the results obtained in this research 
are indicative of the potency of these avermectins against H.contortus. This 
investigation may also demonstrate which subunits predominate in each life 
cycle stage. Gill and Lacey (1998) found differences in the major effect of 
ivermectin depending on whether in vivo or in vitro analysis was used. It is 
probable that the in vivo situation will differ to some extent from experiments 
on individual recombinant subunits and the data presented here does not 
reflect clinical usefulness. Data pertaining to the activity of these avermectins 
against H.contortus in their host would be an interesting comparison with the 
research on recombinant GluCI subunits.
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The similarity of the GluCI to the other members of the cys-loop ligand-gated 
ion channel superfamily (cLGIC) predicts that the native receptor will be 
heteromeric. Interactions between co-expressed subunits are observed in 
other cLGIC both in terms of their synthesis and ligand-binding site (Gorrie et 
al., 1997; Taylor et al., 2000; Miles and Huganir, 1998; Blount et al., 1990; 
Gu et al., 1991; Saedi et al., 1991). It is probable that all GluCI receptor 
subunits play some role in the native receptor and that their co-expression 
may result in different pharmacology; as is seen with the C.elegans GluCIa 
and -p subunits (Cully et al., 1994; Vassilatis et al., 1997). Localisation 
studies have supported the hypothesis of a heteromeric native receptor in 
both C.elegans and H.contortus. The pattern of expression of the C.elegans 
subunits GluCla2 and GluClp is similar, with both being expressed in the 
pharyngeal muscle pm4 (Laughton et al., 1997; Dent et al., 1997). These 
subunits co-assemble to form channels gated by both ivermectin and 
glutamate (Vassilatis et al., 1997). Antibodies have localised the expression 
of the H.contortus HG4 and HG5 polypeptides to the motor neuron 
commissures from both the ventral and dorsal nerve cords (Delany et al., 
1997; Portillo et al., 2000). The expression pattern of these subunits is 
identical to the non-pharyngeal regions inhibited by the avermectins, 
suggesting that they may co-assemble to form the target of these drugs 
(Geary et al., 1993). It is possible that HG2 and HG4 require co-expression 
with other GluCI subunits for the formation of a functional receptor. The 
reduced number of binding sites in COS 7 cell membranes expressing 
recombinant HG5, as opposed to HG3, may be indicative of a requirement 
for co-expression with additional GluCI subunits; co-localisation studies 
highlight HG4 as the probable candidate. Electrophysiological investigations 
would be useful to determine if functional receptors are formed by each of the 
cloned H.contortus GluCI subunits and if co-assembly alters their channel 
properties. Comparison of the genes encoding GluCI in C.elegans and 
H.contortus suggests that further GluCI subunits may be present in 
H.contortus. Studies contrasting the pharmacology of known GluCI subunits 
with the native receptor may result in the identification of novel polypeptides.
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6. Conclusions
This research aimed to assess the pharmacology of the glutamate-gated 
chloride channel receptor subunits from the parasitic nematode 
Haemonchus contortus with respect to the anthelmintic ivermectin. Prior to 
this study, two of the four known GluCI subunits from H.contortus were 
available as full-length cDNAs. HG2 and HG5 cDNAs were therefore RT- 
PCR amplified to allow in vitro analysis of the interaction of all four GluCI 
subunits with ivermectin. Gene transfer into mammalian cells allowed 
analysis of protein expression and radiolabelled ivermectin was used to 
study its binding site. This was the first study to demonstrate an interaction 
between recombinant GluCI from parasitic nematodes and ivermectin. The 
involvement of HG5 cDNA in ivermectin resistance was also assessed.
•  No coding differences were apparent between HG5 cDNA from the 
ivermectin-resistant White River II H.contortus field isolate (IVR) 
and HG5 cDNA from an ivermectin-sensitive H.contortus isolate 
(IVS). Amplification of this subunit was more difficult from IVR and 
only achieved from adults, which have the highest levels of HG5 
expression in IVS (Forrester et al., 1999). It is possible that HG5 is 
down regulated as part of the ivermectin-resistance mechanism.
•  Stable expression of the GluCI subunits in a mammalian cell line is 
very problematic. Following selection for integration of 
recombinant HG3 and HG4 into the host cell genome, subunit 
mRNA, but not protein, was detected.
• Transient expression of GluCI subunits in the COS 7 cell line 
resulted in high affinity ivermectin binding to recombinant HG3 and 
HG5. HG2 and HG4 polypeptides did not bind ivermectin.
• The affinity of ivermectin for recombinant HG3 and membrane 
preparations from H.contortus L3 larvae is very similar. HG5 is 
differentially expressed with maximal expression in the adult stage
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(Forrester et al., 1999). HG3 may be the major component of the 
ivermectin-binding site in L3 larvae.
•  The ivermectin-binding capacity and alternative splicing of 
orthologous GluCI subunits from parasitic and free-living 
nematodes appear to be conserved, but differences in the number 
and importance of the individual subunits to the overall binding 
between species and/or at different stages of the life-cycle are 
probable.
• All avermectins tested competed for the ivermectin-binding site of 
recombinant H G 3  and H G 5  with high affinity ( K j  <  0 . 5  nM), though 
none was as effective as ivermectin itself. All compounds showed 
higher affinity for H G 5  than H G 3  and differences were observed in 
the rank order of affinity for the two subunits suggesting variation 
in the composition of the ivermectin-binding site.
• GABA, glutamate, fipronil and picrotoxin did not compete for the 
ivermectin-binding site on either recombinant GluCI subunit. 
These ligands either do not bind to these polypeptides or they 
have a different binding-site to ivermectin.
It is probable that native GluCI receptors are heteromeric and that the co- 
expression of subunits will alter the observed pharmacology. Future work 
should include electrophysiological or fluorescent chloride imaging 
investigations to investigate the co-expression of subunits, to ascertain 
whether functional receptors are formed by the individual subunits and to 
allow the pharmacological profile to be extended. Further binding studies 
could incorporate adult and egg H.contortus membranes to look for 
correlations between ivermectin receptor affinity for recombinant GluCI 
subunits and each life cycle stage. Comparison of the avermectin profile 
demonstrated in this study with the potency of the same avermectins against 
H.contortus both in culture and in the host may yield further information with 
regard to the clinical usefulness of such research.
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Appendix 1
Amino acid identities of GluCI receptor subunits (%)
GluCI
P














80 48 47 46 48 57 43 39 45 47 47 50 44
HG4 48 47 45 48 53 43 38 47 46 46 47 42
Gbr2a 79 79 74 81 62 41 57 57 57 60 52
Gbr2b 72 87 88 57 40 54 54 55 58 50
HG2 75 81 55 37 52 53 54 55 45
HG3 88 56 40 54 55 55 59 49
GluCI
X
66 55 63 63 68 68 55
HG5 44 56 65 55 53 48
C27h5
.5
38 38 38 40 37
GluCI
a1








Key: H.contortus C.elegans O.volvulus D.immitis
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Appendix 2
Map of pCRBIunt II TOPO vector
« 1 S ^  € jc Jjo.ufcfaoj






Map of pBluescript II vector
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RT-PCR and sequencing primer sequences and melting temperatures
Primer Sequence Calculated Tm °C
5HG2full 5’ GCATGCGCAATTCC 
GTCCCTC 3’
55
3HG2full 5’ GCTTCACATCAAGTA 
GACAGCC 3’
52
5HG5ful! 5’ GACACTAATGTTCG 
CCTTAATTCTGC 3’
53
3HG5full 5’ TCATTCCAACTGCG 
CTTGbAC 3’
50
M13 forward 5’ GTAAAACGACGGCC 
AG 3’
50
M13 reverse 5’ CAGGAAACAGCTAT 
GAC 3’
50
HG2seq 5’ CGCCAGACATACGC 
CAATC 3’
53
5HG5seq 5’ GATATCGATACTCC 
GAACAT 3’
48
3HG5seq 5’ CT G ACGTAC AATT AC 
CGGTT 3’
50
5IVRseq 5’ CGATTATCCGCTTGA 
TGTACAGAC 3’
56
3IVRseq 5’ CATCCGTATTCTAT 
GTCTTTCG 3’
51
5HG3part 5’ AGTTGTGCTCGGGT 
CAAACTTC 3’
55
3HG3part 5’ ATACGCATTTCGACC 
CAACATATC 3’
54
5HG4part 5’ GTCATAGCGGCCGC 
GAT CTT GAAT GT CACAGT 
ATA 3’
65
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Appendix 6
Map of the mammalian expression vector pcDNA3
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There is an ATG upstream 
of the Xba I site. Bsml
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AM Avermecti ns/M il bemyci ns
bp base pairs
B.C. Biological Control
BSA Bovine Serum Albumin
CMV Cytomegalovirus
cDNA Copy Deoxyribonucleic acid
DEPC diethyl pyrocarbonate
DIG Digoxygenin





DYT Double Yeast Tryptone
EDTA Ethylenediaminetetracetic acid
EMBL European Molecular Biology Laboratory
FBS Foetal Bovine Serum
FITC Fluorescein isothiocyanate
GABA y-aminobutyric acid
GFP Green Fluorescent Protein
GluCI Glutamate-gated chloride channel receptor






LGIC Ligand-gated ion Channel
MEM Minimal Essential Medium
MOPS (N-morpholino)propanesulfonic acid
mRNA messanger ribonucleic acid
nAChR nicotinic Acetylcholine receptor
O.D. Optical Density
PBS Phosphate-buffered saline
PCR Polymerase Chain Reaction
PMSF (4-bromo) phenylmethylsuphonyl fluoride
Pwo Pyrococcus wosei
RACE Rapid Amplification of cDNA Ends




SDS Sodium Dodecyl Sulphate
Taq Thermus aquaticus
TAE Tris Acetate EDTA
TBE Tris Borate EDTA
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